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INTRODUCTION
The purpose of this thesis is to describe the treatment trajectory after osseointegration 
implant surgery and examine the potential health benefits of a bone-anchored prosthesis 
in previous socket-suspended prosthesis users with a lower extremity amputation. This 
introduction outlines the epidemiology of lower extremity amputation and the origin of bone-
anchored prostheses including the prevalence and the (contra-)indication. Furthermore, it 
describes the lack of evidence regarding the functional outcomes of osseointegration implant 
surgery and following rehabilitation, and the absence of consensus about outcome measures 
used to evaluate the treatment. The International Classification of Functioning, Disability and 
Health (ICF) framework is used to categorise the outcome measures described in this thesis. 
Thereafter, it specifies the gap of knowledge in a) body functions and structures, b) activities, 
c) participation, d) quality of life, e) patient satisfaction, and outlines the outcomes that are 
potentially positively influenced by bone-anchored prosthetic use. Finally, it introduces the 
aims of the various chapters of this thesis.
EPIDEMIOLOGY
A recent global overview of the epidemiology of lower extremity amputation specified per 
etiology is missing in the literature. In 2003, Ephraim et al.1 reported that the incidence of 
dysvascular amputations ranged from 1.0 to 32.0 per 100,000 persons2,3, trauma-related 
amputations ranged from 1.4 to 3.0 per 100,000 persons4,5 and tumour-related amputations 
was 0.8 per 100,000 persons.6 More recent systematic reviews7,8 related to this topic focused 
on specific subpopulations such as the diabetic population and therefore it remains unclear 
what the current world wide incidence is of lower extremity amputation specified per 
etiology. Both globally1,7,9 and within countries1,10, there is a large variability in amputation 
incidence. Possible causes for this variability are: generic differences in local healthcare 
delivery10, ethnicity1,7,10, social deprivation7, the presence of diabetes1,7,8, and socio-political 
circumstances.11,12 Although an up-to-date overview per etiology is missing it is clear that 
lower extremity amputation due to a vascular disease is the most common cause for limb 
loss in developed countries, ranging from 51% to 93%.9 It is likely that the incidence of 
dysvascular amputations will increase in the future due to the increase in the prevalence of 
obesity and diabetes.13 The incidence of non-vascular lower extremity amputations is low, but 
the prevalence is high because this kind of amputation most frequently occurs in adolescents 
and adults below the age of 45 years.13 In the United States, for example, the incidence of 
trauma-related amputations is 16%, while trauma accounts for 45% of the prevalent cases 
with an extremity amputation.13
Rates of prosthetic fitting after a lower extremity amputation vary from 48% to 95%.14-22 
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A successful prosthetic fitting seems more common in persons with a trauma-related 
amputation18 and persons who received post-acute care in a rehabilitation centre.14,21 Between 
34% and 63% of the prosthetic users have chronic skin problems and pain associated with 
the socket.23-28 These problems often have a severe impact on quality of life (QoL) related 
to problems at body function or structures (e.g. limited prosthesis use) and activity level 
(mobility restrictions) with as consequence limitations in participation.15,23,25,29,30
BONE-ANCHORED PROSTHESES
Bone-anchored prostheses using a transcutaneous osseointegration implant might be a 
solution for socket-suspended prostheses users suffering from socket-related problems.31-33 
The term ‘osseointegration’ was introduced by the Swedish Professor P.I. Brånemark and 
has its origin in the Latin words ‘os’ meaning ‘bone’ and the word ‘integrate’ which can be 
interpreted as ‘unify’ or ‘interactive coexistence’.34 During a blood flow experiment with 
rabbits in 1952, Professor P.I. Brånemark discovered by accident that bone integrated in 
titanium implant chambers and that this resulted in a strong anchorage.35,36 This coincidental 
finding set the basis for development of a screw-shaped titanium implant to attach a dental 
prosthesis to the jawbone in 1965.36,37 In 1977, an osseointegation implant was first applied 
to attach a bone-anchored hearing device.35,36 Dr. R. Brånemark, the son of Professor P.I. 
Brånemark, developed a osseointegration implant for intramedullary use and started in 1990 
to use titanium osseointegation implants for the attachment of bone-anchored prostheses in 
persons with an extremity amputation (Sweden, Gothenburg).36,37 The screw-shaped titanium 
implant (OPRA: Ossseointegrated Prostheses for the Rehabilitation of Amputees) is implanted 
in a two-stage surgery followed by a standardised rehabilitation programme of 6 months.37,38 
In the first surgery the screw-shaped titanium implant is inserted in the residual bone and left 
unloaded for six months so that bone ingrowth can occur. In the second surgery the muscle 
endings are sutured to the periosteum 5–10mm proximal to the bone. The distal skin flap 
is trimmed of subcutaneous fat and attached to the end of the bone. Then, a penetration 
through the skin is made and a titanium abutment is attached to the distal end of the implant 
(Figure 1).37 The total treatment period is approximately 12 months.37 Recently, attempts 
have been made to speed up the surgical protocol by opting for an interlude of 6 weeks 
between the surgeries, but results have not yet been published.39
In 1999, a press-fit cobalt-chromium-molybdenum osseointegration implant was 
introduced by Dr. H. Aschoff and Dr. H Grundei in Germany (Lübeck).40,41 This implant (EEFP: 
Endo-Exo Femoral Prosthesis, currently known as ILP: Integrated Leg Prosthesis)42 is also 
implanted in two surgeries, however the time between two surgeries is only six weeks. In 
the first surgery a cementless stem is press-fit inserted into the intramedullary canal. A 
reduction of the soft tissue is performed and the dorsal and ventral muscle groups of the 
thigh are connected to the distal femoral cortex with sutures to construct a myodesis. In the 
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second surgery a soft tissue stoma is created by cutting a circular skin incision after which a 
transcutaneous adapter (dual-cone) is attached into the intramedullary stem (Figure 2).41,43 
The design of the ILP implant changed a couple of times over the years in an attempt to 
solve the high rate of soft tissue infections (Figure 3).42,44 The model designed in 2009 (type 
C) received an update (type D) in 2015 after a change in manufacturer. The ILP type D is 
currently still used in Germany.45 The ILP type C implant was introduced in the Netherlands 
Figure 1. OPRA osseointegration implant
A: X-ray of the OPRA implant system; B: 
Schematic image of the OPRA implant system, 
1) bone, 2) skin, 3) intramedullary fixture, 2) 
abutment, 3) abutment screw. C: Abutment 
penetrating through the distal skin flap; D: 
Exploded view of the OPRA implant system, 
1) intramedullary fixture, 2) abutment, 3) 
abutment screw. Image A is printed with 
courtesy of Leiden University Medical Centre, 
the Netherlands. Source image B and D: 
Integrum AB, Götenborg, Sweden. Image 
C is printed with permission of Sahlgrenska 
University Hospital Gothenburg, Sweden.
Figure 2. ILP osseointegration implant
A: X-ray of a bone-anchored prostheses 
using the ILP osseointegration implant; B: 
Schematic image of the ILP implant system, 
1) intramedullary stem, 2) soft tissue stoma, 
3) Morse taper, 4) dual-cone adapter, 5) male 
part of the knee connecting adapter; C: X-ray 
of the ILP implant system. Images are printed 
with courtesy of Dr. H. Aschoff.
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(Nijmegen) in 200930 and in Australia (Sydney) in 2010.46 In 2013 a press-fit implant of titanium 
alloy (OPL: Osseointegrated Prosthetic Limb) was introduced in Australia47 and since 2015 the 
OPL implant is also used in the Netherlands (Figure 4).48 The preference for the OPL implant 
over the ILP implant was due to breakage of some of the intramedullary ILP stems.48 The 
OPL implant was hypothesised to have a lower failure rate than the ILP because it is made of 
forged titanium instead of moulded cobalt-chromium-molybdenum.48 Several studies30,40,41,49 
reported that the press-fit implant, both the ILP and OPL, could be loaded within 2 weeks 
after the second surgery. The briefly described rehabilitation programmes for persons with 
a press-fit osseointegration implant ranged from 4 to 14 weeks.30,43,49 This implies a total 
treatment period of 12 to 22 weeks for a press-fit implant, which is much shorter that the 
described treatment time for the screw implant. Recently, a study protocol for single-stage 
surgery of the OPL implant was published which hypothetically will decrease the treatment 
time even further to 3 to 6 weeks as suggested by the authors.50
Figure 3. Design change of the ILP osseointegration implant
A: ILP type 1. Both the intramedullary region and the subdermal region was covered with 
rough “spongiosa metal” to enhance osseointegration and ingrowth. The bone-stabilising 
bracket aimed to improve the fatigue properties of the implant; B: ILP type 2 with a bracket 
(although smaller than that of type 1), the rough metal on the subdermal region was removed; 
C: ILP type 2 without a bracket; D: ILP type 3. Revised connection intramedullary stem, dual-
cone adapter, and knee connecting adapter; E) ILP type 4. The currently used model; F: 
Exploded view of ILP type 3. 1) final propeller screw, 2) distal part of the male part of the knee 
connecting adapter, 3) screw to fixate the dual-cone in the intramedullary stem, 4) proximal 
part of the male part of the knee connecting adapter, 5) dual-cone adapter including anti-
rotation safety pin (‘weak-point’), 6) intramedullary stem, 7) provisional screw. Images are 
printed with courtesy of Dr. H. Aschoff.
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The exact prevalence of persons with a bone-anchored prosthesis using a transcutaneous 
osseointegration implant is unknown. A global registry for osseointegration implantation 
is lacking and not all centres performing osseointegration implant surgery are publishing 
their results.38,51 There are four prominent centres in the world who perform the majority 
of the osseointegration implant surgeries: 1) Sweden (Gothenburg), 2) Germany (Lübeck), 
3) the Netherlands (Nijmegen) and 4) Australia (Sydney). A rough estimate based on various 
conferences (e.g. ISPO World May 2017 and OT World May 2018) shows that approximately 
1000 persons with a lower extremity amputation received an osseointegration implant 
of which 25% a screw-type and 75% a press-fit type. Bone-anchored prostheses are 
predominately prescribed for persons with a transfemoral amputation.32 OPRA, ILP and OPL 
are currently the only commercially available osseointegration implants for attachment of 
Figure 4. OPL osseointegration implant
A: Assembled OPL implant system; B: X-ray of the Intramedullary stem immediately post-
operatively; C: X-ray of the osseointegrated implant at the 2-year follow-up; D: Bi-lateral 
transfemoral bone-anchored prosthesis user; E: Soft-tissue stoma; F) Exploded view of the OPL 
implant system. 1) intramedullary stem, 2) dual-cone adapter including anti-rotation safety 
pin (‘weak-point’), 3) screw to fixate the dual-cone in the intramedullary stem, 4) male part of 
the knee connecting adapter, 5) final screw. Source Images A and F: Pro-Motion Medical B.V., 
Zwijndrecht, the Netherlands.
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a bone-anchored prosthesis, but a number of other systems are currently developed.51 A 
percutaneous version of the COMPRESS system is the only implant with published results of 
use in a cohort of human subjects (n= 11).52 The COMPRESS system is neither a screw nor 
a press-fit osseointegration implant but is fixated in the intramedullary canal by transverse 
pins.51,52 Another development is the use of patient-specific press-fit implants for persons 
with a short femoral remnant or persons with a transtibial amputation (Figure 5).48,53,54
ELIGIBILITY CRITERIA FOR OSSEOINTEGRATION  
IMPLANT SURGERY
Up to 2014, persons with a primary amputation due to a vascular disease with or 
without diabetes were excluded for osseointegration implant surgery, regardless the 
type of osseointegration implant.30,37,49,55 This policy was based on the assumption that 
osseointegration implant surgery was associated with a risk of osteitis or osteomyelitis.48 
Other universal exclusion criteria were: treatment with specific drugs (e.g. chemotherapy, 
immunosuppression), a growing/immature skeleton, previous radiotherapy to the affected 
residual limb, pregnancy, non-compliant behaviour and the presence of disabling cognitive 
or psychiatric disorders. A recent safety evaluation among a cohort of non-vascular patients 
revealed that severe infections resulting in septic implant loosening were rare. Since 2014, 
persons with a primary amputation due to a vascular disease with or without diabetes are 
eligible for osseointegration implant surgery in the Netherlands if the vascular status of the 
residual limb is sufficient.48 A small case-series of persons with a transtibial amputation due 
to a vascular disease revealed no osteitis, osteomyelitis or implant failure within the first 
year after implantation of a press-fit osseointegration implant.56 Future research is needed to 
show whether an osseointegration implant is a feasible alternative for the socket-suspended 
prosthesis in persons with a lower extremity amputation due to a vascular disease.
Figure 5. Patient-specific press-fit implants
Left: transfemoral amputation; Right: transtibial amputation
A: Pre-operative situation; B: design of a 3D printed titanium implant; C: Post-operative 
situation
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OUTCOMES
Given that bone-anchored prostheses are around for almost 30 years, it is quite remarkable 
that the number of (longitudinal) studies evaluating functional outcome is limited.31-33 Persons 
who opt for a bone-anchored-prosthesis face an intensive trajectory including surgery and 
rehabilitation, and are at risk for a number of adverse events including infection, (a)septic 
loosening of the implant and breakage of the implant. To be able to make a well-informed 
choice as a patient, but also as a health-care professional or a (health insurance) policy maker, 
an overview of the potential functional benefits of bone-anchored prostheses compared 
to socket-suspended prostheses is essential. To date, the direct costs of bone-anchored 
prosthesis (including the surgical treatment and treatment of adverse events) are higher 
compared to socket-suspended prosthesis.57-60 In order to compensate for these higher direct 
costs, better functional outcomes are a prerequisite.
Functional outcome is a broad term and includes various constructs including quality of 
life which is important for cost-effectiveness analysis because it enables the calculation of 
quality adjusted life-years (QALYs).57,60 Constructs that are described by multiple research 
groups engaged in bone-anchored prostheses are e.g. prosthesis wearing time30,61, mobility 
level30,49,61, walking ability30,49 and quality of life.30,49,61 Despite some overlap in outcome 
measures a core-set of outcome measures is lacking within the literature that evaluates 
bone-anchored prosthesis use compared to socket-suspended prosthesis use. Also within 
the general field of lower extremity prosthetics there is a lack of consensus about a core-set 
of outcome measures62, even though attempts have been made to reach a consensus.63
The ICF framework of the World Health Organisation (WHO) can be used to ensure that 
all important domains are covered within a core-set of outcome measures.64 This framework 
provides a universal classification of human functioning and disability, and as such, 
provides a common language for describing health and health-related status,64,65 facilitating 
multidisciplinary responsibility, coordination and evaluation of rehabilitation interventions.65,66 
The ICF framework consists of two parts (Figure 6).64,67 Part 1 covers function and disability, 
and includes the categories: a) body functions and structures, b) activities and c) participation. 
Part 2 covers the contextual factors and includes the categories: a) environmental factors, 
and b) personal factors. Ideally the various constructs are measured by patient-reported 
measures, performance tests and monitoring in daily life because they measure different 
aspects of the construct and may vary in responsiveness.68,69 
For this thesis we decided to present quality of life and satisfaction level as separate 
constructs parallel to categories of part 1 of the ICF framework which was used to categorise 
the other outcome measures presented in this thesis.
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GAP OF KNOWLEDGE
Outcome measures that measure common problems of socket-suspended prosthesis users 
are important in the evaluation of the added value of bone-anchored prostheses. It is well 
known that the symmetry in spatio-temporal, kinematic and kinetic parameters during gait 
is reduced in socket-suspended prosthesis users compared to able-bodied persons.70-73 A 
poor socket fit is associated with gait asymmetry, both in persons with a transtibial74-76 and a 
transfemoral amputation.73 In the latter group an abduction position of the femoral remnant, 
instead of a normal anatomical adduction position, is common despite optimised socket 
designs and alignment.77 An abduction position of the femoral remnant results in an active 
insufficiency of the abductor muscles.78 In addition to socket fitting problems, decreased 
hip abductor strength73,79,80 and changed muscle activity patterns81 may be a possible cause 
for gait asymmetry. Hip abductor muscle strength is lower in the residual limb in persons 
with a transfemoral amputation compared to the sound side and to healthy subjects.78,82,83 
Muscle strength weakness of the thigh is associated with the presence of muscle atrophy.84,85 
Muscle atrophy is present in the residual limb, and can be as high as 73%, despite the almost 
continuous activation of the hip muscles during gait, which presumably is needed to stabilise 
the residual limb in the socket and to stabilise the pelvis.81,86-88 Gait asymmetry, specifically in 
the coronal89-91 and sagittal plane90, are considered to be associated with back pain, a common 
Figure 6. The International Classification of Functioning, Disability and Health (ICF) framework of 
the World Health Organisation (WHO)
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secondary disability in socket-suspended prosthesis users.92 The prevalence of back pain is 
high (52-84%) in patients with a lower extremity amputation using a socket prosthesis.93-96 
Both, socket-related problems and back pain can lead to limited prosthetic use23,93, activity 
level23,93, participation level23,93, and reduced health-related quality of life (HRQoL).23,25
It might be hypothesised that a bone-anchored prosthesis may decrease several of the 
above described problems of socket-suspended prosthesis users. First, it will solve the 
chronic skin problems related to the use of a socket and the fitting problems caused by 
volume changes of the residual limb, but it is unknown what the prevalence and intensity of 
stump pain is of bone-anchored prosthesis users. Reactivation of the residual limb muscles, 
the presence of a soft tissue stoma and re-use of the hip joint for weight bearing can cause 
stump pain in bone-anchored prosthesis users.32,38,97 The level of satisfaction experienced 
by the patient with respect to their prosthesis will be influenced by these aspects. Research 
on the level of satisfaction is scarce.98 Second, recovery of hip abductor strength may be 
hypothesised because bone-anchored prosthesis users present more physiological muscle 
activity in the residual limb, and better hip and pelvic kinematics than socket-suspended 
prosthesis users.99,100 Third, the potential recovery of hip abductor strength, the direct 
attachment of the prosthetic parts to the bone and the presence of osseoperception may 
increase gait symmetry and thereby decrease secondary complaints such as back pain. 
Osseoperception is the phenomenon that persons with a bone-anchored prosthesis have a 
better ability to detect vibrotactile and pressure stimuli of the prosthetic limb compared to 
socket-suspended prosthesis users.36,101,102 Lastly, by eliminating socket-related problems, the 
prosthetic comfort will hopefully increase. This, together with the potentially increase in hip 
abductor strength and decrease in back pain, may lead to an improvement of the prosthesis 
wearing time, activity level, participation level and quality of life of persons with a lower 
extremity amputation.
OUTLINE OF THESIS
The general aim of this thesis is to describe the treatment trajectory after osseointegration 
implant surgery and examine the potential health benefits of a bone-anchored prosthesis in 
previous socket-suspended prosthesis users with a lower extremity amputation. With this 
thesis we have the intention to optimise the treatment trajectories of persons who opt for a 
bone-anchored prosthesis and make it applicable for daily practice.
In chapter 2 of this thesis we present a systematic review in which we aimed to : 1) give an 
overview of the instruments used to evaluate outcomes in terms of quality of life, function, 
activity and participation level in studies comparing bone-anchored prostheses and socket-
suspended prostheses for patients with a lower extremity amputation, and 2) provide a 
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systematic review of the literature comparing outcomes measured in terms of quality of life, 
function, activity and participation level for patients with a lower extremity amputation using 
bone-anchored prostheses relative to socket-suspended prostheses.
In chapter 3 we describe the treatment trajectory of a person with a transfemoral bone-
anchored prosthesis. This case report was used to detail the rehabilitation programme for 
persons with a transfemoral press-fit osseointegration implant. The rehabilitation programme 
focused on improving hip abductor strength, core stability, symmetry of gait pattern and level 
of activity.
In chapter 4 we report a feasibility study in which we evaluated the eligibility of a magnetic 
resonance imaging (MRI) based three-dimensional muscle reconstruction technique to 
evaluate hip abductor muscle volume in a person after receiving a transfemoral press-fit 
cobalt-chrome-molybdenum osseointegration implant. This single-case study was performed 
in the same person as described in chapter 3.
In chapter 5 we present the study protocol of a 5-year follow-up study in order to collect 
long-term outcomes following lower extremity press-fit bone-anchored prosthesis. Through 
publishing this study protocol we aim to: a) increase the transparency of our data collection, 
b) prevent publication bias and selective reporting, c) prevent data dredging. The study has 
four aims: 1) to describe the change in the level of function, activity, HRQoL and satisfaction 
in patients with a lower extremity amputation after receiving a press-fit osseointegration 
implant at short-term (six-months and one-year), mid-term (two-years) and long-term 
(five-years) follow-up in comparison to baseline. 2) to examine potential predictors for the 
change of coronal plane kinematics, prosthetic use, walking ability, HRQoL and prosthesis 
comfort over time: outcomes that are the main reason why patients opt for a bone-anchored 
prosthesis. 3) to examine predictors for the level of stump pain at short-term, mid-term and 
long-term follow-up. 4) to examine potential mechanisms for changes in back pain at short-
term, mid-term and long-term follow-up.
In chapter 6 we describe the development of a suitable handheld dynamometer technique to 
test hip abduction strength in individuals with a lower extremity amputation, irrespective of 
their amputation level. This study involved three phases, in which the clinimetric properties 
of two techniques were evaluated. The reproducibility of both techniques was tested while 
the validity was only tested of the most optimised handheld dynamometer technique.
In chapter 7 we present the reproducibility and discriminant validity of two newly developed 
measurement methods to obtain coronal plane gait kinematics in participants with a lower 
extremity amputation in daily clinical practice.
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1In chapter 8 we report the first preliminary results of our follow-up study as presented in 
chapter 5. The primary aim was to describe the change in the level of function, activity, 
HRQoL and satisfaction in persons with a lower extremity amputation after implantation of a 
press-fit osseointegration implant at six- and twelve-month follow-up in comparison to their 
pre-operative status. Additionally, we aimed to provide insight in the outcomes stratified 
by amputation level (i.e., transfemoral and transtibial) and in the influence of wheelchair-
boundedness prior to osseointegration surgery on the course of the outcomes. The secondary 
aim of this study was to describe the number and severity of adverse events during the study 
period.
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ABSTRACT
Purpose
This study aimed to provide an overview of (a) the used measurement instruments in studies 
evaluating effects on quality of life (QoL), function, activity and participation level in patients 
with a lower extremity amputation using bone-anchored prostheses compared to socket 
prostheses and (b) the effects themselves.
Method
A systematic literature search was conducted in MEDLINE, Cochrane, Embase, CINAHL, and 
Web of Science. Included studies compared QoL, function, activity and/or participation 
level in patients with bone-anchored or socket prostheses. A best-evidence synthesis was 
performed.
Results
Out of 226 studies, five cohort and two cross-sectional studies were eligible for inclusion, 
all with methodological shortcomings. These studies used ten different measurement 
instruments and two separate questions to assess outcome. Bone-anchored prostheses were 
associated with better condition-specific QoL and better outcomes on several of the physical 
QoL subscales, outcomes on the physical bodily pain subscale were inconclusive. Outcomes 
on function and activity level increased, no change was found at participation level. The level 
of evidence was limited.
Conclusions
There is a need for a standard set of instruments. There was limited evidence that bone-
anchored prostheses resulted in higher QoL, function, and activity levels than socket 
prostheses, in patients with socket-related problems.
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INTRODUCTION
In 2005 one in 190 people in the United States were living with limb loss.1 The incidence 
of lower extremity amputation in the Netherlands is 18-20 per 100,000; 90-94% of the 
amputation are due to vascular disease, 3% to trauma and 3% to tumour resection.2 The 
incidence of non-vascular lower extremity amputations is low, but the prevalence is high 
because this kind of amputation is most frequently in adolescents and adults below the age 
of 45 years.1 There is a lack of recent data on incidence and prevalence of lower extremity 
amputation.
Approximately 86% of patients with a lower extremity amputation are fitted with a socket 
prosthesis3, 34-63% of these patients have chronic skin problems and pain associated with 
the socket.4-9 These problems often have a severe impact on quality of life (QoL) related 
to problems at body function or structures (e.g., limited prosthesis use) and activity level 
(mobility restrictions) with as consequence limitations in participation.4,6,10-12
One approach to treat socket-related problems is to attach the prosthesis to the skeleton 
transcutaneously by osseointegration using an intramedullary implant.13 Bone-anchored 
prostheses are an option when the cause of amputation was trauma or cancer and the patient 
is experiencing socket-related problems. Because of the risk of infection bone-anchored 
prostheses are not currently recommended for patients whose amputation had a vascular 
cause.12-15 In the future, however, bone-anchored prostheses might also be an option for 
patients with stable vascular disease16 and for patients without socket-related problems who 
wish to increase their prosthesis use.12 At present, there are two implants for bone-anchored 
prosthesis which are used in humans17: the Osseointegrated Prosthesis for the Rehabilitation 
of Amputees (OPRA)18 and Endo-Exo Femoral Prosthesis (EEFP).12,19 Both are intramedullary 
implants, but OPRA is a titanium screw13 while EEFP is a cobalt-chrome press-fit fixation.19 
The two-step surgery technique used with both implants has been well described. When 
OPRA.15,18,20,21 is used the two operations are separated by a minimum of six months, with 
EEFP12,14,19,22,23 the inter-surgery interval is six to eight weeks. Rehabilitation of OPRA has been 
described extensively15,21, of EEFP rehabilitation there is a less detailed description.12,19 An 
important difference in rehabilitation protocols is that with EEFP the load on the prosthesis 
can be increased more rapidly so the rehabilitation programme can be shorter.
Since the introduction of bone-anchored prostheses for patients with a lower extremity 
amputation using osseointegration in 199013, a number of studies have investigated incidence 
of infection and survival of the implants.14,19,21,23-25 These studies showed frequent problems 
around the skin-penetrating stoma region, but a low (1.8-10.4%) frequency of disability or 
implant removal as result of infections or other problems such as peri-prosthetic fractures. 
The majority of treatment failures occurred in the early years of bone-anchored prosthesis 
surgery.21
Recent research has shown that the mean annual costs associated with socket prostheses 
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and bone-anchored prostheses are comparable.26 Although bone-anchored prosthesis users 
were provided with more advanced costly prosthetic components, they made significantly 
fewer visits to the prosthesist than socket prosthesis users, resulting in lower post-surgery 
costs.26 One qualitative, phenomenological study has been performed. All the participants 
described living with bone-anchored prosthesis as a positive, revolutionary change that went 
beyond the functional improvements, integrating the existential implications in the concept 
of QoL.27 Osseoperception, the ability to perceive pressure, load, position and balance28, is 
one of the benefits attributed to bone-anchored prostheses.13,28,29 In socket prosthesis users, 
low hip abductor strength is correlated with asymmetrical gait30,31, which may explain back 
pain and pain in other regions such as the residual limb, sound side, buttocks, hips and neck or 
shoulder.32 Two studies33,34 compared muscle function of the residual limb in bone-anchored 
prosthesis users with muscle function in healthy subjects. These studies showed that muscle 
activity patterns retained aspects of activity patterns found in healthy subjects during gait34; 
however, bone-anchored prosthesis users were unable to maintain a maximum voluntary 
contraction of constant amplitude.33 There has been no research comparing muscle function 
in users of bone-anchored prostheses and socket prostheses. A critical issue for clinicians 
and funding bodies is the extent to which bone-anchored prostheses improve outcomes 
with respect to QoL, body function or structures (hereafter referred as function), activity and 
participation level relative to socket prostheses.35-37 It is important for patients considering 
bone-anchored prosthesis surgery to have access to this information, so that they are able to 
make an informed choice. At present there is no systematic analysis of instruments used to 
evaluate functional outcomes after bone-anchored prostheses surgery and only one review38 
concerning the effects of bone-anchored prostheses compared to socket prostheses. Insight 
in measurement instruments is important to allow professionals to evaluate bone-anchored 
prosthesis surgery and the effectiveness of rehabilitation programmes.
The two aims of this study were to (a) give an overview of the instruments used to evaluate 
outcomes in terms of QoL, function, activity and participation level in studies comparing bone-
anchored prostheses and socket prostheses for patients with a lower extremity amputation 
and (b) provide a systematic review of the literature comparing outcomes measured in 
terms of QoL, function, activity and participation level for patients with a lower extremity 
amputation using bone-anchored prosthesis relative to socket prosthesis.
METHODS
Design
This systematic review of published, peer-reviewed articles with original data followed the 
guidelines of the PRISMA statement.39
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Information sources
We searched the following electronic databases (last search 16 April 2016): MEDLINE 
(accessed via PubMed), Cochrane Central Register of Controlled Trials, Embase (accessed via 
EBSCO), CINAHL and Web of Science.
Search strategy
A search strategy based on the PICO strategy was developed by the first author (RL) with the 
support of a medical librarian. In order to obtain a broad range of records, the comparison 
and outcome elements were not included in the search string but were used at the article 
selection stage. There were no language or publication date criteria within the search. The 
following MeSH terms and keywords were used: osseointegration [MeSH], osseointegrat*, 
osseo-integrat*, bone-anchored prosthe*, amputation [MeSH], amputees [MeSH] and 
amputation traumatic [MeSH], amputations stumps [MeSH] and amput*. The complete 
search strategy can be found in Appendix 1.
Inclusion criteria
We (RL and GvH) systematically screened studies and considered them eligible for inclusion 
if they: (a) were conducted in humans with a lower extremity bone-anchored prosthesis; (b) 
studies with original data comparing bone-anchored prostheses with socket prostheses; (c) 
evaluated outcomes in terms of QoL, function, activity or participation level (instruments 
were classified in line with the review by Samuelsson et al.40); (d) the studies were published 
in English, Dutch or German. Articles were excluded if they were: (a) not quantitative studies; 
(b) a conference abstract, letter to the editor, textbook, article for educational purposes, case 
report or case series; (c) presented only implant survival or infection data. The same criteria 
were used to include individual studies embedded in systematic reviews, if not already 
detected by the search string.
Study selection
Two authors (RL and GvH) independently reviewed the retrieved studies to determine 
eligibility. Initially studies were screened on the basis of, title and abstract; full texts were 
obtained for studies considered potentially eligible. Disagreements between the reviewers 
were solved by discussion. We also tracked the references of all included articles (Figure 1). 
Reasons for exclusion based on assessment of the title and abstract or full text were noted.
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Data extraction
The first reviewer (RL) extracted data using a standard extraction form; the results were 
checked by GvH. Data extracted from the included articles were: (a) authors, publication 
year, and study location; (b) study design; (c) participants; (d) intervention; (e) measurement 
instruments; (f) results.
Methodological quality
Two reviewers (RL and GvH) independently assessed the methodological quality of the 
included articles; they were not blinded with respect to either authorship or journal. The 
methodological quality (risk of bias) was scored using the Effective Public Health Practice 
Project (EPHPP) Quality Assessment Tool for Quantitative Studies.41,42 This critical appraisal 
tool was chosen because we expected to encounter different types of non-randomised 
Figure 1. Flow scheme for included studies
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studies. The EPHPP tool assesses six aspects of methodology: (a) likelihood that the study 
participants are representative of the target population; (b) study design; (c) control of 
confounding variables; (d) blinding of participants and investigators; (e) validity and reliability 
of the data collection tools; and (f) proportion of withdrawals and drop-outs. This tool 
was separately applied to all studies; studies were rated “strong”, “moderate” or “weak” 
with respect to each aspect of methodology using standard criteria set out in the EPHPP 
dictionary.41,42 Overall ratings of quality rating (global ratings) were derived from the domain 
ratings as follows. Studies were classed as having “strong” methodology when none of the 
aspects was rated weak, “moderate” when there was one weak aspect and “weak” if there 
were two or more aspects of methodology rated weak.42,43 The ratings of the data collection 
tools was based on the EPHPP dictionary42, but if a gold standard tool (e.g. gait laboratory) was 
used this aspect of methodology was also rated as strong. The EPHPP tool has been shown 
to be a reliable and valid tool for critical appraising study methodology.43,44 Disagreements 
between the two raters were resolved by discussion, cases of persistent disagreement were 
referred to a third rater (JBS). Inter-rater agreement on the EPHPP tool domain ratings was 
measured with linear, weighted Cohen’s κ coefficient45 as proposed by Byrt.46 Values were 
classified as follows: 0.41-0.60: fair agreement; 0.61-0.80: good agreement; 0.81-0.92: very 
good agreement; 0.93-1.00: excellent agreement.
We conducted meta-analysis in cases where three or more studies were used the same 
outcome measures. In cases of clinical heterogeneity (e.g. diversity of follow-up time points) 
we performed a best evidence synthesis of outcomes related to QoL, function, activity and 
participation level, which were used in two or more studies. As we anticipated that included 
studies would be non-randomised, we ranked the levels of evidence per comparison and 
for each outcome using a method described by Yusuf et al.47, which is a modification of the 
guidelines on systematic review of the Cochrane Collaboration Back Review Group.48 This 
modified method was also used by Veenhof et al.49 and ranks the level of evidence in five 
levels (Table 1).
Table 1. Level of evidence47
Strong evidence Generally consistent findings in multiple high quality cohort studies.
Moderate evidence Generally consistent findings in one high quality cohort study and ≥2  high quality
 case-control studies, or in in ≥3 high quality case-control studies.
Limited evidence (Generally consistent) findings in a single cohort study, or in maximum two case- 
 control studies, or in multiple cross-sectional studies.
Conflicting evidence Less than 75% of the studies reported consistent findings.
Insufficient evidence Less than two low quality studies available.
No evidence Provided when no studies could be found.
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RESULTS
Selected studies
We retrieved 226 potential eligible studies. Thirty-six were classified as potentially eligible 
on preliminary screening. Assessment of full texts of these studies resulted in seven 
studies12,18,20,35,50-52 being rated eligible for inclusion. A flowchart of the selection process, 
including reasons of the articles subjected to a review of the full text, is presented in Figure 
1. Reasons for exclusion of the articles screened out on the basis of the title and abstract are 
presented Appendix 2.
Study characteristics
Table 2 provides a profile of the included studies. Seven studies were included in the systematic 
review, of which five were longitudinal (before and after) cohort studies12,18,20,51,52 and two 
were cross-sectional studies.35,50 In one cohort study52, the intervention group was compared 
to a control group of healthy subjects. Our search did not retrieve any randomised controlled 
trials (RCTs) or Controlled Clinical Trials (CCTs) comparing bone-anchored prostheses with 
socket prostheses. The cohort studies assessed a grand total of 110 patients with a lower 
extremity amputation and the cross-sectional studies assessed a total of 185 socket prosthesis 
users and 32 bone-anchored prosthesis users. The age at inclusion for the cohort studies 
ranged from 20 to 70 years; in cross-sectional studies the age at inclusion ranged from 28 to 
70 years for socket prostheses users and 26 to 67 years for bone-anchored prostheses users. 
Time from primary amputation to inclusion in the cohort studies ranged from 10 months to 
45 years. In the cross-sectional studies time from primary amputation to inclusion varied 
from 2 to 56 years for socket prostheses users and, from 6 to 46 years for bone-anchored 
prostheses users. All patients in the included studies had a transfemoral amputation and the 
most common cause of primary amputation was trauma. The recruitment period for all the 
studies covered the period from 2005 to 2014. The studies were performed in two countries, 
Sweden (n = 6)18,20,35,50-52 and the Netherlands (n = 1).12 In Sweden bone-anchored prostheses 
were placed with OPRA and in the Netherlands with EEFP. The sample size in the cohort 
studies ranged from 18 to 51 participants; in the cross-sectional studies the number of socket 
prosthesis users ranged from 43 to 142 participants and, the number of the bone-anchored 
prosthesis users from 12 to 20. The study of Hagberg et al.51 is not included in the above 
presented summary concerning the grand total of assessed patients because the sample was 
also analysed by Branemark et al.20 However, we decided not to exclude the study entirely 
because the majority of the outcome measures were different from those used by Branemark 
et al.20 To our knowledge, there is no other instance of overlap between participants in the 
included studies.
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Methodological quality assessment
There was 93% inter-rater agreement between the two reviewers on the ratings of individual 
domains of methodological quality. The estimated mean linear weighted Kappa value was 0.86 
± 0.07. The most common shortcomings were lack of adjustment for confounding variables 
and failure to blind assessors and participants. The few disagreements about domain ratings 
were due to errors of comprehension or differences in interpretation of the methodological 
quality criteria; in no case did they affect the global score. All disagreements were resolved 
by discussion. The global rating of methodological quality was weak for all seven studies. 
Global EPHPP scores and scores for the six domains of methodological quality are presented 
in Table 3.
Measurement instruments used in the studies
Ten different measurement instruments were used across the seven included studies and 
two studies also used separate questions about sitting comfort50 and working status18 (Table 
4). Instruments were classified as measuring QoL, function, activity or participation level 
outcome measures in line with the review by Samuelsson et al.40 The most frequently used 
instrument was the Questionnaire for persons with Transfemoral Amputation (Q-TFA). Three 
different questionnaires were used in evaluation of QoL, the Q-TFA (problem score18,20,51 and 
global score12,18,20,51), the 36-item Short-Form health survey (SF-36)18,20,51 and the revised 
36-item short-form health survey, which assesses six dimensions of health status (SF-6D).51 
The Q-TFA was also used to assesses outcome on function level (prosthetic use 12,18,20,51) and 
activity level (prosthetic mobility18,20,51). Range of hip motion (assessed using a goniometer50) 
and biomechanical gait characteristics (assessed using a transducer35 and laboratory 
measurements52) were also used as indicators of function level. Four physical performance 
measures were used to evaluate the activity level. The 6-Minute Walk Test (6MWT)12 and 
Table 3. Methodological quality assessment ratings based on the Effective Public Health 
Practice Project tool for quantitative studies
Authors (year) Selection bias Study design Confounders Blinding Data collection Withdrawals Global
and drop-outs rating
Branemark et al. (2014)20 Moderate Moderate Weak Weak Strong Strong Weak
Frossard et al. (2010)35 Moderate Weak Weak Weak Weak Moderate Weak
Hagberg et al. (2014)51 Moderate Moderate Weak Weak Strong Strong Weak
Hagberg et al. (2008)18 Moderate Moderate Weak Weak Strong Strong Weak
Hagberg et al. (2005)50 Moderate Weak Weak Weak Weak Moderate Weak
Tranberg et al. (2011)52 Moderate Moderate Weak Weak Strong Strong Weak
Van de Meent et al. (2013)12 Moderate Moderate Weak Weak Strong Strong Weak
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 44
2
44
Ta
bl
e 
4.
 M
ea
su
re
m
en
t 
in
st
ru
m
en
ts
 u
se
d
Q
ua
lit
y 
of
 L
ife
Im
pa
ir
m
en
ts
 in
 b
od
y 
fu
nc
tio
n 
or
 s
tr
uc
tu
re
A
cti
vi
ty
 li
m
ita
tio
ns
 P
ar
tic
ip
ati
on
 r
es
tr
ic
tio
ns
• 
SF
-3
61
8,
20
,5
1
• 
G
on
io
m
et
er
50
; r
an
ge
 o
f h
ip
 m
oti
on
• 
Q
ue
sti
on
 s
itti
ng
 c
om
fo
rt
50
• 
Q
ue
sti
on
 w
or
k 
st
at
us
18
- p
hy
si
ca
l f
un
cti
on
in
g 
(P
F)
18
,2
0,
51
• 
Q
ua
lis
ys
 m
cu
 2
40
52
; s
ag
itt
al
 p
la
ne
 k
in
em
ati
c 
• 
6-
M
in
ut
e 
W
al
k 
Te
st
 (6
M
W
T)
12
- r
ol
e 
ph
ys
ic
al
 fu
nc
tio
ni
ng
 (R
P)
18
,2
0
da
ta
 h
ip
 a
nd
 p
el
vi
s 
du
ri
ng
 g
ai
t
• 
Ti
m
ed
 U
p 
&
 G
o 
(T
U
G
)1
2
- b
od
ily
 p
ai
n 
(B
P)
18
,2
0
• 
Tr
an
sd
uc
er
35
; t
em
po
ra
l g
ai
t 
ch
ar
ac
te
ri
sti
cs
• 
O
xy
ge
n 
co
ns
um
pti
on
 la
bo
ra
to
ry
  m
ea
su
re
m
en
t
- g
en
er
al
 h
ea
lt
h 
(G
P)
18
,2
0
(c
ad
en
ce
, d
ur
ati
on
 g
ai
t 
cy
cl
e,
 s
w
in
g 
ph
as
e 
an
d
du
ri
ng
 w
al
ki
ng
 a
t 
se
lf-
pr
ef
er
re
d 
w
al
ki
ng
 s
pe
ed
12
- v
ita
lit
y 
(V
T)
18
,2
0
st
an
ce
 p
ha
se
)
• 
Ph
ys
io
lo
gi
ca
l C
os
t 
In
de
x 
(P
CI
)2
0
- s
oc
ia
l f
un
cti
on
in
g 
(S
F)
18
,2
0
• 
Q
-T
FA
12
,1
8,
20
,5
1
• 
Q
-T
FA
12
,1
8,
20
,5
1
- r
ol
e 
em
oti
on
al
 (R
E)
18
,2
0
- p
ro
st
he
tic
 u
se
 s
co
re
 (P
U
S)
12
,1
8,
20
,5
1
- p
ro
st
he
tic
 m
ob
ili
ty
 s
co
re
 (P
M
S)
18
,2
0,
51
- m
en
ta
l h
ea
lt
h 
(M
H
)1
8,
20
- p
hy
si
ca
l c
om
po
ne
nt
 s
um
m
ar
y 
(P
CS
)1
8,
20
,5
1
- m
en
ta
l c
om
po
ne
nt
 s
um
m
ar
y 
(M
CS
)1
8,
20
• 
SF
-6
D
51
• 
Q
-T
FA
12
,1
8,
20
,5
1
- p
ro
bl
em
 s
co
re
 (P
S)
18
,2
0,
51
- g
lo
ba
l s
co
re
 (G
S)
12
,1
8,
20
,5
1
SF
-3
6:
 3
6-
ite
m
 s
ho
rt
-f
or
m
 h
ea
lt
h 
su
rv
ey
, d
iv
id
ed
 in
 8
 s
ub
sc
al
es
: 4
 r
ol
e 
lim
ita
tio
ns
 d
ue
 t
o 
ph
ys
ic
al
 h
ea
lt
h:
 p
hy
si
ca
l f
un
cti
on
in
g 
(P
F)
, r
ol
e 
ph
ys
ic
al
 f
un
cti
on
in
g 
(R
P)
, b
od
ily
 p
ai
n 
(B
P)
 a
nd
 
ge
ne
ra
l h
ea
lt
h 
(G
P)
 a
nd
 4
 r
ol
e 
lim
ita
tio
ns
 d
ue
 t
o 
m
en
ta
l h
ea
lt
h:
 v
ita
lit
y 
(V
T)
, 
so
ci
al
 f
un
cti
on
in
g 
(S
F)
, 
ro
le
 e
m
oti
on
al
 (
RE
) 
an
d 
m
en
ta
l h
ea
lt
h 
(M
H
) 
an
d 
2 
su
m
m
ar
y 
co
m
po
ne
nt
 s
co
re
: 
ph
ys
ic
al
 c
om
po
ne
nt
 s
co
re
 (P
CS
) a
nd
 m
en
ta
l c
om
po
ne
nt
 s
co
re
 (M
CS
). 
Ra
ng
e 
fo
r 
al
l s
ub
sc
al
es
 a
nd
 s
um
m
ar
y 
sc
or
es
 0
-1
00
 p
oi
nt
s,
 h
ig
he
r 
sc
or
es
 re
pr
es
en
t b
ett
er
 h
ea
lt
h;
 S
F-
6D
; r
ev
is
ed
 3
6-
ite
m
 s
ho
rt
-f
or
m
 h
ea
lt
h 
su
rv
ey
 (r
an
ge
 0
-1
, w
he
re
 1
 in
di
ca
te
s 
fu
ll 
he
al
th
 a
nd
 0
 in
di
ca
te
s 
de
at
h)
; Q
-T
FA
: Q
ue
sti
on
na
ir
e 
fo
r 
pe
rs
on
s 
w
it
h 
Tr
an
sf
em
or
al
 A
m
pu
ta
tio
n,
 d
iv
id
ed
 in
to
 4
 s
ub
sc
al
es
; 
pr
os
th
eti
c 
us
e 
sc
or
e 
(P
U
S)
, p
ro
st
he
tic
 m
ob
ili
ty
 s
co
re
 (
PM
S)
, p
ro
bl
em
 s
co
re
 (
PS
) 
an
d 
gl
ob
al
 s
co
re
 (
G
S)
 (
ra
ng
e 
0-
10
0 
po
in
ts
, h
ig
he
r 
sc
or
es
 r
ep
re
se
nt
 b
ett
er
 h
ea
lt
h,
 e
xc
ep
t 
in
 t
he
 c
as
e 
of
 
PS
; P
U
S 
ca
n 
be
 e
xp
re
ss
ed
 a
s 
a 
po
in
t 
sc
or
e 
(0
-1
00
)1
8,
20
,5
1  o
r 
in
 h
ou
rs
 p
er
 w
ee
k 
(0
-1
08
.5
)1
2 )
; Q
ue
sti
on
 s
itti
ng
 c
om
fo
rt
 (a
ns
w
er
 o
n 
5 
po
in
t 
lik
er
t 
sc
al
e;
 n
o 
tr
ou
bl
e 
to
 a
 g
re
at
 d
ea
l o
f t
ro
ub
le
);
 
Q
ue
sti
on
 w
or
ki
ng
 s
ta
tu
s 
(a
ns
w
er
 o
pti
on
s:
 w
or
ki
ng
, p
en
si
on
, d
is
ab
ili
ty
 p
en
si
on
, s
ic
k)
.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 45
2
45
Chapter 2 | Systemetic review of bone-anchored versus socket-suspended prostheses
Timed Up & Go (TUG)12 were used to assess walking ability in terms of distance covered in 
6-minutes and time needed to get up from a chair, walk 3-meter up and down a walkway and 
sit again. The energetic cost of walking was assessed clinically using the Physiological Cost 
Index (PCI)51 or with laboratory measurements.12
Synthesis of results/meta-analysis
Owing to the diversity of instruments, follow-up time points and study designs meta-analysis 
of the data would not have been meaningful. The Q-TFA was the most frequently used 
measure of outcome, but scores were analysed differently in the various studies. For example 
the Swedish studies18,20,51 calculated the prosthetic use score in points and the Dutch study12 in 
hours per week. Furthermore, two articles presented overlapping results extracted from the 
Q-TFA and SF-36 because they assessed an overlapping sample.20,51 Because of this overlap 
we excluded the Hagberg et al.51 Q-TFA data (with exception of the subscales of the mobility 
score) and data from SF-36. A best evidence synthesis was carried out for all outcomes used 
in at least two studies; these data are presented in Table 5.
Table 5. Best evidence synthesis  
Outcome and follow-up Effectiveness of BAPs relative Best evidence synthesis
to SPs (risk of bias)
Condition-specific QoL (PS, GS)   
1 year after BAP Greater (low12,20) Limited evidence
2 year after BAP Greater (low18,20) Limited evidence
General QoL; physical functioning   
1 year after BAP Greater (low20) Limited evidence
2 year after BAP Greater (low 18,20) Limited evidence
General QoL; role physical
1 year after BAP Greater (low20) Limited evidence
2 year after BAP Greater (low18,20) Limited evidence
General QoL; bodily pain   
1 year after BAP Similar (low20) Limited evidence
2 year after BAP Greater (low18), Similar (low20) Conflicting evidence
General QoL; general health
1 year after BAP Similar (low20) Limited evidence
2 year after BAP Similar (low18,20) Limited evidence
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Results of individual studies
Table 6 presents a comparison of the outcome of socket prostheses use compared to bone-
anchored prostheses use.
Table 5. Best evidence synthesis (continued)
Outcome and follow-up Effectiveness of BAPs relative Best evidence synthesis
to SPs (risk of bias)
General QoL; physical component score
1 year after BAP Greater (low20) Limited evidence
2 year after BAP Greater (low18,20) Limited evidence
General QoL; mental health (VT, SF, RE, MH, MCS)
1 year after BAP Similar (low20) Limited evidence
2 year after BAP No (low18,20) Limited evidence
Function level; PUS
1 year after BAP Greater (low12,20) Limited evidence
2 year after BAP Greater (low18,20) Limited evidence
Activity level; PMS
1 year after BAP Greater (low20) Limited evidence
2 year after BAP Greater (low18,20) Limited evidence
Activity level; PMS subscores capability and walking habit
2 year after BAP Greater (low18,51) Limited evidence
Activity level; PMS subscore walking habit
2 year after BAP Similar (low18,51) Limited evidence
Activity level; energy cost of walking   
1 year after BAP Greater (low12,51) Limited evidence
2 year after BAP Greater (low51) Limited evidence
BAP: bone-anchored prosthesis; SP: socket prosthesis: Condition-specific Quality of Life (QoL) assessed using Q-TFA: 
Questionnaire for persons with Transfemoral Amputation (2 subscales: problem score (PS) and global score (GS)). 
General QoL; mental health assessed using the 36-item short-form health survey (4 subscales: vitality (VT), social 
functioning (SF), role emotional (RE) and mental health (MH) and 1 summary component score, mental component 
score (MCS)). Function level assessed using Q-TFA prosthetic use score (PUS). Activity level assessed using Q-TFA 
prosthetic mobility score (PMS) and energetic cost of walking (Physiological Cost Index and laboratory measurement).
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Chapter 2 | Systemetic review of bone-anchored versus socket-suspended prostheses
Quality of life
Two low-quality cohort studies used the Q-TFA problem score as a measure of condition-
specific QoL18,20 and three low-quality cohort studies used the Q-TFA global score.12,18,20 All five 
studies reported that condition-specific QoL improved significantly by use of bone-anchored 
prosthesis rather than socket prosthesis. This constitutes limited evidence for an improvement 
in condition-specific QoL in the first12,20 and in the second18,20 year after bone-anchored 
prosthesis surgery relative to socket prosthesis use. Two low-quality cohort studies used the 
SF-36 to assess general QoL18,20. They reported that the physical functioning score18,20, role 
physical functioning score18,20 and physical component summary18,20 improved significantly 
with use of a bone-anchored prosthesis rather than a socket prostheses. Hagberg et al.18 
reported that SF-36 bodily pain score improved significantly using bone-anchored prosthesis 
compared to socket prosthesis, however Branemark et al.20 reported no change. Scores on 
other subscales of the SF-3618,20 did not change significantly as a result of replacing socket 
prostheses with bone-anchored prostheses. In conclusion, there is limited evidence that 
scores on the SF-36 measures of physical health (physical functioning score18,20, role physical 
functioning score18,20 and physical component summary18,20) improved in the first20 and in 
the second18,20 year after bone-anchored prosthesis surgery relative to socket prosthesis use. 
There was limited evidence that the physical bodily pain subscale score did not change in 
the first20 year after surgery to fit a bone-anchored prosthesis and conflicting evidence on 
change in the second post-surgery year.18,20 Furthermore, there was limited evidence that the 
physical general health subscale and all mental health subscales (measured with SF-36) did 
not change in the first20 and in the second18,20 year after bone-anchored prosthesis surgery 
relative to socket prosthesis use. One low-quality study51 used a utility instrument53, namely 
SF-6D; this study reported an improvement in general health status in the second year after 
bone-anchored prosthesis surgery relative to socket prosthesis use.
Function level
Three low-quality cohort studies12,18,20 used the Q-TFA prosthetic use score to assess 
prosthesis wearing time. All the studies found that wearing time improved significantly with 
use of a bone-anchored prosthesis relative to use of a socket prosthesis. There was limited 
evidence that wearing time improved in the first12,20 and in the second18,20 year after bone-
anchored prosthesis surgery relative to socket prosthesis use. One low-quality cross-sectional 
study50 compared range of hip motion with and without the prosthesis in users of bone-
anchored prostheses and socket prostheses. This study showed that range of hip motion was 
lower when wearing the prosthesis compared to without it for socket prosthesis users but 
not for bone-anchored prosthesis users; the bone-anchored prosthesis users were assessed 
between two and ten years after bone-anchored prosthesis surgery.50 The same study found 
that users of bone-anchored prostheses had a significant larger range of hip motion than 
socket prosthesis users, while wearing the prosthesis.50 The other low-quality cross-sectional 
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study35 assessed temporal gait variables (cadence, duration gait cycle and duration support 
phase) in bone-anchored prosthesis users who were at least one year post-surgery, socket 
prosthesis users and healthy subjects. This study found that bone-anchored prosthesis 
users had a gait more similar to that of healthy subjects than did socket prosthesis users, 
except with respect to swing phase duration.35 One low-quality cohort study52 assessed gait 
kinematics in the sagittal plane. This study found that during the stance phase use of a bone-
anchored prosthesis increased hip extension and decreased anterior pelvic tilt relative to use 
of a socket prosthesis.52 These kinematics while using a bone-anchored prosthesis are more 
similar to that of healthy subjects relative to socket prosthesis use, but that they still differ 
significantly with respect to healthy subjects.52
Activity level
Two low-quality cohort studies used the Q-TFA mobility score as an indicator of mobility 
level.18,20 Two low-quality cohort studies analysed the walking aid, capability and walking 
habit subscores of the Q-TFA mobility score.18,51 All studies found that using a bone-anchored 
prosthesis resulted in significant improvements in overall mobility score, capability subscore 
and walking habit subscore during bone-anchored prostheses use compared to socket 
prostheses use, but there was no change in walking aid subscore.18,51 In conclusion, there is 
limited evidence that mobility level improved in the first20 and second18,20 year after bone-
anchored prosthesis surgery relative to mobility with a socket prosthesis. There is limited 
evidence that bone-anchored prosthesis surgery did not change walking aid use in the first 
two year after surgery relative to use with a socket prosthesis.18,51 One low-quality cross-
sectional study50 assessed discomfort when sitting in users of bone-anchored prosthesis and 
socket prosthesis users, and found that using a bone-anchored prosthesis was associated 
with less discomfort when sitting than use of a socket prosthesis.50 One low-quality cohort 
study12 assessed walking ability and found that it improved significantly in the first year after 
bone-anchored prosthesis surgery relative to use of a socket prosthesis, both in terms of 
distance covered in 6-minutes and time needed to get up from a chair, walk 3-meter up and 
down a walkway and sit again.12 Two low-quality cohort studies12,51 assessed energy cost of 
walking; both studies found that use of a bone-anchored prosthesis reduced the energetic 
cost of walking significantly compared with use of a socket prosthesis. In conclusion, limited 
evidence was found that in the first12 and the second51 year after surgery using a bone-
anchored prosthesis reduced energy costs of walking relative to a socket prosthesis.
Participation level
One low-quality cohort study18 assessed work situation. This study found no evidence that 
work situation two years after bone-anchored prosthesis surgery was different from before 
this surgery.18
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DISCUSSION
This review has demonstrated that studies comparing bone-anchored prostheses with 
socket prostheses have used a wide variety of instruments to evaluate outcome. There was 
consensus within the included studies with respect to indicators of QoL, with the Q-TFA12,18,20,51 
being used to assess condition-specific QoL and the SF-3618,20,51 for general QoL. The Q-TFA 
was also used to assess function12,18,20,51 and activity level18,20,51. However, the Q-TFA prosthetic 
use score was analysed differently in the various studies. The Q-TFA was the only indicator 
of function, activity and participation level used in more than one study. We also concluded 
that relative to use of a socket prosthesis, use of a bone-anchored prosthesis resulted in 
better condition-specific QoL12,18,20,51 and better general physical health QoL in terms of most 
indicators.18,20,51 The evidence on the effects on physical bodily pain of replacing a socket 
prosthesis with a bone-anchored prosthesis was inconclusive.18,20 We also concluded that 
relative to use of a socket prosthesis, use of a bone-anchored prosthesis resulted in better 
function12,18,20,35,50-52 and activity level12,18,20,50,51, but had no effect on participation level.18 We 
also noted that in 25 years of bone-anchored prosthesis surgery13, only seven studies have 
compared the outcomes of bone-anchored prosthesis use relative to socket prosthesis use in 
terms of QoL, function, activity and participation level and all these studies were conducted 
in the last ten years. Participation level after bone-anchored prosthesis surgery relative to 
socket prosthesis use is rarely assessed. 
Three articles54-56 were excluded because of their study design however are worthwhile 
to discuss. Khemka et al.55 described four patients with a transtibial amputation who 
underwent a total knee replacement combined with an osseointegrated implant. Khemka 
et al.54 described three patients with a transfemoral amputation who underwent a total hip 
replacement combined with an osseointegrated implant. Both studies of Khemka et al. used 
measurement instruments included in this review, namely the Q-TFA to assess condition-
specific QoL, SF-36 (physical and mental component summary) for general QoL and 6-Minute 
Walk Test and Timed Up & Go to assess walking ability. Furthermore, they introduced two 
additional measurement instrument, including K-levels to assess mobility level and a dual axis 
accelerometer to assess physical activity level in daily life. Noteworthy is that the Q-TFA is used 
differently compared to the studies included in this review. Khemka et al. used a summary 
score (0-100) of all four subscales of the Q-TFA to assess condition-specific QoL instead of the 
score of only the subscales problem and global score. Both studies reported an improvement 
of all outcome measures at follow-ups relative to before surgery with exception of one patient 
with a transtibial amputation who remained at the same K-level as before surgery and three 
patients with a transtibial amputation who had a stable mental component summary (SF-36). 
Follow-up time periods ranged from 12 to 30 months. The study of Schalk et al.56 included 
one patient with a bilateral transfemoral amputation with an eight-months follow-up after 
bilateral press-fit BAP surgery. In this study, two patient-reported measurement instruments, 
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the Lower Extremity Functional Scale (LEFS) and the life habits questionnaire (LIFE-H), were 
used to assess activity and participation level, respectively. The activity level of this patient 
increased after BAP surgery relative to baseline (two-years before BAP surgery). Participation 
level increased on the majority of the categories such as recreation, community life, mobility, 
housing, and fitness however decreased on the categories work and relationships. The 
increased activity level is in line with the results of our review. Work is the only comparable 
category with our review within participation level, which showed a different trend.
The systematic review of Van Eck et al.38 had one overlapping research question on 
functional outcomes with this review however they searched in less databases, reported 
their results less detailed and without a clear structure such as the International Classification 
of Functioning, Disability and Health (ICF). In addition, Van Eck et al. also reported the 
complications and costs of bone-anchored prostheses. As a result of this Van Eck et al. 
included six studies more than we did, however three relevant studies 35,51,52 concerning 
functional outcomes of bone-anchored prostheses are lacking compared to our review. From 
the overlapping studies12,18,20,50 Van Eck et al. concluded similar to our critical appraisal that 
the methodological quality of the individual studies had flaws. The conclusions concerning 
the functional outcomes of these studies were similar to our conclusions, however Van Eck 
failed to report the change over time of the before-after cohort study of Hagberg et al.18 and 
did not report the functional outcomes of the cross-sectional study of Hagberg et al.50 No 
best evidence synthesis was performed by Van Eck et al.
Strengths and limitations
It is important to note that it is very likely that all the patients included in this review used a 
bone-anchored prosthesis after a period of socket prosthesis use. This is definitely the case 
for the patients enrolled in the longitudinal cohort studies and is very likely in the case of 
patients in the cross-sectional studies as the introductions to the reports of both these studies 
state that a bone-anchored prosthesis is an alternative option for patients with socket-related 
problems with a socket prosthesis. We decided not to use the ICF categories to categorize the 
various aspects of QoL. In this we followed Samuelsson et al.40, who also classified the SF-36, 
a utility instrument (e.g., EQ-5D) and Q-TFA problem score and global score as indicators of 
QoL rather than the ICF categories. We found a different utility instrument (SF-6D51) which 
is based on the SF-36, therefore we classified the outcome as indicator of QoL. It may be 
more correct to categorize the various aspects of QoL into the ICF categories, however than 
the ICF linking rules had to be used to interpret the QoL instruments.57 We decided that this 
approach was beyond the scope of this review. We followed Samuelsson et al.40 in treating 
the Q-TFA prosthetic mobility score as an indicator of activity level. We decided to classify 
the Q-TFA prosthetic use score as an indicator of function level because it assesses prosthesis 
wearing time rather than use in specific activities.
A discussion point in the judgement of the used critical appraisal tool is the appraisal 
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of the study design.42 In our opinion a longitudinal cohort (before and after design) is a 
good and ethical way to compare bone-anchored prostheses and socket prostheses in 
clinical practice; however the EPHPP tool assigns such a design low ratings for handling of 
confounding variables and lack of blinding, which means that overall methodological quality 
is rated “weak”. The EPHPP tool also tends to assign cross-sectional designs lower ratings 
than longitudinal designs.58 A consequence of the used research designs was that the found 
differences between bone-anchored prostheses and socket prostheses were rated as ”limited 
evidence” in the best evidence synthesis. In their review Sanderson et al.59 found that there 
was no obvious candidate tool for assessing the quality of observational, epidemiological 
studies; this highlights the difficulty of evaluating the methodological quality of observational 
studies. Where bone-anchored prostheses to be used as a primary prosthesis, then it 
would be possible to use quasi-experimental designs or propensity score-matched cohorts; 
which are more powerful methods of investigating the differences between bone-anchored 
prostheses and socket prostheses.
The clinimetric properties of some of the instruments used, for example the goniometer50 
and physiological cost index51,60, were poor or untested in patients with a lower extremity 
amputation. The most frequently used instrument was the Q-TFA, this instrument was 
developed for use in patients with a lower extremity amputation but in our opinion the 
problem subscale score is not appropriate for bone-anchored prosthesis users because some 
question relate specifically to socket prostheses.
In four12,18,20,51 of the five cohort studies, the results for several outcome indicators were 
based on asymmetrical pre- and post-surgery samples. Because the differences in participant 
numbers were small we consider it unlikely that this biased the results. The study of Hagberg 
et al.51 may have suffered from selection bias. This study used the same sample as Branemark 
et al.20, but without the patients with a bilateral transfemoral amputation (n = 6) and the 
patients who were lost to follow up (n = 6). Given the very small differences between these 
two studies20,51 with respect to SF-36 and Q-TFA scores we consider it unlikely that this biased 
our findings.
A number of factors decreased the generalisability of the findings of this review. Firstly, 
socket-related problems are the main reason for receipt of a bone-anchored prosthesis, so it 
is possible that the socket prosthesis patients in the cohort studies were not representative 
of the general population of socket prosthesis users. It is possible that the socket-related 
problems experienced by these patients meant that their outcomes at baseline (before bone-
anchored prosthesis surgery) were inferior to those of socket prosthesis users in general, 
which may have resulted in an overestimation of the influence of bone-anchored prostheses 
on the outcomes discussed in our review, especially concerning QoL level, prosthesis wearing 
time, mobility level and walking ability. Secondly, only two groups of researchers from two 
different countries were represented in the studies included in this review (Sweden and the 
Netherlands), although bone-anchored prosthesis surgery is performed in several countries 
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(e.g. Sweden, Germany, Australia and the Netherlands). However, the studies of Khemka et 
al.54,55 and Schalk et al.56 discussed above revealed studies of additional independent groups 
of researchers in the Netherlands and Australia. This resulted in a broader perspective of 
the used measurement instruments in evaluation of BAP surgery. Condition-specific QoL 
was assessed with the Q-TFA by three groups of researchers, although it was used in slightly 
different ways. General QoL was assessed with the SF-36 by two groups of researchers. 
Walking ability is assessed by the 6-Minute Walk Test and Timed Up & Go by two groups 
of researchers. Lastly, none of the studies included bone-anchored prosthesis users with a 
transtibial amputation, although bone-anchored prosthesis surgery is also performed in this 
population22,61. Khemka et al.55 discussed a very specific bone-anchored prosthesis transtibial 
amputation population with additional total knee replacement, but published peer-reviewed 
bone-anchored prostheses studies with functional outcomes in the general population with 
a transtibial amputation are lacking.
A strong point of this review is that this is the first systematic review that provides an 
overview of the measurement instruments used to evaluate outcomes in terms of QoL, 
function, activity and participation level in studies comparing bone-anchored prostheses and 
socket prostheses for patients with a lower extremity amputation. Furthermore, the use of 
the ICF to structure the used measurements and outcomes of bone-anchored prostheses 
surgery is a strength. The high level of agreement between the two reviewers about ratings 
of methodological quality is a further strength; there was complete agreement about global 
EPHPP scores and a high level of agreement about domain ratings scored.
This review has revealed the lack of consensus about choice of instruments for evaluating 
interventions for patients with a lower extremity amputation. Samuelson et al.40 reached a 
similar conclusion, noting that fourteen different measurement instruments were used to 
evaluate QoL, activity level and participation level across eight studies of the effectiveness 
studies of socket prostheses. Deathe et al.62 identified 17 instruments that had been used to 
assess the outcome of lower extremity amputation rehabilitation in socket prostheses patients 
in terms of function, activity and participation level and further concluded that there was a 
lack of good evidence demonstrating their sensitivity. The overlap in instruments considered 
in these reviews40,62 and this review is very small, being limited to the SF-3640, Q-TFA40,62 and 
Timed Up & Go.62 This shows that there is little agreement about how to evaluate the outcome 
of rehabilitation from lower extremity amputation, except with respect to QoL indicators. 
This hinders comparison of studies and reduces the generalisability of findings.
Recommendation for future research
First of all it is important to develop a standard set of evaluation instruments based on the 
ICF in order to provide a common method of assessing interventions for patients with a lower 
extremity amputation.63 The first steps towards this have already been taken by Kohler et al.64 
In our opinion the core set should cover QoL (condition-specific and general); various aspects 
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of function level, namely pain (e.g., residual limb and phantom limb), range of motion, 
muscle strength (e.g., hip abductor) and gait quality (e.g., use of compensation strategies 
in coronal plane); various aspects of activity level, namely walking ability (e.g., 6-Minute 
Walk Test and Timed Up & Go), physical activity level in daily life (e.g., accelerometer) and 
energy costs (e.g., physiological cost index); and indicators of participation level (e.g. return 
to work). Secondly, there is a need for further research into the clinometric properties of the 
instruments currently in use.62 Moreover, new instruments should be developed specifically 
for use in bone-anchored prostheses users, covering aspects of outcome such as stoma 
related problems, residual limb pain as result of reactivating muscles and sensation during 
terminal impact in the swing phase during gait as a result of osseoperception. There is also a 
need for consensus about the time points at which follow-up assessments should be carried 
out so that future data can be subjected to meta-analysis. We suggest that pre-operative 
assessment and a one, two, five, ten and twenty year post-operative follow-ups should be 
used to capture short- and long-term results. There is also a need for greater understanding 
of factors which predict improvements in QoL, function and activity level following bone-
anchored prosthesis surgery to allow medical professionals and health insurance companies 
to predict which patients are likely to benefit from the procedure. A cost effectiveness study 
should be carried out to explore whether the combination of QoL improvement presented 
in this review and post-surgery costs presented by Haggstrom et al.26 makes bone-anchored 
prostheses a more cost effective intervention than socket prostheses for patients with 
a transfemoral amputation. The numbers lost to follow-up in the studies included in this 
review were low, despite the fact that in 6-11% of participants amputation was due to causes 
other than trauma and cancer, for example arterial embolus and infection. This suggests that 
the eligibility criteria for receipt of a bone-anchored prosthesis could be broadened, but a 
systematic review of evidence on implant survival and infection rates would be needed to 
confirm this.
To provide a comprehensive picture of the differences in outcome with bone-anchored 
prostheses and socket prostheses it would be necessary for all clinicians and researchers 
involved with bone-anchored prostheses surgery and rehabilitation to publish not only their 
infection and survival data, but also data on outcome in terms of QoL, function, activity and 
participation level at both at short- and long-term follow-ups. It is also important to publish 
data on transtibial bone-anchored prosthesis users to facilitate evaluation of the value of 
bone-anchored prosthesis surgery for transtibial socket prosthesis users who suffer from 
socket-related problems or limited prosthetic use.
CONCLUSION
This systematic comparison of outcomes with bone-anchored prostheses and socket 
prostheses revealed that there is consensus about how to evaluate QoL; however, there is 
little consistency in the instruments used to evaluate function, activity and participation level. 
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We found limited evidence that in patients with a transfemoral amputation use of a bone-
anchored prostheses use increased condition-specific and general physical QoL compared 
with socket prostheses use, and was associated with higher function and activity.
The findings are of clinical relevance to patients with a lower extremity amputation who are 
considering bone-anchored prosthesis surgery, professionals in the surgery and rehabilitation 
field and health insurance companies; they should help these groups to make well-informed 
choices. The review should also help professionals to choose instruments for the comparative 
evaluation of bone-anchored prostheses and socket prostheses and facilitate comparison of 
OPRA, EEFP and future implants. Furthermore, we hope that this review will lead to more 
research into bone-anchored prostheses use.
IMPLICATIONS FOR REHABILITATION
• Use of bone-anchored prostheses in combination with intensive outpatient rehabilitation 
may improve QoL, function and activity level compared with socket prosthesis use in 
patients with a transfemoral amputation and socket related-problems.
• All clinicians and researchers involved with bone-anchored prostheses should use and 
publish data on QoL, function, activity and participation level.
• There needs to be agreement on a standard set of instruments so that interventions for 
patients with a lower extremity amputation are assessed consistently.
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APPENDIX 1. SEARCH STRATEGY (16-04-2016)
MEDLINE (accessed by PubMed) => 133 hits:
(Amputation[MeSH] OR Amputees[MeSH] OR Amputation, Traumatic[MeSH] OR Amputation 
Stumps[MeSH] OR Amput*[Title/Abstract]) AND (osseointegration[MeSH Terms] OR osseointegrat*[Title/
Abstract] OR osseo-integrat*[Title/Abstract] OR bone-anchored prosthe*[Title/Abstract])
Cochrane Central Register of Controlled Trials => 2 hits:
#1 MeSH descriptor: [Osseointegration] explode all trees
#2 osseointegrat*:ti,ab,kw (Word variations have been searched)
#3 “osseo-integrated”:ti,ab,kw (Word variations have been searched)
#4 “osseo-integrate”:ti,ab,kw (Word variations have been searched)
#5 “osseo-integrat”:ti,ab,kw (Word variations have been searched)
#6 “osseo-integration”:ti,ab,kw (Word variations have been searched)
#7 “bone-anchored prostheses”:ti,ab,kw (Word variations have been searched)
#8 “bone-anchored prosthesis”:ti,ab,kw (Word variations have been searched)
#9 “bone-anchored prosthetics”:ti,ab,kw (Word variations have been searched)
#10 MeSH descriptor: [Amputation] explode all trees
#11 MeSH descriptor: [Amputation Stumps] explode all trees
#12 MeSH descriptor: [Amputation, Traumatic] explode all trees
#13 ampu*:ti,ab,kw (Word variations have been searched)
#14 MeSH descriptor: [Amputees] explode all trees
#15 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9) and (#10 or #11 or #12 or #13 or #14)
Embase (accessed by EBSCO) => 148 hits:
‘prosthesis implantation’/exp OR osseointegrat*:ab,ti OR ‘osseo-integrated’:ab,ti OR ‘osseo-
integrate’:ab,ti OR ‘osseo-integrat’:ab,ti OR ‘osseo-integration’:ab,ti OR ‘bone-anchored prostheses’:ab,ti 
OR ‘bone-anchored prosthesis’:ab,ti OR ‘bone-anchored prosthetics’:ab,ti AND (‘amputation’/exp OR 
amput*:ab,ti OR ‘disabled person’/exp OR ‘disabled person’:ab,ti)
CINAHL => 43 hits:
( (MH “Amputation+”) OR (MH “Amputation, Traumatic”) OR (MH “Amputees”) OR (TI amput*) OR (AB 
amput*) ) AND ( (TI osseointegrat* ) OR (AB osseointegrat* ) OR (TI “osseo-integrat*”) OR (AB “osseo-
integrat*”) OR (TI “bone-anchored prosthe*”) OR (AB “bone-anchored prosthe*”) )
Web of Science => 143 hits:
TOPIC: (osseointegrat* OR osseo-integrat* OR bone-anchored prosthe*) AND TOPIC: (amput*)
Total: 469 hits
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ABSTRACT
Background
In patients with a transfemoral amputation socket-related problems are associated with 
reduced prosthetic use, activity, and quality of life. Furthermore, gait asymmetries are 
present that may explain secondary complaints. Bone-anchored prostheses (BAPs) may help 
these patients. Two types of BAP are available, screw and press-fit implants. Rehabilitation 
following surgery for a press-fit BAP is poorly described.
Purpose
To describe a rehabilitation programme designed to minimise compensation strategies 
and increase activity using a case-report of an active, 70-year-old man with a traumatic 
transfemoral amputation who had used a socket prosthesis for 52 years and received a press-
fit BAP [Endo-Exo Femoral Prosthesis - EEFP].
Intervention
A 13-week physiotherapy programme.
Outcomes
Outcomes were assessed before surgery, at the end of rehabilitation, and six-month and one-
year follow-ups. After rehabilitation gait had improved, the patient had more arm movement, 
more pelvic shift, less hip rotation during swing phase on the prosthetic side, and absence 
of vaulting on the sound side. Isometric hip abductor strength was 15% higher on the sound 
side and 16% higher on the prosthetic side, and walking distance increased from 200 m to 
1500 m. At the six-month follow-up, the patient had lower back complications and reduced 
hip abductor strength and walking distance. At one-year follow-up, walking distance had 
recovered to 1000 m and gait pattern had improved again, with yielding and absence of 
terminal impact on the prosthetic side.
Conclusion
The described rehabilitation programme may be an effective method of improving gait in 
patients with an EEFP even after long-term socket usage.
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INTRODUCTION
The incidence of lower extremity amputation in the Netherlands is 18 to 20 per 100,000; 
90-94% of lower extremity amputations are due to vascular disease, 3% to trauma and 3% 
to tumour resection.1 Approximately 86% of patients are fitted with a socket prosthesis (SP) 
after amputation.1 The most important reasons for not fitting a SP are poor general health, 
oncological complications, and stump and wound healing problems.2 Between 34% and 63% 
of patients with a SP have chronic skin problems and pain associated with the socket.3-7 These 
skin problems often seriously limit use of the prosthesis and, hence, activity level and quality 
of life (QoL).3,5,8-10
A further problem is that during gait, pelvic and thoracic angular ranges of motion (ROMs) 
are higher for patients with a lower extremity amputation than in able-bodied persons.11 
Often ipsilateral lateral flexion of the trunk over the stance limb, combined with a passive 
contralateral pelvic tilt (pelvic hike), is used to prevent the contralateral pelvic drop caused 
by hip abductor insufficiency.12-15 The lateral displacement of the body centre of gravity (CG) 
in the frontal plane, referred to as the pelvic shift movement, also tends to be absent.13-15 
Gait symmetry is variable; for example, higher amputations are associated with larger gait 
asymmetries of the pelvis and trunk motion.11,12,16 Although some patients achieve a more 
symmetrical gait, with smaller thoracic ROM and a more stable pelvis during the stance 
phase, the gait asymmetries are still more evident than in able-bodied persons.13,16 Moreover, 
compared with able-bodied persons, SP users have reduced outdoor walking distances, lower 
walking velocity, and shorter stance phase; the energy costs of walking are also higher in 
these patients.11,14,17,18 The changes in gait may account for lower back pain (LBP) and pain in 
other regions such as the stump, sound side, buttocks, hips and neck and shoulder.19 
One treatment option for SP users with socket-related problems is to attach the prosthesis 
to the skeleton transcutaneously by osseointegration using an intramedullary femoral 
implant.20 At present, there are two types of implant suitable for bone-anchored prostheses 
(BAPs): the Osseointegrated Prosthesis for the Rehabilitation of Amputees (OPRA) and the 
Endo-Exo Femoral Prosthesis (EEFP).20-23 Both are intramedullary implants, but the OPRA 
is a titanium screw and the EEFP a cobalt-chrome press-fit fixation.20-22 The patient with 
a transfemoral amputation whose case is reported here received an EEFP, also known as 
an Integral Leg Prosthesis (AQ Implants GmbH).8 The surgical procedure for fitting an EEFP 
consists of two steps.24 First, a cementless intramedullary femur prosthesis with a spongiosa 
metal-configured relief surface is inserted, and the skin is closed. Six weeks later, a soft tissue 
stoma is created, and the transcutaneous osseointegration prosthesis unit is bolted into the 
implant.24 Improved gait quality represents one potential advantage of a BAP over a SP.25-27 A 
comparison of BAP and SP users found that BAP users had a greater hip ROM during use of 
the prosthesis.26 Another study reported that BAP use increased hip extension and decreased 
anterior pelvic tilt compared to SP use, although gait still differed from that of able-bodied 
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persons.27 Cadence, duration of the gait cycle, and duration of the support phase of BAP 
users are also more similar to those of able-bodied persons than of SP users.25 A further 
advantage of BAP is the improved sensory feedback, known as osseoperception, resulting 
from the direct link between the prosthesis and skeletal system.20,24,28,29 OPRA rehabilitation 
has been extensively described, but there are few descriptions of rehabilitation for patients 
with EEFP in the peer-reviewed literature.8,24,30
The aim of this case report was to describe the use of an EEFP protocol and gait training 
programme designed to decrease use of compensation strategies and increase activity level. 
We report a case of a 70-year-old man with a transfemoral amputation who received an EEFP 
after having used an SP for 52 years. Rehabilitation following EEFP surgery was in accordance 
with the Radboud university medical centre rehabilitation protocol (Radboudumc Amputation 
protocol EEFP; RAp-EEFP).
CASE DESCRIPTION
A 70-year-old man (1.78 m and 81.0 kg without prosthesis) who had undergone a right-
side traumatic transfemoral amputation at 18 years was referred to the outpatient clinic 
with socket-related folliculitis at the proximal socket edge and ischial tuberosity lesions. A 
rehabilitation physician and trauma surgeon recommended EEFP.8 The patient had a history 
of several transient ischaemic attacks, cardiac arrhythmia, and a cerebral vascular accident 
that resulted in temporary problems with memory, taste, and balance that had resolved by 
the time of admission. The patient had full ROM in the hip joint, the hybrid SP was functioning 
well, and it could be used all day despite the socket-related problems; however, walking 
distance was short (200 m). The patient was able to walk unaided on flat, uneven, and 
steep surfaces and could climb stairs. During the previous five years the prosthesis had been 
modified three times in an attempt to reduce skin problems.
The patient was referred to the physical therapist for a pre-operative baseline assessment 
of functioning using his SP. The patient’s primary rehabilitation aim was to be able to walk 
with reduced use of compensatory strategies during common daily activities. A secondary 
goal was to be able to cycle. Surgery was performed according to protocol.8 Between the 
second surgery and commencement of rehabilitation, a three-day hospital admission was 
necessary due to distal inflammation of the stump, which was treated with antibiotics and 
wound lavage.
PRE-OPERATIVE EXAMINATION
See Table 1 for the findings.
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Gait pattern
Gait was recorded on video, displayed using Dartfish® software, and analysed using a 
modification of the Gait Analysis List Nijmegen (GALN) referred to as the Gait Analysis 
List Amputation Nijmegen (GALAN); see Appendix 1.31 During walking, the patient walked 
with less ipsilateral than contralateral arm movement. During the stance phase there was 
ipsilateral lateral flexion of the trunk, lack of pelvic shift, passive pelvic hike, and absence of 
yielding on the prosthetic side. During the early swing phase, there was internal rotation of 
the hip and a rapid forward movement of the lower leg resulting in over-forced full extension 
of the knee during the late swing phase (hard terminal impact) on the prosthetic side. On the 
sound, side the patient showed vaulting in the mid stance phase and an increased plantar 
flexion in the early stance phase. Investigation of the cause of the increased plantar flexion 
was deferred until the start of post-surgery rehabilitation.
Hip abductor strength
Eccentric maximal strength was measured using a handheld dynamometer (HHD; Hogan 
microFET2TM). The patient was tested in a supine position. The HHD was placed 15 cm distal 
from the greater trochanter and a ‘break’-test was used (Appendix 2). The HHD has good 
intra- and inter-rater reliability and good validity.32 Maximal hip abductor force was lower on 
the prosthetic side than the sound side (Table 1).
Walking distance
Self-reported walking distance in everyday life (Table 1) was measured using the question: 
‘How far can you walk in one go in everyday life?’.
POST-OPERATIVE EXAMINATION
At the start of rehabilitation, the wound showed no signs of inflammation and pain was zero 
(self-report using an eleven-point (0-10) Likert scale). On the sound side, there was crural 
hypoesthesia and reduced in strength in both dorsal and plantar flexion, four on the five-
point Medical Research Council (MRC) scale. Measurement of ankle ROM using a standard 
goniometer (Mathys) demonstrated 10° deficit in dorsiflexion to the neutral (0°) position. The 
patient was fitted with a modified shoe to correct the dorsal flexion deficit.
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INTERVENTION
The RAp-EEFP focuses on improving hip abductor strength, core stability, and gait quality. 
The clinical rationale for the protocol is presented in Figure 1. Figure 2 summarises the 
rehabilitation schedule; however, progress depends on the patient’s pain and how long it 
takes before he or she can execute the tasks correctly. The standard rehabilitation schedule is 
indicated in grey in Table 2, and the patient’s progress is indicated with crosses. The patient 
trained under the supervision of an experienced physical therapist for two hours twice weekly 
and independently five times a week.
Figure 1. Flowchart showing clinical reasoning
Figure 2. Timeframe of the measurements and the interventions
T: follow-up moment.
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Table 2. Radboudumc Amputation rehabilitation protocol for Endo-Exo Femoral Prosthesis;
Supervised training sessions: 1 2 3 4 5 6 7 8 9
Phase 1 (short prosthesis):          
1) Symmetric posture training x1 x x x      
2) Pelvic shift x1 x2 x3 x4      
3) Active pelvic tilt x1 x2 x3 x4      
4) Entire stance phase x2 x3 x4      
5) Hip mobility/strength and core stability x x x x      
6) Fall and rise up strategies x      
7) Pendulum exercises x      
Phase 2 (full length prosthesis):
1) Hip mobility/strength and core stability x x x
2) Using the click-safety adapter x x
3) Symmetric posture training x x x x x
4) Pelvic shift x x x x x
5) Active pelvic tilt x x x x x
6) Entire stance phase x x x x x
7) Swing phase x x x
8) Gait training between bars x x
9) Gait training with 2 crutches in 3-point gait x
10) Gait training with 2 crutches in 2-point gait
11) Gait training with 2 canes in 2-point gait
12) Gait training without walking aids
13) Stair climbing
14) Gait training with at different velocities
15) Gait training on uneven surfaces
16) Several gait forms: sideways, backwards,      
stopping, turning, slalom
17) Gait training on slopes
18) Fall and rise up strategies
19) Gait training with obstacles
20) Gait training and skills with dual tasks
21) Circuit training
22) Cycling
23) Pendulum exercises x x
24) Cycling on a stationary bike x x
1: maximum of 40kg; 2: maximum of 60kg; 3: maximum of 75 kg; 4: maximum of 81kg
= General rehabilitation timetable;  x =  Patient’s actual progress
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 13 week rehabilitation programme
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Phase 1: pre-prosthesis phase
The pre-prosthesis phase of intervention started two weeks after surgery. It was designed 
as a practical home-based programme of partial axial load bearing on the short prosthesis 
using standard bathroom scales (Soehnle Form). Axial load training was based on the OPRA 
protocol.29,30 Initially, rehabilitation consisted of two 30-minute sessions, increasing to three 
1-hour sessions with full weight bearing; load and exact exercise time were dependent on 
stump pain. To prevent overload pain had to be less than five on the eleven-point (0-10) 
Numerical Rating Scale (NRS). Because the load on the EEFP can be increased more quickly, 
this phase of rehabilitation is shorter than described in the OPRA protocol; full body weight 
bearing can be achieved in two weeks.24
To encourage a normal pattern of axial load during gait, pelvic shift and hip abductor 
activation (tilt) were trained during the mid stance phase using standard bathroom scales.12,14,15 
Thereafter, training consisted of practicing the early and late stance phases.
In phase 1 and 2 hip mobility, hip strength and core stability were trained functionally 
once daily. Hip strength was trained with an elastic resistance band, starting with two sets 
of 10 repetitions using a resistance that produced muscle fatigue. In the case reported 
here, the patient started exercising with a blue (extra heavy; 3.2 kg) resistance band from 
TheraBand®. The number of repetitions was gradually increased to four sets of 20 and then 
increased further by changing the resistance band.36 Because strength training depended 
on the number of repetitions required to produce muscle fatigue it was easy to adjust the 
programme to a more aggressive exercise programme.36 Core stability was trained using core-
specific floor exercises (Appendix 3).37
Phase 2: prosthesis phase
The prosthesis phase started four weeks after the second surgical procedure when the 
prosthesis was attached to the transcutaneous unit using a click-safety adapter (OTN).8 
Alignment of the prosthesis was performed with LASAR® (Otto Bock). The patient’s personal 
prosthesis parts were used in this phase (Table 1). The prosthesis was aligned to provide a 
narrow support base in the frontal plane in order to reduce the amount of pelvic shift needed 
during the stance phase.15 During phase 2, the original Multiflex (Endolite) prosthetic foot 
was changed to a 1C30 Trias (Otto Bock) because the original did not function well in the 
early stance phase. 
The intensity and load criteria for training in phase 2 were similar to those for phase 1. 
Initially, gait training was performed using parallel bars and the same load bearing as has 
been performed with the short prosthesis in phase 1. When the patient could perform 
these exercises correctly he progressed to swing phase exercises and walking between the 
bars. When the gait pattern was acceptable, crutches were introduced and the patient was 
instructed to use the prosthesis in everyday life. Weight bearing was increased depending 
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on pain (NRS < 5), and the patient was given feedback based on the video analysis of his 
gait pattern. The patient was advised to do pendulum exercises or to cycle on a stationary 
bike without any load when suffering from muscle tension or stump pain.38,39 The patient 
practiced at different walking velocities and walking on uneven surfaces. When the patient 
demonstrated acceptable two-point gait with two canes, he progressed to unaided gait 
training, and more complex gait skills such as slope walking, negotiating obstacles, and dual 
tasks were introduced. At the end of phase 2, the patient practised cycling using a bike with 
a low entry with his prosthetic foot fixed to the pedal. Rehabilitation was finished when the 
patient was able to walk without crutches, to perform complex gait, to climb stairs with 
acceptable gait quality and to ride a bike; this point was reached after 12 weeks of supervised 
training. The patient’s training diary showed that prosthesis wearing time increased 
progressively from the start of phase 2.
Phase 3: advanced prosthesis phase
Patients with BAPs may receive advanced prosthesis training if they have specific work-
related problems or receive new prosthetic parts, especially new micro-processed prosthetic 
knees. Our patient received a C-leg knee (Otto Bock) seven months after his second surgery. 
Following this, he had three training sessions with the prosthetist and the physiotherapist 
to adjust the alignment of the prosthesis and for gait re-education. At the six-month follow-
up, he reported LBP from degenerative disc disease in the 4th and 5th lumbar vertebrae. 
This was treated with an epidural steroid injection ten months after the second surgery; and 
thereafter, the LBP diminished and he was able to carry out strength and gait training at home 
as intensively as before the period of LBP.
OUTCOMES
Assessments were carried out at the pre-operative examination, at the end of rehabilitation, 
and six-month and one-year follow-ups. The primary outcomes were gait quality (assessed 
with the GALAN), hip abductor strength (assessed with a HHD) and self-reported maximum 
continuous walking distance (in meters). Secondary outcomes were cadence, prosthesis 
wearing time, use of a walking aid in everyday life, Special Interest Group in Amputee 
Medicine Workgroup Amputation and Prosthetics (SIGAM WAP) mobility scale score33, 
questionnaire for patients with a transfemoral amputation (Q-TFA) global score34, Prosthesis 
Comfort Score (PCS), ISO stump characteristics35 and LBP. The PCS is an indicator developed 
specifically for this case. It is a modification of the Socket Comfort Score40, the patient was 
asked ‘How satisfied are you with your current prosthesis on a scale of 0 to 10, where 0 
means ’not satisfied at all’ and 10 means ‘extremely satisfied’?’.
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The patient was asked to record prosthesis wearing time, level of stump pain, and location 
of pain during exercising in a paper diary throughout phases 1 and 2 of his rehabilitation, to 
provide an indication of the intensity of home training. The patient was advised to use pain 
medication as necessary in order to maintain a pain score of less than five during exercising 
and to record the dosage used at the end of each day. The diary was checked at every 
supervised training session and a summary of the contents is presented in Appendix 4.
Gait analysis was performed more frequently in order to monitor progress (i.e. in weeks 5, 
7, 8, 9 and 12 of rehabilitation).
Primary outcomes
Prosthetic parts varied over the course of the assessment period; the used parts are noted 
in Table 1.
Gait pattern
The GALAN score indicated that gait improved relative to the pre-operative assessment at 
the end of rehabilitation and the six-month and one-year follow-ups in terms of more arm 
movement, more pelvic shift, less hip rotation during the swing phase on the prosthetic side, 
and absence of vaulting at the sound side. At the one-year follow-up, which was after receipt 
of the C-Leg knee (Otto Bock), the GALAN score had improved by an additional two points, 
representing the presence of yielding during the early stance phase and the absence of hard 
knee extension during the late swing phase. No change of plantar flexion of the ankle on the 
sound side was detected during the one-year follow-up period.
Hip abductor strength
Maximal eccentric strength was higher on both sides after rehabilitation than at the pre-
operative assessment, but had reduced to below pre-operative levels at six-month and one-
year follow-ups (Table 1).
Walking distance
Self-reported walking distance in everyday life improved over time, but the score at the six-
month follow-up was lower, presumably owing to the patient’s LBP; following treatment, 
walking distance increased again.
Secondary outcomes
Cadence did not change substantially over time (Table 1). Prosthesis wearing time increased 
with one hour a day. The SIGAM WAP mobility score showed that the patient was most active 
at the end of rehabilitation and one year after surgery. At the end of rehabilitation and one 
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year after surgery, the Q-TFA global score and PCS were 25 points and three points higher, 
respectively, compared to the pre-operative assessment. Gains were smaller at the six-month 
follow-up. The ISO stump characteristics indicated that the stump was shorter and thicker 
relative to the pre-operative assessment at the end of rehabilitation and the six-month and 
one-year follow-ups.
DISCUSSION
Chronic compensatory gait strategies, hip abductor strength, and walking distance all 
improved after rehabilitation; the improvements in gait and walking distance were maintained 
at the one-year follow-up. Outcomes were worse at the six-month follow-up presumably due 
to severe LBP the patient suffered as a result of lumbar degenerative disc disease.
As expected, the sound side was stronger than the prosthetic side both pre-operatively 
and after rehabilitation; however, there was a response to training on both sides, which is 
consistent with previous reports.17,41,42 The bilateral increase in strength is consistent with 
the improvement in gait pattern and supports the hypothesis that poor gait may be due to 
hip abductor insufficiency on the prosthetic side.14,16 Moving from a SP to an EEFP may have 
improved gait pattern because of the beneficial effects on hip and pelvic motion, muscle 
force transmission, and osseoperception.24,27 Previous studies also noted an increase in Q-TFA 
global score after converting from SP to BAP.8,21,43,44 The magnitude of the increase in this 
case (25 points) is in line with another one-year follow-up of patients with press-fit BAPs.8 
In our patient, the improvement was evident at the end of rehabilitation training and was 
also evident at the one-year follow-up, although there was a dip around the time of the six-
month follow-up which can be attributed to severe LBP caused by degenerative disc disease. 
This is important because it suggests that with this protocol there are improvements of QoL 
by the end of formal rehabilitation. Studies of patients who received screw BAPs reported 
greater improvements in Q-TFA global score one year (37 points) and two years (37-39 
points) after surgery; however, in these cases, baseline scores (36-38 points) were lower 
than in our patient (50 points).21,43,44 Reported prosthesis wearing time was slightly higher 
after EEFP rehabilitation than at the pre-operative assessment, but there was a greater 
improvement in maximum walking distance to which the lack of socket-related skin problems 
may have contributed. It was obvious in this case that walking distance was also influenced 
by LBP (absent at the end of rehabilitation, present at the six-month follow-up, and absent 
at one-year follow-up). The increased PCS and Q-TFA global score confirmed that the patient 
experienced less problems with the prosthesis and increased QoL. In our opinion, the 
decrease in experienced prosthesis problems was clinically relevant because this suggested a 
further improvement in functioning with the prosthesis over time.
To our knowledge, this is the first report to describe a physical therapy intervention for 
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a patient with BAP that focused on gait quality. Some studies have reported changes in gait 
following replacement of a SP with a BAP, but the results are mixed. Hagberg et al.30 concluded 
that patients should be aware that their gait pattern might not change significantly, whereas 
Tranberg et al.27 concluded that gait pattern improved significantly with respect to the typical 
socket-related gait abnormalities, namely reduced hip extension and increased anterior 
pelvic tilt. We suggest that good gait pattern is essential to the prevention of secondary 
complaints in patients with an amputation, especially in patients whose amputation was due 
to a nonvascular cause, who are more likely to be young and still active and productive.19,27,45 
The RAp-EEFP was designed for patients with a press-fit BAP, but the programme includes 
elements such as muscle strength training and gait re-education that are also suitable 
for patients with a SP as it is important to adjust the typical biomechanical patterns used 
by SP users.13 The patient’s personal prosthesis parts were used throughout phase 2 of 
rehabilitation. We hypothesise that changes in prosthetic parts may lead to changes in 
alignment, and thus influence gait strategies. Lee et al.46 concluded that common activities 
of everyday life also require different gait strategies to control the prosthetic knee joint. This 
implies that exchanging parts in the first weeks of phase 2 should be avoided because it is 
likely to disrupt gait re-education.
One limitation of this case report is that the psychometric properties of the GALAN, which 
was used to measure gait quality, and the HHD procedure used to measure hip abductor 
strength are not known and no reference data are available. The reliability of the GALAN 
and the strength test are now in preparation. The gold-standard gait analysis instrument, 
Vicon®, and strength measurement tools such as Biodex® are reliable and valid, but they 
are not suitable for use in routine clinical practice.47 This case report demonstrates that the 
GALAN is not sensitive to subtle differences in gait that can be detected with laboratory tests. 
The GALAN characterises gait in terms of the presence or the absence of the most common 
gait strategies; it does not provide a continuous measure of deviation from the norm. In 
our opinion, it is especially important to be able to track the patient’s progress during the 
rehabilitation process. Using an accelerometer in combination with an instrument that 
measures temporal parameters of gait, such as a transducer or GAITRite®, might provide more 
precise information about deviation.25,48,49 A transducer would also provide more insight into 
dynamic forces and moments on the prosthetic limb, and load bearing in early rehabilitation 
could be monitored more accurately than with bathroom scales.50-53 The Microsoft Kinect® 
also has promise as a clinical tool for measuring gait deviations.54
Maximal strength test was assessed in the supine position, a gravity neutralised position, 
to prevent bias due to different weight of the residual and sound limb; however, because 
force was applied with a HHD, the patient not only had to compete with the therapist but 
also had to stop himself from sliding along the table. The strength of the therapist might 
also affect the results owing to the short lever arm, because this demands more force of the 
examiner to overcome force production capacity of the patient.55 However, in this case, all 
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measurements were made by the same experienced therapist using a standardised protocol 
to reduce bias. Walking distance in everyday life was self-reported and therefore potentially 
biased.
The use of a patient diary is a strength of this case report as it allowed us to track changes 
in prosthesis wearing time, training intensity, and problems (i.e. pain) executing scheduled 
training. In the first week of phase 2, the pain was located in the greater trochanter area; 
thereafter, the pain was mainly located at the distal side of the stump. The diary also showed 
that pain increased when the patient started walking between bars but diminished with 
training. By using pain medication the patient was generally able to maintain a pain score 
of less than five. The value of this case report is that it provides a detailed description of the 
EEFP protocol and demonstrates that gait quality could be improved even in this patient who 
was a long-term SP user.
A randomised controlled trial is needed to evaluate the added value of rehabilitation 
programmes that focus on gait quality. Further, research is also needed to develop clinically 
usable tools for assessing gait quality and hip abductor strength in patients with a lower 
extremity amputation.
CONCLUSION
The patient showed clinically important improvements in gait pattern and hip abductor 
strength after a 12-week rehabilitation programme following EEFP surgery relative to his pre-
operative performance when using an SP.
This case report shows that gait quality is important in addition to outcomes of activity 
level.
ACKNOWLEDGEMENTS
We thank Joanne Postma for reading and correcting the manuscripts.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 84
84
3
REFERENCES
1. Rommers GM, Vos LD, Groothoff JW, Schuiling CH, Eisma WH. Epidemiology of lower limb 
amputees in the north of The Netherlands: aetiology, discharge destination and prosthetic use. 
Prosthet Orthot Int. 1997;21(2):92-9. Epub 1997/08/01.
2. Rommers GM, Vos LD, Groothoff JW, Eisma WH. Clinical rehabilitation of the amputee: a 
retrospective study. Prosthet Orthot Int. 1996;20(2):72-8.
3. Butler K, Bowen C, Hughes AM, Torah R, Ayala I, Tudor J, et al. A systematic review of the key 
factors affecting tissue viability and rehabilitation outcomes of the residual limb in lower extremity 
traumatic amputees. J Tissue Viability. 2014;23(3):81-93.
4. Dudek NL, Marks MB, Marshall SC, Chardon JP. Dermatologic conditions associated with use of a 
lower-extremity prosthesis. Arch Phys Med Rehabil. 2005;86(4):659-63.
5. Hagberg K, Branemark R. Consequences of non-vascular trans-femoral amputation: a survey 
of quality of life, prosthetic use and problems. Prosthet Orthot Int. 2001;25(3):186-94. Epub 
2002/02/28.
6. Lyon CC, Kulkarni J, Zimerson E, Van Ross E, Beck MH. Skin disorders in amputees. J Am Acad 
Dermatol. 2000;42(3):501-7. Epub 2000/02/25.
7. Meulenbelt HE, Geertzen JH, Jonkman MF, Dijkstra PU. Determinants of skin problems of the 
stump in lower-limb amputees. Arch Phys Med Rehabil. 2009;90(1):74-81. Epub 2009/01/22.
8. Van de Meent H, Hopman MT, Frolke JP. Walking ability and quality of life in subjects with 
transfemoral amputation: a comparison of osseointegration with socket prostheses. Arch Phys 
Med Rehabil. 2013;94(11):2174-8. Epub 2013/06/19.
9. Dillingham TR, Pezzin LE, MacKenzie EJ, Burgess AR. Use and satisfaction with prosthetic devices 
among persons with trauma-related amputations: a long-term outcome study. Am J Phys Med 
Rehabil. 2001;80(8):563-71.
10. Demet K, Martinet N, Guillemin F, Paysant J, Andre JM. Health related quality of life and related 
factors in 539 persons with amputation of upper and lower limb. Disabil Rehabil. 2003;25(9):480-
6.
11. Goujon-Pillet H, Sapin E, Fode P, Lavaste F. Three-dimensional motions of trunk and pelvis during 
transfemoral amputee gait. Arch Phys Med Rehabil. 2008;89(1):87-94.
12. Michaud SB, Gard SA, Childress DS. A preliminary investigation of pelvic obliquity patterns during 
gait in persons with transtibial and transfemoral amputation. J Rehabil Res Dev. 2000;37(1):1-10. 
Epub 2000/06/10.
13. Molina-Rueda F, Alguacil-Diego IM, Cuesta-Gomez A, Iglesias-Gimenez J, Martin-Vivaldi A, 
Miangolarra-Page JC. Thorax, pelvis and hip pattern in the frontal plane during walking in unilateral 
transtibial amputees: biomechanical analysis. Braz J Phys Ther. 2014;18(3):252-8.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 85
85
Chapter 3 | Rehabilitation following transfemoral osseointegration implant surgery
3
14. Sjodahl C, Jarnlo GB, Soderberg B, Persson BM. Pelvic motion in trans-femoral amputees in the 
frontal and transverse plane before and after special gait re-education. Prosthet Orthot Int. 
2003;27(3):227-37. Epub 2004/01/20.
15. Perry J. Gait Analysis: Normal and Pathological Function (2nd ed). Thorofare, New Jersey, SLACK 
Incorporated. 2010.
16. Tazawa E. Analysis of torso movement of trans-femoral amputees during level walking. Prosthet 
Orthot Int. 1997;21(2):129-40.
17. Jaegers SM, Arendzen JH, de Jongh HJ. Changes in hip muscles after above-knee amputation. Clin 
Orthop Relat Res. 1995(319):276-84.
18. Hagberg K, Haggstrom E, Branemark R. Physiological cost index (PCI) and walking performance 
in individuals with transfemoral prostheses compared to healthy controls. Disabil Rehabil. 
2007;29(8):643-9.
19. Ehde DM, Czerniecki JM, Smith DG, Campbell KM, Edwards WT, Jensen MP, et al. Chronic phantom 
sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation. 
Arch Phys Med Rehabil. 2000;81(8):1039-44. Epub 2000/08/16.
20. Branemark R, Branemark PI, Rydevik B, Myers RR. Osseointegration in skeletal reconstruction and 
rehabilitation: a review. J Rehabil Res Dev. 2001;38(2):175-81. Epub 2001/06/08.
21. Branemark R, Berlin O, Hagberg K, Bergh P, Gunterberg B, Rydevik B. A novel osseointegrated 
percutaneous prosthetic system for the treatment of patients with transfemoral amputation: A 
prospective study of 51 patients. Bone Joint J. 2014;96-B(1):106-13. Epub 2014/01/08.
22. Aschoff HH, Clausen A, Hoffmeister T. [The endo-exo femur prosthesis--a new concept of 
bone-guided, prosthetic rehabilitation following above-knee amputation]. Z Orthop Unfall. 
2009;147(5):610-5. Epub 2009/11/26.
23. Pitkin M. Design features of implants for direct skeletal attachment of limb prostheses. J Biomed 
Mater Res A. 2013;101(11):3339-48. Epub 2013/04/05.
24. Aschoff HH, Clausen A, Tsoumpris K, Hoffmeister T. [Implantation of the endo-exo femur prosthesis 
to improve the mobility of amputees]. Oper Orthop Traumatol. 2011;23(5):462-72. Epub 
2011/11/16.
25. Frossard L, Hagberg K, Häggström E, Gow DL, Brånemark R, Pearcy M. Functional outcome of 
transfemoral amputees fitted with an osseointegrated fixation: temporal gait characteristics. J 
Prosthet Orthot. 2010;22(1):11-20.
26. Hagberg K, Haggstrom E, Uden M, Branemark R. Socket versus bone-anchored trans-femoral 
prostheses: hip range of motion and sitting comfort. Prosthet Orthot Int. 2005;29(2):153-63. Epub 
2005/11/12.
27. Tranberg R, Zugner R, Karrholm J. Improvements in hip- and pelvic motion for patients with 
osseointegrated trans-femoral prostheses. Gait & posture. 2011;33(2):165-8. Epub 2010/12/07.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 86
86
3
28. Haggstrom E, Hagberg K, Rydevik B, Branemark R. Vibrotactile evaluation: osseointegrated 
versus socket-suspended transfemoral prostheses. J Rehabil Res Dev. 2013;50(10):1423-34. Epub 
2014/04/05.
29. Sullivan J, Uden M, Robinson KP, Sooriakumaran S. Rehabilitation of the trans-femoral amputee 
with an osseointegrated prosthesis: the United Kingdom experience. Prosthet Orthot Int. 
2003;27(2):114-20. Epub 2003/10/24.
30. Hagberg K, Branemark R. One hundred patients treated with osseointegrated transfemoral 
amputation prostheses--rehabilitation perspective. J Rehabil Res Dev. 2009;46(3):331-44. Epub 
2009/08/14.
31. Brunnekreef JJ, van Uden CJ, van Moorsel S, Kooloos JG. Reliability of videotaped observational gait 
analysis in patients with orthopedic impairments. BMC Musculoskelet Disord. 2005;6:17.
32. Hebert LJ, Maltais DB, Lepage C, Saulnier J, Crete M, Perron M. Isometric muscle strength in youth 
assessed by hand-held dynamometry: a feasibility, reliability, and validity study. Pediatr Phys Ther. 
2011;23(3):289-99.
33. Rommers GM, Ryall NH, Kap A, De Laat F, Van der Linde H. The mobility scale for lower limb 
amputees: the SIGAM/WAP mobility scale. Disabil Rehabil. 2008;30(15):1106-15.
34. Hagberg K, Branemark R, Hagg O. Questionnaire for Persons with a Transfemoral Amputation 
(Q-TFA): initial validity and reliability of a new outcome measure. J Rehabil Res Dev. 2004;41(5):695-
706. Epub 2004/11/24.
35. International Standards Organization. ISO 8548-2. Prosthetics and orthotics - Limb deficiencies - 
Part 2: Method of describing lower limb amputation stumps. Geneva1993.
36. Dancewicz TM, Krebs DE, McGibbon CA. Lower-limb extensor power and lifting characteristics in 
disabled elders. J Rehabil Res Dev. 2003;40(4):337-47.
37. Martuscello JM, Nuzzo JL, Ashley CD, Campbell BI, Orriola JJ, Mayer JM. Systematic review of core 
muscle activity during physical fitness exercises. J Strength Cond Res. 2013;27(6):1684-98.
38. Ellsworth AA, Mullaney M, Tyler TF, McHugh M, Nicholas S. Electromyography of Selected Shoulder 
Musculature During Un-weighted and Weighted Pendulum Exercises. N Am J Sports Phys Ther. 
2006;1(2):73-9.
39. Childers WL, Kistenberg RS, Gregor RJ. The biomechanics of cycling with a transtibial amputation: 
Recommendations for prosthetic design and direction for future research. Prosthet Orthot Int. 
2009;33(3):256-71.
40. Hanspal RS, Fisher K, Nieveen R. Prosthetic socket fit comfort score. Disabil Rehabil. 
2003;25(22):1278-80.
41. Moirenfeld I, Ayalon M, Ben-Sira D, Isakov E. Isokinetic strength and endurance of the knee 
extensors and flexors in trans-tibial amputees. Prosthet Orthot Int. 2000;24(3):221-5.
42. Nolan L. A training programme to improve hip strength in persons with lower limb amputation. J 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 87
87
Chapter 3 | Rehabilitation following transfemoral osseointegration implant surgery
3
Rehabil Med. 2012;44(3):241-8.
43. Hagberg K, Branemark R, Gunterberg B, Rydevik B. Osseointegrated trans-femoral amputation 
prostheses: prospective results of general and condition-specific quality of life in 18 patients at 
2-year follow-up. Prosthet Orthot Int. 2008;32(1):29-41. Epub 2008/03/12.
44. Hagberg K, Hansson E, Branemark R. Outcome of percutaneous osseointegrated prostheses for 
patients with unilateral transfemoral amputation at two-year follow-up. Arch Phys Med Rehabil. 
2014;95(11):2120-7. Epub 2014/07/30.
45. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence 
of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. 2008;89(3):422-9. Epub 
2008/02/26.
46. Lee WC, Frossard LA, Hagberg K, Haggstrom E, Branemark R, Evans JH, et al. Kinetics of transfemoral 
amputees with osseointegrated fixation performing common activities of daily living. Clin Biomech 
(Bristol, Avon). 2007;22(6):665-73. Epub 2007/04/03.
47. Stark B, Emanuelsson P, Gunnarsson U, Strigard K. Validation of Biodex system 4 for measuring the 
strength of muscles in patients with rectus diastasis. J Plast Surg Hand Surg. 2012;46(2):102-5.
48. Kavanagh JJ, Menz HB. Accelerometry: a technique for quantifying movement patterns during 
walking. Gait & posture. 2008;28(1):1-15.
49. Lin SJ, Winston KD, Mitchell J, Girlinghouse J, Crochet K. Physical activity, functional capacity, 
and step variability during walking in people with lower-limb amputation. Gait & posture. 
2014;40(1):140-4.
50. Dumas R, Cheze L, Frossard L. Loading applied on prosthetic knee of transfemoral amputee: 
comparison of inverse dynamics and direct measurements. Gait & posture. 2009;30(4):560-2.
51. Frossard L, Gow DL, Hagberg K, Cairns N, Contoyannis B, Gray S, et al. Apparatus for monitoring 
load bearing rehabilitation exercises of a transfemoral amputee fitted with an osseointegrated 
fixation: a proof-of-concept study. Gait & posture. 2010;31(2):223-8. Epub 2009/11/21.
52. Vertriest S, Coorevits P, Hagberg K, Branemark R, Haggstrom E, Vanderstraeten G, et al. Static 
load bearing exercises of individuals with transfemoral amputation fitted with an osseointegrated 
implant: reliability of kinetic data. IEEE Trans Neural Syst Rehabil Eng. 2015;23(3):423-30.
53. Frossard L, Cheze L, Dumas R. Dynamic input to determine hip joint moments, power and work on 
the prosthetic limb of transfemoral amputees: ground reaction vs knee reaction. Prosthet Orthot 
Int. 2011;35(2):140-9.
54. Clark RA, Pua YH, Bryant AL, Hunt MA. Validity of the Microsoft Kinect for providing lateral trunk 
lean feedback during gait retraining. Gait & posture. 2013;38(4):1064-6.
55. Krause DA, Neuger MD, Lambert KA, Johnson AE, DeVinny HA, Hollman JH. Effects of examiner 
strength on reliability of hip-strength testing using a handheld dynamometer. J Sport Rehabil. 
2014;23(1):56-64.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 88
88
3
ST
A
N
CE
 P
H
A
SE
SW
IN
G
 P
H
A
SE
Pl
an
e
It
em
Q
ue
sti
on
Ea
rl
y
M
id
La
te
Ea
rl
y
La
te
Pr
io
ri
ty
G
en
er
al
S
1
Is
 t
he
 s
ta
nc
e 
ph
as
e 
sh
or
te
ne
d?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
Tr
un
k
F
2
Is
 t
he
re
 la
te
ra
l b
en
di
ng
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
3
Is
 a
rm
 s
w
in
g 
re
du
ce
d?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
Pe
lv
is
F
4
Is
 t
he
 p
el
vi
c 
sh
ift
 r
ed
uc
ed
?
Le
ft
ye
s/
no
ye
s/
no
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
ye
s/
no
ye
s/
no
F
5
Is
 t
he
 p
el
vi
c 
til
t 
in
su
ffi
ci
en
t 
or
 e
xc
es
si
ve
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
6
Is
 p
os
te
ri
or
 r
ot
ati
on
 in
cr
ea
se
d?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
H
ip
S
7
Is
 e
xt
en
si
on
 r
ed
uc
ed
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
F
8
Is
 t
he
re
 r
ot
ati
on
al
 d
ev
ia
tio
n?
Le
ft
ye
s/
no
ye
s/
no
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
ye
s/
no
ye
s/
no
A
P
P
EN
D
IX
 1
. G
A
IT
 A
N
A
LY
SI
S 
LI
ST
 A
M
P
U
TA
TI
O
N
 N
IJ
M
EG
EN
 (
G
A
LA
N
)
D
at
e 
as
se
ss
m
en
t…
…
…
…
./
…
…
…
…
./
…
…
…
…
. 
 
N
am
e 
pa
tie
nt
: :
…
…
..…
…
…
…
…
…
…
…
…
…
…
Re
vi
ew
ed
 b
y 
:…
…
..…
…
…
…
…
…
…
…
…
…
…
…
.. 
 
D
at
e 
of
 b
ir
th
: …
…
…
…
../
…
…
…
…
./
…
…
…
…
.
pr
os
th
eti
c 
si
de
: 
 O
 le
ft
 /
  O
 r
ig
ht
 
 
 
St
ep
 fr
eq
ue
nc
y:
…
…
…
…
.. 
st
ri
de
s/
m
in
ut
e
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 89
89
Chapter 3 | Rehabilitation following transfemoral osseointegration implant surgery
3
Kn
ee
S
9
Is
 t
he
re
 u
nc
on
tr
ol
le
d 
fle
xi
on
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
10
Is
 y
ie
ld
in
g 
ab
se
nt
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
11
Is
 t
he
re
 e
xt
en
si
on
 d
ev
ati
on
?
Le
ft
ye
s/
no
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
ye
s/
no
F
12
Is
 t
he
re
 r
ot
ati
on
al
 d
ev
ia
tio
n?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
F
13
Is
 t
he
re
 a
 v
ar
us
/v
al
gu
s 
m
ov
em
en
t?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
A
nk
le
S
14
Is
 t
he
re
 v
au
lti
ng
?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
15
Is
 t
he
re
 in
cr
ea
se
d 
do
rs
al
 fl
ex
io
n?
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
S
16
Is
 t
he
re
 in
cr
ea
se
d 
pl
an
ta
r 
fle
xi
on
? 
Le
ft
ye
s/
no
ye
s/
no
Ri
gh
t
ye
s/
no
ye
s/
no
 =
N
ot
 a
pp
lic
ab
le
, S
= 
Sa
gi
tt
al
 p
la
ne
, F
= 
Fr
on
ta
l p
la
ne
 
In
st
ru
cti
on
s:
If 
an
 it
em
 is
 in
te
rm
itt
en
tl
y 
ev
id
en
t 
it
 s
ho
ul
d 
be
 s
co
re
d 
as
 p
re
se
nt
 (
“y
es
” 
re
sp
on
se
);
 if
 t
he
 r
at
er
 is
 u
ns
ur
e 
w
he
th
er
 t
he
 it
em
 is
 p
re
se
nt
 it
 s
ho
ul
d 
be
 s
co
re
d 
as
 a
bs
en
t 
(“
no
”)
.
If 
an
 it
em
 is
 p
re
se
nt
 (
“y
es
” 
re
sp
on
se
) 
an
d 
th
e 
ite
m
 is
 o
ne
 o
f 
th
e 
ke
y 
fa
ct
or
s 
fo
r 
th
e 
di
st
ur
be
d 
ga
it
 p
att
er
n,
 t
he
 it
em
 h
as
 t
o 
be
 s
co
re
d 
w
it
h 
a 
“y
es
” 
in
 t
he
 
“p
ri
or
it
y”
 c
ol
um
n.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 90
90
3
APPENDIX 2. MODIFIED MAXIMAL HIP ABDUCTOR 
STRENGTH TEST
The patient should be supine with the spine and legs in neutral position (feet shoulder-width 
apart and foot pointing at the ceiling). The treatment table should be covered with a mat to 
prevent sliding. The therapist applies force at a point 15-cm distal to the most distal aspect 
of the greater trochanter using a handheld dynamometer (Hogan microFET2TM) (Figure 1). 
The patient is instructed to resist the force and maintain a neutral position. The force is 
gradually increased to the point where the patient is not able to maintain the neutral position 
(break-test). This marks the end of the procedure, and the force at break point is noted. The 
procedure is repeated twice more with the same leg. After this the other leg is tested. There 
should be no rests between trials. The score for a given leg is the highest break point force 
recorded for that leg.
The HHD we used in this study measured ‘force’ in pounds (lbs); values were converted 
into Newtons by multiplying by 4.448.
Figure 1. Assessment set-up
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APPENDIX 3. CORE STABILITY EXERCISE
• Hold this posture …….seconds
• Do …….repetitions
• To decrease load:
• Support oneself on elbows
• Support oneself on knees (using the prosthesis)
• To Increase load:
• Execute a push up
Exercise 1: Front planks
Exercise 2: Airplaning
• Hold this posture …….seconds, then switch sides
• Do …….repetitions
• To decrease load:
• Stretch either arm or leg (i.e. use 3 points of support) 
• To increase load:
• Use a dumbbell
• Use a second person to generate balance 
disturbances
Exercise 3: Gluteal bridging (1 leg)
• Make a bridge by pushing the leg into the cushion 
(buttocks off the floor)
• Hold this posture …….seconds
• Do …….repetitions, then switch side
• To decrease load:
• Do not lift the buttocks maximum range of motion
• Do the exercise using both legs to lift
• To increase load:
• Do not touch the ground at the return movement
• Stretch the contralateral leg
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• Execute a crunch
• Make …….repetitions
• To decrease load:
• Execute a crunch with smaller range of motion
• To increase load:
• Do not touch the ground during the return 
movement
• Variations:
• Reverse crunch (legs off the floor, execute an 
posterior pelvic tilt)
• Bicycle crunch
• Make a bridge by pushing the leg into the cushion  
(underlying hip off the floor)
• Make sure that the upper and lower body are in line
• Hold this posture …….seconds
• Do …….repetitions, then switch side
• To decrease load:
• Do not lift the hip maximum range of motion
• To increase load:
• Do not touch the ground at the return movement
• Do not hold the legs together during the exercise
Exercise 4: Side planks
Exercise 5: Crunch
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APPENDIX 4. GRAPHICAL SUMMARY OF THE  
PATIENT’S REHABILITATION DIARY
Figure a. Stance and gait training
Exercise time in minutes a day
Figure b. Strength training
Exercise time in minutes a day
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Figure c. Pain
NRS: Numerical Rating Scale
Figure d. Use of pain medication
Total units per day of paracetamol (500mg), Lyrica (75mg), Oxycodon (10mg), Oxycodon 
(5mg) or Arthrotec (50mg). Choice of medication was depended on the cause and type of 
pain.
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ABSTRACT
Background
Persons with transfemoral amputation typically have severe muscle atrophy of the residual 
limb. The effect of bone-anchored prosthesis use on existing muscle atrophy is unknown. 
A potentially feasible method to evaluate this is magnetic resonance imaging (MRI)-based 
three-dimensional (3D) muscle reconstruction. We aimed to: a) examine the feasibility of MRI-
based 3D muscle reconstruction technique in a person with a cobalt–chrome–molybdenum 
transfemoral bone-anchored prosthesis and b) describe the change of hip abductor muscle 
volume over time.
Methods
In this single case, one-year follow-up study we reconstructed the 3D hip abductor muscle 
volumes semiautomatically from MRI scans at baseline, six- and twelve-month follow-up. 
The number of adverse events, difficulties in data analysis, time investment and participants’ 
burden determined the level of feasibility.
Results
We included a man (70y) with a transfemoral amputation who received a bone-anchored 
prosthesis after 52 years of socket prosthesis use. No adverse events occurred. The accuracy 
of the 3D reconstruction was potentially reduced by severe adipose tissue interposition. 
Data analysis was time-intensive (115 hours). Participants’ burden was limited to 3-hour time 
investment. Compared to baseline, the total hip abductor volume of both the residual limb 
(six-month: 5.5%; twelve-month: 7.4%) and sound limb (six-month: 7.8%; twelve-month: 
5.5%) increased.
Conclusion
The presented technique appears feasible to follow muscle volume changes over time in a 
person with a cobalt–chrome–molybdenum transfemoral bone-anchored prosthesis in an 
experimental setting. Future research should focus on analysis of muscle tissue composition 
and the feasibility in bone-anchored prostheses of other alloys.
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INTRODUCTION
Hip abductor muscle strength is lower in the residual limb in persons with a transfemoral 
amputation compared to the sound side and to healthy subjects.1-3 Muscle strength weakness 
of the thigh is associated with the presence of muscle atrophy.4,5 Muscle atrophy is present in 
the residual limb, and can be as high as 73%, despite the almost continuous activation of the 
hip muscles during gait, which presumably is needed to stabilise the stump in the socket and 
to stabilise the pelvis.6-9 Muscle tissue composition changes as a result of the amputation, 
as cleaved muscles that are not fixed retract and degenerate into adipose tissue.6 Inferior 
and asymmetric muscle strength and high levels of muscle atrophy are associated with an 
asymmetric gait pattern, such as increased trunk lateral bending toward the prosthetic side 
and an unstable pelvis during stance.6,8,10-13 The current method for the attachment of a 
prosthesis after a transfemoral amputation is using a prosthetic socket. The socket attachment 
is, however, associated with chronic skin problems and residual limb pain.14 These socket-
related problems can lead to limited prosthetic use and decreased Health-Related Quality of 
Life (HRQoL).15
Bone-anchored prosthetics is a promising method to attach the prosthesis directly 
to the human skeleton, which can be a solution for persons suffering from socket-related 
problems.16 It has been shown that the use of bone-anchored prostheses is associated 
with increased prosthetic use, a higher activity level and a better HRQoL relative to socket 
attached prostheses.17 In contrast to the socket attachment, which can be used for passive 
stabilisation during the stance phase of gait, persons with bone-anchored prostheses are 
forced to stabilise their residual limb and pelvis solely by means of their residual limb muscles. 
Persons with bone-anchored prostheses present more physiological muscle activity in the 
residual limb, and better hip and pelvic kinematics compared to persons with socket attached 
prostheses.18,19 These benefits, combined with the absence of external compression on the 
residual limb muscles may, in theory, result in preservation of muscle volumes, muscle tissue 
composition and a more symmetric gait pattern.
To date, there has been no evaluation of muscle volumes or muscle tissue composition 
in persons with a bone-anchored prosthesis. It is unknown whether the muscle changes, 
caused by wearing a socket prosthesis, are reversed by using a bone-anchored prosthesis. 
To study this, repeated three-dimensional (3D) muscle reconstruction based on magnetic 
resonance imaging (MRI) can be utilized in persons after implantation of a bone-anchored 
prosthesis. Jaegers et al.6 used this volumetric measurement technique successfully despite 
the changed geometry of some muscles and the presence of transected muscles in a 
cross-sectional study including persons with a transfemoral amputation who used a socket 
attached prosthesis. It is unknown whether this procedure is applicable in persons with a 
bone-anchored prosthesis since metal implants can cause artefacts that may hinder exact 
evaluation of muscle measurements.20 
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In this single case, one-year follow-up study with repeated measures we used an MRI-
based 3D muscle reconstruction technique to evaluate hip abductor muscle volume in 
a person after receiving a transfemoral cobalt–chrome–molybdenum bone-anchored 
prosthesis. The primary aim of this study was to examine the feasibility of an MRI-based 
3D muscle reconstruction technique. Our secondary aim was to describe the change of hip 
abductor muscle volume in the first year after implantation of a transfemoral bone-anchored 
prosthesis.
METHODS
A comprehensive description of the participant, surgery, 12-week rehabilitation programme 
and clinical outcomes, including hip abductor muscle strength obtained by hand-held 
dynamometry and self-reported walking distance in everyday life has already been reported 
elsewhere.21 Consequently, only the most relevant information will be presented here. 
The baseline assessment to collect the participants’ demographic and anthropometric 
characteristics and the clinical outcomes was conducted 2.5 weeks prior to the first surgery. 
The bone-anchored prosthesis was implanted in a two-step surgery, six weeks apart. The 
baseline MRI was made five weeks after the first surgery, including implantation of the 
intramedullary implant (Figure 1). One week later the second surgery was executed in which 
a soft tissue stoma was created and a transcutaneous connector (Figure 1) was bolted into 
the intramedullary stem. Rehabilitation started two weeks after the second surgery. The 
prosthetic parts were attached to the transcutaneous unit using a stainless steel click-safety 
adapter (OTN, Nijmegen, the Netherlands). The timing of the baseline MRI was chosen aiming 
at equal geometry of the soft tissue at all assessments in order to prevent measurement bias 
due to soft tissue modification which often is included in the first surgery. The two follow-
up MRI scans were made six- and twelve-months after the first MRI. At the follow-ups the 
stainless steel male part of the click-safety adapter (Figure 1) was removed before MRI 
scanning, in order to reduce the amount of artefacts and to avoid overheating the metallic 
parts outside the body.
The study was conducted according to the principles of the Declaration of Helsinki (64th 
version, 19-10-2013). The protocol of this study was approved by the Ethics Committees of 
Radboud university medical centre.
Feasibility
The level of feasibility of the MRI-based 3D muscle reconstruction technique was determined 
through evaluation of various aspects of the procedure. First, adverse events during the MRI 
sessions such as loosening and migration of the intramedullary implant/transcutaneous 
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connector, heating of the metal with surrounding tissue, thermal damage and injuries due to 
physical contact with the MRI scanner as result of ferromagnetism of the implant were noted 
when observed by the participant or the caregivers.22 Second, difficulties in data analysis, for 
example due to limited or obscured visibility of the muscles, were documented after a verbal 
evaluation. Third, the time investment for data collection and analysis was recorded. Lastly, 
participants’ burden in terms of time investment and discomfort was verbally evaluated after 
each assessment.
Volume measurement
A Siemens Magnetom 1.5 Tesla (T) MRI scanner (Siemens medical systems, Malvern, PA, USA) 
was used to obtain transverse images (Figure 2) of the lower body from the upper edge of 
the cresta iliaca to the tibial tuberosity in the supine position. The scan protocol was based 
on previous research by Scheys in order to yield optimal distinction of muscle boundaries and 
to reduce metal artefacts.23 We used T1-weighted images (with a repetition time of 600 ms, 
echo time of 7.7 ms, slice thickness of 3.3 mm, flip angle of 150°, and an in plane resolution 
of 1x1 mm). The region of interest was scanned in three successive series, with an overlap of 
Figure 1. Bone-anchored prosthesis and click-safety adapter
Intramedullary implant
Transcutaneous dual cone adaptor / cap to fixate a wound dressing
Male part click-safety adapter
Transfemoral female part click-safety adapter
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at least two slices between series. The image stacks produced were combined into a single 
volume (Figure 3) using Mimics software (Version 18, Materialise N.V., Leuven, Belgium).24
Muscle volume of the hip abductor muscles (m. gluteus maximus, m. gluteus medius, m. 
gluteus minimus, m. piriformis and m. tensor fasciae latae) were segmented and calculated 
using Mimics. The procedure to analyse the baseline MRI of the residual limb and sound 
limb was different. For the residual limb, the abductor muscles were outlined manually slice-
by-slice, and with optional use of a threshold tool for inclusion of voxels with a predefined 
grey value (159-388). The regions of interest were first analysed in the transverse plane 
and checked, thereafter, also in the sagittal and coronal plane. This procedure resulted in a 
tailored reconstruction of all muscles of interest, hereafter called “atlas” (Figure 4). For the 
segmentation of the sound limb, an existing set of ten atlases was used as starting point, 
which was based on the MRI scans of ten healthy subjects.24 These ten atlases and the 
Mimics software were used to semi-automatically segment the hip abductor muscles of the 
sound limb, following the procedure described by Kolk et al.24 The follow-up MRI scans were 
segmented semi-automatically using the baseline tailored atlases previously obtained for the 
sound and residual limbs. The Mimics feature “Calculate 3D” was then applied to all atlases 
to reconstruct the final 3D muscle geometries. No additional smoothing was applied, to not 
arbitrarily alter the volume reconstructions. Individual muscle volumes (in units of cm3) were 
calculated from the 3D muscle geometries (Figure 5) using Mimics.
The baseline MRI of the residual side was manually segmented by a student (TB). An 
engineer (LD) processed all segmentations. In the presence of debate about the exact muscle 
boundaries, a consensus meeting with three raters, radiologist (MP), engineer (LD), and 
physiotherapist (RL) established consensus about the exact muscle boundaries.
Figure 2. Transverse plane MR image at baseline
Note: the presence of severe adipose tissue on the residual limb side compared to the sound 
side.
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Figure 3. Frontal plane MR image at baseline
Note: the presence of metal artefacts at the distal end of the residual limb and the abrupt 
transition between adjacent stacks after combining the MR volumes.
Figure 4. Tailored atlas of the residual limb (above) and sound limb (below) at baseline
M. gluteus maximus (yellow), m. gluteus medius (purple), m. gluteus minimus (green), m. 
piriformis (red) and m. tensor fasciae latae (blue)
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Data analysis
On the residual and sound limb the muscle volume of the final 3D geometries of m. gluteus 
maximus, m. gluteus medius, m. gluteus minimus, m. piriformis, and m. tensor fasciae latae 
were presented separately for the baseline assessment and for the six- and twelve-month 
follow-ups. The volume changes between follow-ups and baseline were calculated and 
expressed in percentages. Additionally, the difference in volume between sound and residual 
limb was calculated within each assessment and expressed in percentages.
RESULTS
Participant characteristics
A 70-year-old man (1.78 m) with a traumatic transfemoral amputation who underwent 
implantation of a cobalt–chrome–molybdenum endo-exo femoral prosthesis (EEFP) after 52 
years of socket prosthesis use participated in this study. Body mass index (BMI) adjusted for 
limb loss25 was 28 kg/m2 at baseline and 30 kg/m2 at both follow-up times. In the residual 
Figure 5. Final 3D reconstruction hip abductor muscles of the residual limb (left) and sound 
limb (right) at baseline
M. gluteus maximus (yellow), m. gluteus medius (purple), m. gluteus minimus (green), m. 
piriformis (red) and m. tensor fasciae latae (blue)
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limb, hip abductor strength reduced by 2.2% at six-month follow-up compared to baseline 
and was comparable to baseline at twelve-month follow-up. In the sound limb, hip abductor 
strength reduced by 13.6% and 16.6% compared to baseline at six-month and twelve-month 
follow-up, respectively. Walking distance in everyday life decreased by 50% at six-month 
follow-up and increased by 400% at twelve-month follow-up, compared to baseline. The 
participant reported severe low back pain at the six-month follow-up from degenerative disc 
disease, which was treated successfully with an epidural steroid injection 10 months after 
the second surgery.
Feasibility
No adverse events, such as heating of the metallic parts, were reported by the participant or 
the caregivers. MRI artefacts were mainly present toward the distal end of the residual limb 
(Figure 3). These artefacts caused no difficulties in the 3D reconstruction of the hip abductor 
muscles because the region of interest was proximal to these artefacts. The visibility of the 
boundaries of the residual limb muscles was less clear compared to the sound limb, as a 
result of the adipose tissue interposition (Figure 2). Adipose tissue was present between 
muscles (intermuscular adipose tissue) and within the boundaries of muscles’ fasciae 
(intramuscular adipose tissue). When adipose tissue was present in a large extent relative 
to the muscle volume, more discussion was necessary to reach consensus about the exact 
boundaries of the individual muscles. This was the case, for instance, of m. piriformis (Figure 
4). The manual segmentation of the residual limb of the baseline MRI, the manual correction 
within the semiautomatic segmentation process and the consensus meetings were time-
intensive (approximately 115-h in total). No disagreement between the raters occurred 
within the three consensus meetings of 5-h that were necessary to established consensus 
about the exact muscle boundaries. Because the male part of the click-safety adapter (Figure 
1) had to be removed during the MRI scan, a certified prosthetist of the treatment team had 
to be present during the MRI session, which caused some logistic challenges. Participants’ 
burden consisted out of approximately 1-h time investment per MRI scan. The participant 
experienced no discomfort during the MRI sessions.
Muscle volume change
In the residual limb, individual hip abductor muscle volumes increased in the range of 2.2-
22.4% at six-month follow-up and 1.5-22.4% at twelve-month follow-up relative to baseline. 
The volume of m. piriformis decreased by 8.9% at twelve-month follow-up relative to baseline 
(Table 1). The total hip abductor muscle volume increased by 5.5% at six-month follow-up and 
7.4% at twelve-month follow-up relative to baseline (Table 1 and Figure 6). In the sound limb, 
individual hip abductor muscle volumes increased in the range of 5.8-15.4% at six-month 
follow-up and 1.9-6.3% at twelve-month follow-up relative to baseline (Table 1). The total hip 
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abductor muscle volume increased 7.8% at six-month follow-up and 5.5% at twelve-month 
follow-up relative to baseline (Table 1 and Figure 6).
The degree and the trend of asymmetry between residual and sound limb remained 
consistent over time (Table 1 and Figure 6). The total hip abductor muscle volume of the 
residual limb was 35%, 37% and 34% lower than the total hip abductor muscle volume of 
the sound limb, at baseline, six-month and twelve-month follow-up, respectively. Within the 
individual muscles, we found the following trends (Table 1 and Figure 6), the asymmetry of 
Table 1. Hip abductor muscle volumes
 Baseline 6-month 12-month Difference Difference
 (cm3) (cm3) (cm3) T1-T0 (%) T2-T0 (%)
Residual limb
m. gluteus maximus 716 736 762 2.8% 6.4%
m. gluteus medius 297 320 326 7.7% 9.8%
m. gluteus minimus 76 93 93 22.4% 22.4%
m. piriformis 45 46 41 2.2% -8.9%
m. tensor fasciae latae 67 72 68 7.5% 1.5%
Total 1201 1267 1290 5.5% 7.4%
Sound limb
m. gluteus maximus 1167 1235 1235 5.8% 5.8%
m. gluteus medius 422 471 444 11.6% 5.2%
m. gluteus minimus 85 96 87 12.9% 2.4%
m. piriformis 52 60 53 15.4% 1.9%
m. tensor fasciae latae 126 135 134 7.1% 6.3%
Total 1852 1997 1953 7.8% 5.5%
Difference residual limb versus sound limb (%)
m. gluteus maximus -38.6% -40.4% -38.3%
m. gluteus medius -29.6% -32.1% -26.6%
m. gluteus minimus -10.6% -3.1% 6.9%
m. piriformis -13.5% -23.3% -22.6%
m. tensor fasciae latae -46.8% -46.7% -49.3%
Total -35.2% -36.6% -33.9%   
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m. gluteus maximus and m. gluteus medius increased at six-month follow-up and decreased 
at twelve-month follow-up compared to baseline. The asymmetry of m. gluteus minimus 
decreased and the asymmetry of the m. piriformis increased at both follow-ups relative to 
baseline. The asymmetry of m. tensor fasciae latae decreased at six-month follow-up and 
increased at twelve-month follow-up compared to baseline.
DISCUSSION
The results of this study showed that the MRI-based 3D muscle reconstruction technique 
is feasible to assess hip abductor muscle volume in a person with a transfemoral cobalt–
chrome–molybdenum bone-anchored prosthesis in an experimental setting. No adverse 
events were reported. MRI artefacts due to metal hardware did occur, but they did not 
influence the 3D muscle reconstructions. The severe presence of adipose tissue hampered 
the exact volume measurements in some of the residual limb muscles, which may have led 
to measurement bias. Participants’ burden was acceptable because it was limited to 3-h time 
investment (1-h per MRI scan), but both the need for technical support during the MRI scans 
and the time-intensive data analysis, decrease the feasibility in studies with a large sample 
size. We opted a 1.5T MRI scanner and an MRI protocol based on previous research.23 in 
Figure 6. Total hip abductor muscle volume
SL: sound limb; RL: residual limb
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an attempt to achieve optimal distinction of muscle boundaries and concurrently reduce 
metal artefacts.20,26,27 These choices were successful, as illustrated by the high image quality 
obtained (Figure 2) and the absence of image artefacts within the regions of interest (Figure 
3). This is in line with studies in persons with a total hip arthroplasty.26,27 The MRI artefacts at 
the distal end of the residual limb were probably caused by the absence of bone in that area 
and the limited covering of the implant by soft tissue. Therefore, the MRI-based 3D muscle 
reconstruction technique will not be suitable to examine problems related to the soft tissue 
stoma.
In this single case study, the total hip abductor muscle volume asymmetry remained 
stable over time. The asymmetry ranged from 34 to 37% and was in favour of the sound side, 
which is comparable with the findings of Jaegers et al.6 The total hip abductor muscle volume 
of both limbs increased at both follow-ups compared to baseline. The increase in muscle 
volume of the majority of the individual muscles exceeded the 1-3% intra-rater volume 
differences (interpretational error) of MRI-based 3D hip abductor muscle reconstruction.28 
These observation may indicate a possible reversion of the muscle atrophy process in a 
person with severe disuse muscle atrophy. Although larger studies are required to support 
this observation, this is the first description in reversibility of disuse-related muscle atrophy in 
a person with a transfemoral amputation using a bone-anchored prosthesis. Muscle volume 
at baseline in this case report are in line with the cross-sectional data of Jaegers and co-
workers.6 Jaegers et al. assessed muscle volume of the lower extremity using an MRI-based 
3D muscle reconstruction technique in twelve persons with a transfemoral amputation. All 
persons used a socket prosthesis and the time between primary amputation and inclusion 
ranged from 2 to 35 years. The volumes of the m. gluteus maximus, m. gluteus medius, m. 
gluteus minimus and m. tensor fasciae latae in our study fell all within one standard deviation 
of the volumes found by Jaegers et al. M. piriformis was not analysed by Jaegers et al. In 
contrast to Jaegers et al. we found intramuscular adipose tissue in non-cleaved muscles, 
whereas they only found intramuscular adipose tissue in cleaved and non-fixed muscles.
Another important consideration is that the time between primary amputation and 
inclusion for our participant was 52 years. We expect the long-term use of a socket prosthesis 
to be the cause of the massive atrophy and increased adipose tissue in most muscles of 
the residual limb compared to the sound limb. Thus, whether muscle regeneration could be 
expected after such a long time of disuse remains questionable. Despite the age and length of 
post-amputation of this participant, we found an increase in muscle volume over time. This is 
promising for patients of lower age and for those with less time between primary amputation 
and inclusion.
Strengths and limitations
To our knowledge this is the first study that used the MRI-based 3D muscle reconstruction 
technique using repeated measures and the first study that used this technique in a person 
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with a bone-anchored prosthesis. The choice for a repeated measures design in this study is 
of added value because it allowed us to investigate the impact the intervention, in this case 
the bone-anchored prosthesis surgery in combination with rehabilitation, had on tissue level 
which has not been described in the literature previously. Because this was a single case 
study we were not able to examine the causal relationship between the intervention and the 
muscle volume change. It was remarkable that the trend of changes in muscle strength and 
changes in activity level was different from the trend shown in changes of muscle volume. 
The period of severe low back pain was potentially a confounding factor that influenced 
these trends. Future research in a larger cohort should investigate these correlations and 
should examine the causal relationship between the intervention and the muscle volume 
change. MRI-based 3D muscle reconstruction showed to be a safe and non-invasive method 
to obtain detailed information about the total volume of individual muscles. This in contrast 
to previously used methods to analyse the volume of the residual limb which were too 
invasive or too global such as: circumference measurement of the residual limb using a tape 
measure7,29; and analysing cross-sectional areas of muscles using ultrasonography30; muscle 
biopsy4,7; computed tomography4,7; or MRI.6,31 An additional advantage of the MRI-based 3D 
muscle reconstruction technique is that it can be used for finite element modelling.32
An important limitation of our study is that feasibility was evaluated for only one type 
of metal implant. No adverse events were reported in all three MRI acquisitions; therefore, 
we may conclude that the use of 1.5T MRI in persons with a cobalt–chrome–molybdenum 
implant is safe and that the MRI-based 3D muscle reconstruction technique is feasible to assess 
muscle volume. However, it remains unknown whether MRI and the 3D muscle reconstruction 
technique are safe and feasible for bone-anchored prosthesis made with other metal alloys, 
such as titanium. Although titanium implants produces larger metal artefacts than cobalt–
chrome–molybdenum implants20, research concerning titanium plates and screws suggests 
that the use of a 1.5T MRI scanner would be safe and the extent of metal artefacts can be 
minimized.33 A second limitation is that we did not evaluate the muscle tissue composition, 
including the level and changes of intermuscular and intramuscular adipose tissue. Insight in 
the level of adipose tissue would be important because the latter is associated with decreased 
muscle performance and impaired physical function.34 The influence of the increased BMI at 
both follow-up times compared to baseline on the change in muscle volume could not be 
interpreted because we did not analyse the muscle tissue composition and because this was 
a single case study. Presumably, a precise quantification of intermuscular and intramuscular 
adipose tissue would also increase the accuracy and thus the feasibility of the MRI-based 3D 
muscle reconstruction technique. Previous studies used the grey value (or image intensity) of 
subcutaneous adipose tissue to identify the intermuscular and intramuscular adipose tissue 
within T1-weighted MR images.34,35 The validity of this method is questionable, as also other 
tissues (i.e., blood, trabecular bone, mineralisation) besides fat appear hyperintense on T1-
weighted MR images. Specific MRI sequences suitable for the discrimination of water and 
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fat content, such as the DIXON MRI sequence36, probably lead to a more accurate method to 
identify the level of intermuscular and intramuscular adipose tissue. As a third limitation, we 
report the amount of manual correction necessary during the semiautomatic segmentation, 
which was partly due to the large amount of adipose tissue present. This may have caused 
potential measurement bias and decreased accuracy. To minimise these aspects and retain 
accuracy, we used consensus meetings which in turns limited the feasibility as they were 
time-consuming. Another possible cause of the amount of mandatory manual correction 
is that a student performed the manual segmentation of the baseline MRI instead of an 
experienced radiologist. We selected a student for this task because this part of the analysis is 
the most time-intensive. A final limitation was that it was not possible to distinguish whether 
the changes to the muscle volume were attributed solely to the change of type of attachment 
or the rehabilitation program or because of the combination. In our clinical practice, bone-
anchored prosthesis surgery is always followed by a standardised rehabilitation programme 
focussing on improvement of hip abductor strength, core stability, and gait quality.21 To 
investigate the influence of the rehabilitation on the results future studies could include a 
control group of persons with socket attached prostheses.
Recommendation for future research
Future research should focus on improvement of the accuracy of the 3D muscle reconstruction 
technique, options to quantify adipose tissue and to increase the practical applicability. 
The MRI-based 3D muscle reconstruction technique will be more practical if it is less time-
intensive and less or no manual correction is necessary within the analysis process.
The 3D muscle reconstruction is of added value because it can give insight in the impact of 
interventions on tissue level. This is relevant within the discussion concerning the inclusion 
criteria for bone-anchored prosthetic surgery. To date, the time of the onset of muscle 
atrophy and increase of adipose tissue is not clear. Furthermore, there is a lack of knowledge 
concerning the extent of potential reversibility of the atrophic process as a result of a bone-
anchored prosthesis use. Future research should focus on both aspects in a larger repeated 
measures study with persons with a bone-anchored prosthesis, in which stratification of the 
time between primary amputation and bone-anchored prosthesis surgery is implemented.
CONCLUSION
MRI-based 3D muscle reconstruction technique appears to be feasible to assess hip abductor 
muscle volume in a person with a cobalt–chrome–molybdenum bone-anchored prosthesis 
in an experimental setting. The repeated measures design allowed us to investigate the 
impact of the intervention on tissue level. In our participant the majority of hip abductor 
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muscles increased in volume at six-month and twelve-month follow-up relative to baseline. 
The accuracy of the technique was potentially negatively influenced by severe intermuscular 
and intramuscular adipose tissue. Future research should focus on further automation of the 
3D reconstruction technique, the analysis of muscle tissue composition, and the feasibility 
of 3D muscle reconstruction for bone-anchored implants made with other commonly used 
metallic alloys.
ACKNOWLEDGEMENTS
The authors thank Sjoerd Kolk for his assistance in the MRI acquisitions, Tim Blom for his 
assistance with processing the raw data and Léon Driessen for his contribution to the 
semiautomatic segmentation process and the consensus meetings. The research leading to 
these results has received funding from the European Commission FP7 Programme for the 
TLEMsafe project (http://www.tlemsafe.eu) and the European Research Council under the 
European Union’s Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 
323091 awarded to N. Verdonschot.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 112
112
4
REFERENCES
1. Bae TS, Choi K, Hong D, Mun M. Dynamic analysis of above-knee amputee gait. Clin Biomech 
(Bristol, Avon). 2007;22(5):557-66.
2. Kowal M, Rutkowska-Kucharska A. Muscle torque of the hip joint flexors and extensors in physically 
active and inactive amputees. Biomed Hum Kinetics. 2014;6(1):63–8.
3. Ryser DK, Erickson RP, Cahalan T. Isometric and isokinetic hip abductor strength in persons with 
above-knee amputations. Arch Phys Med Rehabil. 1988;69(10):840-5.
4. Klingenstierna U, Renstrom P, Grimby G, Morelli B. Isokinetic strength training in below-knee 
amputees. Scand J Rehabil Med. 1990;22(1):39-43.
5. Renstrom P, Grimby G, Larsson E. Thigh muscle strength in below-knee amputees. Scand J Rehabil 
Med Suppl. 1983;9:163-73.
6. Jaegers SM, Arendzen JH, de Jongh HJ. Changes in hip muscles after above-knee amputation. Clin 
Orthop Relat Res. 1995(319):276-84.
7. Renstrom P, Grimby G, Morelli B, Palmertz B. Thigh muscle atrophy in below-knee amputees. Scand 
J Rehabil Med Suppl. 1983;9:150-62.
8. Jaegers SM, Arendzen JH, de Jongh HJ. An electromyographic study of the hip muscles of 
transfemoral amputees in walking. Clin Orthop Relat Res. 1996(328):119-28. Epub 1996/07/01.
9. Wentink EC, Prinsen EC, Rietman JS, Veltink PH. Comparison of muscle activity patterns of 
transfemoral amputees and control subjects during walking. J Neuroeng Rehabil. 2013;10:87.
10. Jaegers SM, Arendzen JH, de Jongh HJ. Prosthetic gait of unilateral transfemoral amputees: a 
kinematic study. Arch Phys Med Rehabil. 1995;76(8):736-43.
11. Michaud SB, Gard SA, Childress DS. A preliminary investigation of pelvic obliquity patterns during 
gait in persons with transtibial and transfemoral amputation. J Rehabil Res Dev. 2000;37(1):1-10. 
Epub 2000/06/10.
12. Nadollek H, Brauer S, Isles R. Outcomes after trans-tibial amputation: the relationship between 
quiet stance ability, strength of hip abductor muscles and gait. Physiother Res Int. 2002;7(4):203-
14.
13. Sjodahl C, Jarnlo GB, Soderberg B, Persson BM. Pelvic motion in trans-femoral amputees in the 
frontal and transverse plane before and after special gait re-education. Prosthet Orthot Int. 
2003;27(3):227-37. Epub 2004/01/20.
14. Butler K, Bowen C, Hughes AM, Torah R, Ayala I, Tudor J, et al. A systematic review of the key 
factors affecting tissue viability and rehabilitation outcomes of the residual limb in lower extremity 
traumatic amputees. J Tissue Viability. 2014;23(3):81-93.
15. Hagberg K, Branemark R. Consequences of non-vascular trans-femoral amputation: a survey 
of quality of life, prosthetic use and problems. Prosthet Orthot Int. 2001;25(3):186-94. Epub 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 113
113
Chapter 4 | MRI-based 3D muscle reconstruction technique
4
2002/02/28.
16. Pitkin M. Design features of implants for direct skeletal attachment of limb prostheses. J Biomed 
Mater Res A. 2013;101(11):3339-48. Epub 2013/04/05.
17. Leijendekkers RA, van Hinte G, Frolke JP, van de Meent H, Nijhuis-van der Sanden MW, Staal 
JB. Comparison of bone-anchored prostheses and socket prostheses for patients with a lower 
extremity amputation: a systematic review. Disabil Rehabil. 2017;39(11):1045-1058.
18. Pantall A, Ewins D. Muscle activity during stance phase of walking: Comparison of males with 
transfemoral amputation with osseointegrated fixations to nondisabled male volunteers. J Rehabil 
Res Dev. 2013;50(4):499-513.
19. Tranberg R, Zugner R, Karrholm J. Improvements in hip- and pelvic motion for patients with 
osseointegrated trans-femoral prostheses. Gait & posture. 2011;33(2):165-8. Epub 2010/12/07.
20. Panfili E, Pierdicca L, Salvolini L, Imperiale L, Dubbini J, Giovagnoni A. Magnetic resonance imaging 
(MRI) artefacts in hip prostheses: a comparison of different prosthetic compositions. Radiol Med. 
2014;119(2):113-20.
21. Leijendekkers RA, van Hinte G, Nijhuis-van der Sanden MW, Staal JB. Gait rehabilitation for a 
patient with an osseointegrated prosthesis following transfemoral amputation. Physiother Theory 
Pract. 2017;33(2):147-61.
22. Kumar R, Lerski RA, Gandy S, Clift BA, Abboud RJ. Safety of orthopedic implants in magnetic 
resonance imaging: an experimental verification. J Orthop Res. 2006;24(9):1799-802.
23. Scheys L. Personalized musculoskeletal modeling based on magnetic resonance images: use for 
biomechanical analysis of gait [dissertation]. Leuven (Belgium): K.U. Leuven. 2009.
24. Kolk S, Klawer EM, Schepers J, Weerdesteyn V, Visser EP, Verdonschot N. Muscle Activity during 
Walking Measured Using 3D MRI Segmentations and [18F]-Fluorodeoxyglucose in Combination 
with Positron Emission Tomography. Med Sci Sports Exerc. 2015;47(9):1896-905.
25. Osterkamp LK. Current perspective on assessment of human body proportions of relevance to 
amputees. J Am Diet Assoc. 1995;95(2):215-8.
26. Lazik A, Landgraeber S, Schulte P, Kraff O, Lauenstein TC, Theysohn JM. Usefulness of metal artifact 
reduction with WARP technique at 1.5 and 3T MRI in imaging metal-on-metal hip resurfacings. 
Skeletal Radiol. 2015;44(7):941-51.
27. Nardo L, Han M, Kretzschmar M, Guindani M, Koch K, Vail T, et al. Metal artifact suppression at the 
hip: diagnostic performance at 3.0 T versus 1.5 Tesla. Skeletal Radiol. 2015;44(11):1609-16.
28. Jaegers S, Dantuma R, de Jongh HJ. Three-dimensional reconstruction of the hip muscles on the 
basis of magnetic resonance images. Surg Radiol Anat. 1992;14(3):241-9.
29. Isakov E, Burger H, Gregoric M, Marincek C. Stump length as related to atrophy and strength of the 
thigh muscles in trans-tibial amputees. Prosthet Orthot Int. 1996;20(2):96-100.
30. Schmalz T, Blumentritt S, Reimers CD. Selective thigh muscle atrophy in trans-tibial amputees: an 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 114
114
4
ultrasonographic study. Arch Orthop Trauma Surg. 2001;121(6):307-12.
31. Putz C, Block J, Gantz S, Heitzmann DWW, Dreher T, Lehner B, et al. Structural changes in the thigh 
muscles following trans-femoral amputation. Eur J Orthop Surg Traumatol. 2017;27(6):829-35.
32. Portnoy S, Yizhar Z, Shabshin N, Itzchak Y, Kristal A, Dotan-Marom Y, et al. Internal mechanical 
conditions in the soft tissues of a residual limb of a trans-tibial amputee. J Biomech. 2008;41(9):1897-
909.
33. Zou YF, Chu B, Wang CB, Hu ZY. Evaluation of MR issues for the latest standard brands of orthopedic 
metal implants: plates and screws. Eur J Radiol. 2015;84(3):450-7.
34. Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration 
in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: 
association with performance and function. Phys Ther. 2008;88(11):1336-44.
35. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, et al. Adipose tissue in 
muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr. 2005;81(4):903-10.
36. Baudin PY, Marty B, Robert B, Shukelovitch A, Carlier RY, Azzabou N, et al. Qualitative and quantitative 
evaluation of skeletal muscle fatty degenerative changes using whole-body Dixon nuclear magnetic 
resonance imaging for an important reduction of the acquisition time. Neuromuscul Disord. 
2015;25(10):758-63.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 115
115
Chapter 4 | MRI-based 3D muscle reconstruction technique
4
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 116
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 117
Chapter 5
Long-term outcomes following lower extremity 
press-fit bone-anchored prosthesis surgery: 
a 5-year longitudinal study protocol
DOI: 10.1186/s12891-016-1341-z
BMC musculoskeletal disorders
Ruud A. Leijendekkers, J. Bart Staal, Gerben van Hinte, Jan Paul 
Frölke, Hendrik van de Meent, Femke Atsma, Maria W. G. 
Nijhuis-van der Sanden, Thomas J. Hoogeboom
Published: November 22, 2016
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 118
118
5
ABSTRACT
Background
Patients with lower extremity amputation frequently suffer from socket-related problems. 
This seriously limits prosthesis use, level of activity and health-related quality of life (HRQoL). 
An additional problem in patients with lower extremity amputation are asymmetries in 
gait kinematics possibly accounting for back pain. Bone-anchored prostheses (BAPs) are a 
possible solution for socket-related problems. Knowledge concerning the level of function, 
activity and HRQoL after surgery is limited.
The aims of this ongoing study are to: a) describe changes in the level of function, activity, 
HRQoL and satisfaction over time compared to baseline before surgery; b) examine potential 
predictors for changes in kinematics, prosthetic use, walking ability, HRQoL, prosthesis 
comfort over time and level of stump pain at follow-up; c) examine potential mechanisms 
for change of back pain over time by identifying determinants, moderators and mediators.
Methods/design
A prospective 5-year longitudinal study with multiple follow-ups. All adults, between May 
2014 and May 2018, with lower extremity amputation receiving a press-fit BAP are enrolled 
consecutively. Patients with socket-related problems and trauma, tumour resection or stable 
vascular disease as cause of primary amputation will be included. Exclusion criteria are severe 
cognitive or psychiatric disorders. Follow-ups are planned at six-months, one-, two- and five-
years after BAP surgery. The main study outcomes follow, in part, the ICF classification: a) 
level of function defined as kinematics in coronal plane, hip abductor strength, prosthetic 
use, back pain and stump pain; b) level of activity defined as mobility level and walking ability; 
c) HRQoL; d) satisfaction defined as prosthesis comfort and global perceived effect. Changes 
over time for the continuous outcomes and the dichotomized outcome (back pain) will be 
analysed using generalised estimating equations (GEE). Multivariate GEE will be used to 
identify potential predictors for change of coronal plane kinematics, prosthetic use, walking 
ability, HRQoL, prosthesis comfort and for the level of post-operative stump pain. Finally, 
potential mechanisms for change in back pain frequency will be explored using coronal plane 
kinematics as a potential determinant, stump pain as moderator and hip abductor strength 
as mediator.
Discussion
This study may identify predictors for clinically relevant outcome measures.
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BACKGROUND
The population living with a lower extremity amputation is estimated to grow significantly, in 
part, due to the aging population and high rates of vascular disease.1 In the Netherlands, 90-
94% of the lower extremity amputations are due to vascular disease, 3% to trauma and 3% 
to tumour resection.2 The primary amputation level is transtibial in 49% of the patients, knee 
disarticulation in 9%, transfemoral in 34% and bilateral in 9%.3 Approximately 86% of the 
patients with a lower extremity amputation are fitted with a socket prosthesis (SP).4 Within 
socket prosthesis users, 34-63% have reported suffering from socket-related problems 
including chronic skin problems and residual limb pain associated with the socket.5-9 It is 
well known that the symmetry in spatio-temporal, kinematic and kinetic parameters during 
gait is reduced in SP users compared to able-bodied persons.10-12 In addition socket fitting 
problems13, decreased hip abductor strength13-15 and changed muscle activity patterns16 may 
be a possible cause for this asymmetry. Gait asymmetry, specifically in the coronal17-19 and 
sagittal plane18, are considered to be associated with secondary complaints such as back 
pain.20 Both, socket-related problems and back pain can lead to limited prosthetic use5,21 and 
reduced health-related quality of life (HRQoL).5,7
For patients with a lower extremity amputation who suffer from socket-related problems 
the prosthesis can be transcutaneously attached to the bone by osseointegration utilizing 
intramedullary implants, known as bone-anchored prostheses (BAPs)22. BAPs are used in 
patients with a transfemoral23-30 or transtibial amputation.31-33 To date, there are two types of 
implants available: a screw BAP34,35 and a press-fit BAP.29,36 Both are implanted using two-step 
surgery techniques, however, for the press-fit BAP the time between surgeries is 4.5 months 
shorter than for a screw BAP.34,36 Additionally, the rehabilitation period is shorter for press-fit 
BAP because the implant allows more weight bearing in the early post-operative phase.29,34-36
An advantage of direct attachment to the bone, regardless of the used BAP method, is that 
the patient has a better ability to detect vibrotactile and pressure stimuli of the prosthetic limb 
compared to socket prosthesis users.22,37,38 These stimuli are also known as osseoperception. 
Although BAP surgery has been performed for over 25 years only eight and generally small 
longitudinal studies23,25,27-31,39 assessed the level of function, activity and QoL outcomes of 
BAP compared to SP use. Various benefits have been found on body functions or structures 
(hereafter referred to as level of function), level of activity and HRQoL for BAP use compared 
to SP use.40,41 However, functional outcomes seem to be an underexposed part of BAP 
research to date. This is remarkable, because BAP surgery is an invasive intervention aimed to 
overcome problems in physical functioning in SP users with socket-related problems. In the SP 
population, complaints such as back pain may be the result of asymmetries in coronal plane 
gait kinematics and are possibly related to hip abductor strength deficiencies20,42, but have 
not been researched in the BAP population. Research on the level of satisfaction experienced 
by the patient with respect to their prosthesis is absent. Similarly, factors associated with 
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outcomes regarding the levels of function, activity, HRQoL and satisfaction of the prosthesis 
after BAP surgery has not been researched. This study will address the above mentioned 
outcomes and follow, in part, the ICF classification.41 The purpose of this manuscript is to 
detail the study protocol of an ongoing prospective 5-year longitudinal study with multiple 
follow-ups. The study focuses on patients with a lower extremity amputation who are fitted 
with a press-fit BAP and complete a standard rehabilitation programme. Through publishing 
this study protocol we aim to: a) increase the transparency of our data collection; b) prevent 
publication bias and selective reporting; c) prevent data dredging.43 The study has four aims:
Aim 1: to describe the change in the level of function, activity, HRQoL and satisfaction 
in patients with a lower extremity amputation after receiving a press-fit BAP at short-term 
(six-months and one-year), mid-term (two-years) and long-term (five-years) follow-up 
in comparison to baseline. We hypothesise that coronal plane kinematics symmetry, hip 
abductor strength, prosthetic use, mobility level, walking ability, HRQoL and prosthesis 
comfort will improve over time and that the frequency of back pain will decrease over time.
Aim 2: to examine potential predictors for the change of coronal plane kinematics, 
prosthetic use, walking ability, HRQoL and prosthesis comfort over time: outcomes that are 
the main reason why patients choose a BAP The potential predictors which will be included 
in the analysis are: demographic data, patient characteristics, baseline level of function, 
baseline level of activity and baseline level of satisfaction (Appendix 1).
Aim 3: to examine predictors for the level of stump pain at short-term, mid-term and long-
term follow-up (Appendix 1). In our clinic we see that stump pain after BAP surgery negatively 
influences outcomes on the level of function, activity, HRQoL and satisfaction. However, 
we do not have insight in the level of stump pain at follow-up and knowledge concerning 
predictors for stump pain is absent.
Aim 4: to examine potential mechanisms for changes in back pain at short-term, mid-
term and long-term follow-up. We hypothesise that an increase of coronal plane kinematics 
symmetry will be a possible determinant for a decrease in back pain (Figure 1). We also 
hypothesise that stump pain will act as moderator and hip abductor strength will act as 
mediator.
The short-, mid- and long-term outcomes and the results of the various aims of this study 
will be presented in separate articles.
Figure 1. Causal model for change of back pain
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METHODS AND DESIGN
This is an ongoing prospective 5-year longitudinal study with multiple follow-ups. All 
assessments are part of usual care for patients with a lower extremity amputation following 
BAP surgery.
Study population
All patients who are eligible for a press-fit BAP in the Netherlands undergo surgery in one 
hospital (Radboud university medical centre). All consecutive patients in our centre, between 
May 2014 and May 2018, undergoing BAP surgery are eligible for this study. Patients are eligible 
for press-fit BAP surgery if: a) they are adults with a lower extremity amputation suffering 
from socket-related problems contributing to limited prosthetic use; b) the cause of primary 
amputation is congenital or due to a trauma, tumour resection or stable vascular disease. 
Exclusion criteria for surgery are the presence of severe cognitive or psychiatric disorders. 
A multidisciplinary team including a surgeon, rehabilitation physician, physiotherapist and 
prosthesist assess patients for inclusion for BAP using a standard procedure as described 
by Van de Meent et al.29 When patients’ medical history reveals a psychiatric history, a 
psychologist is consulted to assess the patient prior to inclusion.
Sample size
We will not draw a sample, but aim to include the entire population, which started in May 
2014. We expect to have little non-responders as all assessments are part of usual care. This 
expectation is supported by the fact that we had no non-responders since the start of this 
study. Based on the average number of surgeries in the Netherlands during the year 2014 and 
2015 we expect that 18 patients will be included each year.44 For our first aim, investigating 
change over time, we will present the first interim analyses of this growing cohort when we 
have a minimum of 40 patients at the following time points: one-, two- and five-year follow-
up. Press-fit BAP surgery started in the Netherlands in 2009. Between 2009 and 2014, 42 
patients received a BAP. Thus at the time of our first interim analyses (mid of 2017) the total 
Dutch population with a minimum follow-up of one-year will include 82 patients.44 Although, 
the sample size of 40 patients appears to be small, the study will have gathered longitudinal 
data (with a minimum follow-up of one-year) in 49% of the total Dutch population of patients 
with a press-fit BAP. We expect that this is sufficient to be able to generalise the results to the 
Dutch population eligible for a press-fit BAP. Of the patients included in this study to date, 
none have dropped out. We also do not anticipate any high drop-out rates for the remainder 
of the study as the assessments are part of usual care.
We will use the rule-of-thumb for prediction modelling with multiple factors and assume 
that we need ten cases per predictor.45 The various continuous outcomes of interest have a 
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different number of potential predictors (Appendix 1) ranging from three to seven variables. 
A minimum of 30 subjects are needed for prosthetic use, 40 subjects for HRQoL, 50 subjects 
for walking ability and prosthesis comfort, 60 subjects for coronal plane kinematics, and 70 
subjects for stump pain. Based on these numbers we expect to complete the inclusion of 
patients for this study around May 2018. 
Intervention
Press-fit BAP surgery involves two surgeries six to eight weeks apart.29,36 First, a cementless 
intramedullary stem is inserted in the femur or tibia and the wound is closed. After 
osseointegration has been initiated, a second procedure creates a soft tissue stoma with a 
transcutaneous connector which is bolted into the intramedullary stem. Between the two 
surgeries the patient is not allowed to use a socket prosthesis but is permitted to ambulate 
on the sound limb using a walking aid, such as crutches.
All patients start rehabilitation one week after the second surgery. Rehabilitation aims to 
reach predetermined functional goals. These goals include increasing the level of activity and 
minimising gait compensation strategies, such as, an unstable pelvis and ipsilateral lateral 
flexion of the trunk during stance phase. Rehabilitation focuses on improving hip abductor 
strength, core stability, symmetry in spatio-temporal parameters and symmetry in kinematic 
parameters. The detailed rehabilitation programme is described elsewhere.46 The duration 
of the twice weekly rehabilitation programme (Figure 2) depends on the level of amputation 
and ranges from 4 weeks (transtibial amputation) to 11 weeks (transfemoral amputation). 
Rehabilitation is prolonged if the patient is improving but has not met the previously 
determined goals.
Ethics
Patients included in this study are informed about the baseline and follow-up assessments 
Figure 2. Flow chart of assessments and interventions
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by the treating physician during the multidisciplinary out-patient clinic for BAP. A separated 
document, including a patient information letter and informed consent form is attached to 
the baseline assessment appointment letter. Informed consent with permission to use the 
usual care data for research purposes is obtained prior to the baseline assessment. The study 
is conducted according to the principles of the Declaration of Helsinki (64th version, 19-10-
2013). The protocol of this study (registration number 2014/196) was approved by the Ethics 
Committees of Radboud university medical centre.
Study procedures and parameters
Patients are assessed by the treating physiotherapist at baseline (preoperatively) and at six-
month, one-, two- and five-year follow-up (Figure 2). The primary outcomes of this study are 
level of function, activity, HRQoL and satisfaction. Demographics and patient characteristics 
are obtained from the patients. These variables will be used for descriptive statistics, and 
some will be used as potential predictors for change of coronal plane kinematics, prosthetic 
use, walking ability, HRQoL, prosthesis comfort and the level of stump pain at follow-up 
(Appendix 1).
Demographics and patient characteristics
Sex, age, cause of amputation and the time from primary amputation to inclusion are collected 
at baseline from the patients’ medical file. Level of amputation is obtained at baseline and at 
six-month follow-up. Body mass index (BMI) accounting for the limb loss using the adjusted 
body weight47, residual limb and sound limb characteristics46,48 and used prosthesis parts are 
obtained at baseline and all follow-up time points. Rehabilitation characteristics (the duration 
in weeks and the number of rehabilitation sessions) are also obtained. Adjusted body weight 
is calculated with the following formula: actual body weight / (1 minus percentage of the 
amputated part of the limb). The amputation percentages are: Transfemoral Amputation 
(TF): 10.1%, Transtibial Amputation (TT) / knee disarticulation (KD): 5.9%, foot amputation: 
1.5%, bilateral TF: 20.2%, bilateral TT / KD: 11.8%, bilateral foot amputation: 3.0% and TF 
combined with TT / KD: 16.0%.47
Level of function
Coronal plane kinematics
In unaided walkers, kinematics in the coronal plane are recorded using a video camera 
(Panasonic HC-X920) during two activities. First, while a patient walks three times up and 
down a path of 15 metres. Secondly, while a patient performs a step exercise with the 
sound side. The step exercise is performed, two times consecutively using a 11 centimetre 
high aerobic power step (Tunturi® New Fitness, Almere, The Netherlands). The kinematics 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 124
124
5
(continuous scale) in coronal plane (in degrees) are assessed using two methods: a) an overall 
angle between trunk and residual limb during the mid-stance is calculated out of two angle 
measurements, namely the angle between pelvis and residual limb and the angle between 
pelvis and trunk. To be able to assess these angles using Dartfish software (Dartfish, Fribourg, 
Switzerland), a piece of tape (approximately 1.0 by 1.0 cm) is placed on 1) the anterior superior 
iliac spine (ASIS) on both sides, 2) the proximal part of the manubrium and 3) 30 cm distal 
of the ASIS on the ventral side of the residual limb (Figure 3). The reference points for the 
position of the tape on the residual limb varies. In patients with a transtibial amputation the 
middle of the patella is used as a reference for all assessments. At baseline, the middle of the 
socket is used in patients with transfemoral amputation or knee disarticulation, because the 
position of the bone in soft tissue is not visible. At follow-up the transcutaneous connector 
is used in patients with a transfemoral amputation; b) peak pelvis and trunk segment 
angles during stance phase are measured relative to the laboratory axis using two wireless 
gyroscopes (Valedo®Motion, Hocoma, Volketswil, Switzerland) on the first vertebrae of the 
sacrum and 17.5 centimetre cranial of the distal gyroscope respectively, (Figure 3) using an 
applicator. A reproducibility study is now ongoing to assess both angle measurements and 
will determine which instrument will be used to evaluate the kinematics.
Figure 3. Coronal plane kinematics
Left: Position of the tapes; Right: Position of the gyroscopes
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Hip abductor strength
Hip abductor strength (continuous scale) is measured using the ‘make-technique’ with a 
microfet2TM handheld dynamometer (HHD) (Hoggan Scientific LLC., Salt Lake City, Utah, United 
States) with the patient lying in supine position. A fixation-belt is used to stabilise the pelvis 
and prevent sliding. The HHD is applied 22 centimetre distal of the most prominent aspect 
of the greater trochanter. For each strength test, following a warm-up of one submaximal 
contraction, all patients perform three maximal trials for 3 to 5 seconds with a 1-minute 
rest interval. The maximum of three valid trials is used. The torque value (Nm) of the hip 
musculature is normalised by body weight in kilograms (kg), resulting in a torque value in 
Nm/kg. This hip abductor strength test is a modification from the test described by Pua et al.49 
A reproducibility study is now ongoing.
Prosthetic use
The prosthetic use score (continuous scale: 0-100 points) of the Dutch version of the 
questionnaire for persons with a transfemoral amputation (Q-TFA) is used to assess the 
patient-reported prosthesis wearing time.50 A higher score represents a longer wearing time.
Back pain
A single question (ordinal scale) ‘Did you experience back pain within the previous month?’ 
with three response alternatives; ‘no’, ‘yes, with episodes’ and ‘yes, chronic (daily)’ is used to 
assess back pain frequency.46
Stump pain
Post-operative stump pain (continuous scale) is assessed during follow-up using the Numeric 
Rating Scale (NRS: 0-10).51 Pain location (nominal scale) is assessed for descriptive purposes 
with seven response alternatives: ‘no location’, ‘soft tissue stoma’, ‘distal side stump’, ‘ventral 
side stump’, ‘inguinal area’, ‘greater trochanter area’ or ‘other’.
Level of activity
Mobility level
The mobility level is assessed using three patient-reported outcome measures (ordinal 
scales: a-c) and one physical performance measurement (continuous scale: d): a) the 
Medicare Functional Classification Level (MFC-level)52, also known as ‘k-levels’ (0-4) in which 
‘k0’ represents a non-ambulatory person and ‘k4’ a high-level prosthesis user; b) the Special 
Interest Group in Amputee Medicine Workgroup Amputation and Prosthetics (SIGAM WAP) 
mobility score (class A-F)53 where ‘class A’ represents an abandoned prosthesis user and ‘class 
F’ a prosthesis user with a normal gait without aids; c) a question concerning the use of aids in 
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daily life, both for indoor use and outdoor use, with a 5-point likert scale answer; ‘wheelchair-
bound’, ‘walking frame / rollator’, ‘two crutches / canes’, ‘one crutch / cane’, ‘none’; d) the 
timed up and go (TUG) using a standard arm chair (seat height 46 centimetre, arm height 
67 centimetre) and a 3 metre walking course marked by a pylon, representing the level of 
physical mobility.54 The fastest attempt (in seconds) of three TUGs is noted as final time score.
Walking ability
Walking ability is evaluated using two measurements (continuous scales): a) a self-paced 
6-minute walking test (6MWT). Patients walk six minutes as fast as they can without 
encouragement, on a 10 metre course marked by two pylons representing the submaximal 
level of functional capacity.55,56 Total walking distance will be recorded in meters and walking 
speed will be calculated in meters per second as an indicator of gait performance57,58; b) a 
single question: ‘How far can you walk in one go in everyday life?’ representing a patient-
reported estimation of the walking distance in daily life in metres.46
Level of health-related quality of life
The Q-TFA global score (continuous scales: 0-100 points) is used to assess HRQoL and is a 
summary of three items: perception of function, problems with the current prosthesis and 
the perception of the current overall amputation situation.29,50 A higher score reflects a better 
HRQoL. All three items are scored on a 5-point likert scale. For patients not using a prosthesis 
only the single overall question (ordinal scale) is used; ‘How would you summarize your 
overall situation as an amputee?’, with five response alternatives; ‘extremely poor’, ‘poor’, 
‘average’, ‘good’ or ‘extremely good’.
Level of satisfaction
Prosthesis comfort
To assess the satisfaction of the patient in regards to their prosthesis, including the socket 
or bone-anchored prosthesis aspect, the Prosthesis Comfort Score (PCS)46 is used. The PCS 
(continuous scales) is a single question ‘How satisfied are you with your current prosthesis on 
a scale of 0 to 10, where 0 is not satisfied and 10 extremely satisfied?’.
BAP satisfaction
Global perceived effect of BAP (ordinal scale) is assessed within the post-operative follow-up 
using a single question ‘Would you, with your current knowledge, choose for a BAP again?’ 
with five response alternatives; ‘strongly disagree’, ‘disagree’, ‘neutral’, ‘agree’ or ‘strongly 
agree’. 
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Statistical analysis
All outcomes will be analysed non-stratified. Additionally, we will stratify for level of 
amputation and for baseline wheelchair-boundedness when applicable. The size of the 
subgroups will determine whether statistical tests will be used to analyse the outcomes of 
the subgroups, or if only descriptives will be presented. All analyses will be performed using 
SPSS v23 (SPSS Inc., Chicago, Illinois, United States). In all cases, two sided p-values <0.05 will 
be considered to be statistically significant.
Descriptive statistics
Categorical data will be presented as exact numbers. Percentages will be calculated for the 
various levels. For the continuous data, means and standard deviations will be calculated for 
normally distributed variables. For data not-normally distributed median and inter-quartile 
ranges will be used. Missing data will be analysed and imputation techniques will be used 
where necessary.
Aim 1: longitudinal statistics
Change over time in level of function, activity, HRQoL and satisfaction will be analysed for 
all continuous outcomes (coronal plane kinematics, hip abductor strength, prosthetic use, 
mobility level, walking ability, HRQoL and prosthesis comfort) and for one categorical outcome 
(back pain). Generalised estimating equations (GEE) for repeated measurements with an 
exchangeable correlation structure will be used59-61. Back pain will be dichotomised for this 
analysis into ‘no back pain’ and ‘back pain’ (representing the classes ‘yes, with episodes’ and 
‘yes, chronic (daily)’). Continuous outcomes (mean change) and the dichotomised outcome 
(odds ratio) will be presented with 95% confidence intervals.
Aim 2 and 3: prediction models
For the significantly changed outcomes of interest over time (change of coronal plane 
kinematics, prosthetic use, walking ability, HRQoL and prosthesis comfort) and for stump pain 
at follow-up, multivariate GEE59,61 will be used to examine which potential predictors are of 
added value in the prediction of these outcomes (Appendix 1). Potential predictors are age, 
BMI, time from primary amputation to inclusion, cause of amputation, level of amputation, 
length of the residual limb, baseline hip abductor strength, baseline prosthetic use, baseline 
mobility level, baseline walking ability and baseline prosthesis comfort. Baseline values of the 
outcomes of interest will also serve as potential predictors. The multivariate model will be 
reduced by manually removing predictors with a p-value of >0.15 based on the log-likelihood 
ratio test. Model performance will be assessed by the percentage of explained variance (R2) 
and C-statistics for continuous and categorical outcomes, respectively.
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Aim 4: causal model for change of back pain
To explore the potential mechanisms in the causal model for change of back pain over time 
(Figure 1), the potential determinant (coronal plane kinematics), the potential moderator 
(stump pain), the potential mediator (hip abductor strength) and the interaction term of the 
determinant and moderator/mediator will be analysed using GEE.
DISCUSSION
All assessments included in this study are part of usual care. This is, in our opinion, an 
advantage because the risk of missing data and loss to follow-up is expected to be low. The 
Netherlands is a relative small country, resulting in small logistical challenges. This differs 
from other countries where bone-anchored prosthesis surgery is performed (e.g. Sweden, 
Germany, Australia). There are a few limitations to our study design. 1) A disadvantage of 
data collection during usual care is that it may lead to measurement bias. Measurements may 
have to be performed by a different rater in unforeseen circumstances and the rater is also 
the treating physiotherapist. Furthermore, the used measurement instruments are rarely 
gold standard tools. In order to limit measurement bias, we standardised the measuring 
procedures as described in this study protocol, limited the maximum number of raters to 
two across all follow-ups and trained the raters. Three of our measurement instruments 
(Dartfish angle measurement, Valedo®Motion angle measurement and hip abductor strength 
test) are developed specifically for this study. Therefore, no information concerning their 
psychometric properties are readily available, but a reproducibility study concerning these 
measurements is now ongoing. 2) To increase the compatibility of our study results with 
other available literature, we have chosen to use the Q-TFA to evaluate prosthesis wearing 
time (prosthetic use score) and HRQoL (global score) in all patients, regardless of their level of 
amputation. The Q-TFA is specifically developed for patients with a transfemoral amputation, 
but the constructs we investigate in this study do not involve specific questions related to the 
level of amputation that could influence the validity of the results. Furthermore, the Q-TFA 
is widely used in studies which evaluate bone-anchored prosthesis use, both in patients 
with a transtibial as with a transfemoral amputation.40 3) Walking ability is investigated by 
patient-reported estimation of the walking distance in daily life. This may be less accurate 
than using a pedometer or activity tracker, but the results are clinically relevant. Patients 
may overestimate or underestimate, yet this is likely to happen structurally and therefore 
will not lead to biased results. 4) We have not included a measure investigating back pain 
intensity. Although back pain frequency is included, the method is too robust to identify more 
subtle changes, such as back pain intensity, that may also be an important clinical measure of 
treatment. For example, patients may still experience back pain but to a much lesser degree 
than before. The prevalence of back pain is high (52-84%) in patients with a lower extremity 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 129
129
Chapter 5 | A 5-year longitudinal study protocol
5
amputation using a socket prosthesis.21,62-64 This study will explore if back pain is a common 
secondary disability as well in the BAP population and we will examine potential mechanisms 
for change of back pain over time. Knowledge of these mechanisms can influence the content 
of rehabilitation programme and future studies may include questions regards to back pain 
intensity.
In our clinic patients who choose a BAP do this for various reasons, including the 
expectation to increase their level of function, activity, HRQoL and satisfaction. However, to 
our knowledge no previous research has been done concerning predictors for outcomes on 
the level of function, activity, HRQoL or satisfaction. Due to the lack of current evidence, no 
individualised care can be provided. This causes uncertainty concerning the result of the 
actual health benefits that a patient is hoping for when choosing for a BAP. This study will be 
the first to address this topic.
The main inclusion criteria for BAPs in current practice is the presence of socket-related 
problems. By eliminating these problems, patients aim to overcome limitations in their 
physical functioning. However, a part of the BAP population suffers from stump pain as 
result of stoma-related problems, reactivating muscles and reuse of the hip joint for weight 
bearing.34,40,46 Because stump pain after BAP surgery can also negatively influence physical 
functioning it is important to quantify the prevalence, the level of stump pain and identify 
potential predictors. Knowledge concerning these aspects may influence the content of the 
rehabilitation programme.
In summary, the psychometric properties of some of the chosen measurement instruments 
are absent and may influence the interpretation of these outcomes. This study is the first 
to examine coronal plane gait kinematics, hip abductor strength, prevalence of back pain, 
prevalence of stump pain and level of satisfaction in patients after BAP surgery. This study will 
provides preliminary insight in associated factors for clinically relevant outcome measures 
after press-fit BAP surgery. This important knowledge can help patients and professionals 
alike, to establish realistic expectations of the expected natural course after BAP surgery. In 
turn, this could potentially result in new inclusion criteria for BAP surgery in the future.
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APPENDIX 1. PREDICTION MODELS WITH POTEN-
TIAL PREDICTORS
Change of coronal plane kinematics over time compared to baseline= f(time from primary 
amputation to inclusion, baseline length of the residual limb, baseline coronal plane 
kinematics, baseline hip abductor strength, baseline walking ability, baseline prosthesis 
comfort)
Change of prosthetic use over time compared to baseline= f(body mass index, baseline 
prosthetic use, baseline prosthesis comfort)
Change of walking ability over time compared to baseline= f(age, body mass index, baseline 
hip abductor strength, baseline walking ability, baseline prosthesis comfort)
Change of health-related quality of life over time compared to baseline= f(baseline prosthetic 
use, baseline walking ability, baseline health-related quality of life, baseline prosthesis 
comfort)
Change of prosthesis comfort over time compared to baseline = f(body mass index, time 
from primary amputation to inclusion, cause of amputation, level of amputation, baseline 
prosthesis comfort)
Level of stump pain at follow-up= f(time from primary amputation to inclusion, level of 
amputation, baseline length of the residual limb, baseline hip abductor strength, baseline 
prosthetic use, baseline mobility level, baseline walking ability)
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ABSTRACT
Introduction
Suitable handheld dynamometer (HHD)-techniques to test hip abduction strength in 
individuals with a lower extremity amputation, irrespective of their amputation level are 
absent. The aim of this study was to optimise a HHD-technique and to test its reproducibility 
and validity.
Methods
This study involved three phases, in which two techniques were evaluated. Both HHD-
techniques used a lever-arm of 22 centimetre. HHD-technique 1 used a break-technique. 
After obtaining within-session test-retest reproducibility (phase 1) we optimised the HHD-
technique by adding a fixation-belt and using a make-technique (HHD-technique 2). We 
tested the within-session test-retest and inter-rater reproducibility (phase 2) and the validity 
(phase 3) of HHD-technique 2 using an isokinetic dynamometer. New cohorts of participants 
were recruited for each phase.
Results
Phase 1: we tested HHD-technique 1 in 26 participants with a lower extremity amputation. 
It was test-retest reproducible (ICC3.1
agreement
: 0.80-0.92, standard error of measurement 
(SEM): 3.1-4.4 Nm and smallest detectable change (SDC): 8.6-12.3 Nm). There were 
questions regarding the validity of the measurement, because the mean muscle torque of 
the residual limb and sound limb were similar, which is uncommon. Phase 2: reproducibility 
of HHD-technique 2 was tested in 44 participants with a lower extremity amputation. It was 
test-retest reproducible (ICC3.1
agreement
: 0.96-0.97, SEM: 3.9-4.7 Nm and SDC: 10.9-12.9 Nm) 
but not inter-rater reproducible despite having good reliability (ICC3.1
agreement
: 0.92, SEM: 
6.9-7.6 Nm and SDC: 19.2-21.2 Nm). Systematic bias and bias related to the magnitude of 
the muscle torque was suspected. Phase 3: the concurrent validity was established in 30 
healthy participants (r= 0.84). Systematic bias in measurement error was present, including a 
consistent overestimation of the muscle torque of 28% using the HHD.
Conclusion 
HHD-technique 2 is a test-retest reproducible and valid measuring technique The technique 
may be further optimised by the use of an external device to stabilise the HHD.
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INTRODUCTION
Lower extremity muscle strength training is an important element of rehabilitation programmes 
for individuals with a lower extremity amputation.1-6 The importance is supported by the 
following findings: 1) strength of the muscles of the hip joint in the residual limb is decreased 
up to 35% relative to healthy subjects and up to 28% compared to the sound limb7,8; 2) muscle 
atrophy of the residual limb is present up to 73% compared to the sound limb9; 3) decreased 
and asymmetric muscle strength is associated with lower gait speed and an asymmetric gait 
pattern10-13 4) decreased strength of the muscles of the hip joint is associated with lower 
activity levels.7 Reliable, valid and responsive measurement instruments are needed to 
measure muscle strength. This is important to be able to determine the intensity of strength 
training and to evaluate the effectiveness of a rehabilitation programme.
In scientific research various instruments are used to evaluate lower extremity 
muscle strength in individuals with a lower extremity amputation, such as isokinetic 
dynamometers4,7,8,14, an Optical Testing of Isometric Moments (OpTIMo) device13, 10-repetition 
maximum tests on resistance machines1 and handheld dynamometers (HHD).3,15 For daily 
clinical practice a measurement has to be low in cost, non-time-consuming, portable and 
easy to use, which is only the case for HHD measurements.16 Clinimetric properties for muscle 
strength measurement obtained with a HHD are mainly established in able-bodied persons, 
but are lacking for individuals with a lower extremity amputation.16
Various measurement techniques to evaluate hip abduction strength using a HHD are 
described in the current literature.17-27 None of these measurement techniques is suitable for 
individuals with a transfemoral amputation because of the positioning of the HHD in relation 
to the absence of a knee or ankle joint. The main variations in execution are characterised by: 
1) the participants’ position (side-lying or supine position), 2) the position of the HHD (slightly 
proximal to the edge of the lateral femoral condyle or the lateral malleolus, respectively), 
3) the use of additional fixation-belts, 4) the type of resistance technique used (‘break-
technique’ or ‘make-technique’), 5) the use of additional portable devices to stabilise the 
HHD.17-27
The aim of this cross-sectional study was to optimise a hip abduction strength 
measurement technique for individuals with a lower extremity amputation, irrespective of 
their level of amputation, and to test its reproducibility and validity. The optimisation of the 
HHD measurement technique in this study involved three phases (Figure 1), in which two 
techniques were evaluated. In both HHD-techniques the muscle strength of the participant 
was assessed in supine position, a gravity neutralised position22, to prevent measurement 
bias due to weight differences between the residual limb and sound limb. Additionally, 
measurement variation is reduced by testing in a supine position compared to testing in a 
side-lying position.24 A new cohort of participants was recruited for each phase of the study 
(Figure 1). The COSMIN Checklist was followed for the preparation of the manuscript.28
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PHASE 1: TEST-RETEST REPRODUCIBILITY OF HHD-TECHNIQUE 1
METHODS
The aim of this phase was to determine the within-session test-retest reproducibility of HHD-
technique 1; a break-technique without the use of an additional fixation-belt or portable 
device to stabilise the HHD. We chose not to use any additional tools in order to make the test 
as practical as possible and to improve easy implementation in daily clinical practice. 
Figure 1. Flowchart study
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 141
141
Chapter 6 | Hip abductor strength measurement technique
6
Participants
All consecutive individuals within 3 months, with a lower extremity amputation who 
followed a rehabilitation program in our centre or had a regular follow-up were eligible for 
the study (Figure 1). A written informed consent was obtained from all participants prior 
to the assessment. The study was conducted according to the principles of the Declaration 
of Helsinki (64th version, 19-10-2013). The protocol of this phase of this study (registration 
number 2012/547) was approved by the Ethics Committees of the Radboud university 
medical centre. The individual displayed in Figure 2 has given written informed consent (as 
outlined in PLOS consent form) to publish this image.
Study procedure
The test-retest muscle strength assessment was performed by a physiotherapy student (RvE) 
following training from an experienced physiotherapist (RL). A pilot was performed where 
three individuals were tested using the measurement technique to ensure standardisation 
of the procedure. Both, the test and retest assessment were performed consecutively in 
one session on the same day. Both assessments started with muscle strength testing of the 
left limb followed by the right limb. The participants were offered sufficient time (at least 1 
minute) to rest before the muscle strength test of each limb and between the assessments. 
The muscle strength value was not visible for the rater during the test as the screen of the 
HHD was positioned downwards (Figure 2a), to decrease the chance of measurement bias.
Figure 2. Assessment set-up
A: Handheld dynamometer-technique 1; B: Handheld dynamometer-technique 2, in default 
supine position
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 142
142
6
Testing procedure
Participants were positioned in supine position on a treatment table, which was covered with 
an additional anti-slip mat to prevent sliding (Figure 2a). The participants held their arms by 
their chest and the lower limbs were in neutral position (limbs shoulder-width apart). The 
rater placed a marking on the skin to indicate the point where the force would be applied. 
This mark was used for both the test and the re-test. The point was marked 20 centimetre 
(cm) distal of the most prominent aspect of the greater trochanter. When participants had a 
shorter residual limb, the lever-arm was adjusted and noted. Muscle strength was obtained 
in Newton (N) using the break-technique with a portable HHD (MicroFET2TM, Hoggan 
Scientific LLC., Salt Lake City, Utah, United States) including a 4 cm wide transducer pad. 
In this procedure, the rater applied a resistance that was sufficient to counteract the force 
generated by the participant, after which the rater gradually overcame the participants’ force 
and stopped the moment the limb gave way. The lever-arm to the centre of the pad (22 cm) 
was used to calculate the hip abduction torque value in Newtonmetre (Nm).
Following a warming-up of one submaximal contraction, all participants performed three 
maximal contractions for 3 to 5 seconds with a 1-minute rest interval for each limb.22,24 The 
highest score of the three maximal contractions was used for analysis.24 During all strength 
measurements, verbal encouragement was given.22
Statistical analysis
Participant characteristics including sex, age, level of amputation and the length of the 
residual limb were described.29 The residual limb length (cm) was measured from crotch to 
the most distal end of the residual limb. The torque values (Nm) were calculated for both 
the residual limb and the sound limb. The difference in muscle torque (Nm) between the 
test and the retest was calculated. Categorical data were presented as exact numbers and 
percentages were calculated for the various levels. For the continuous data, means and 
standard deviations were calculated.
Reproducibility (test-retest) was divided in reliability and agreement parameters.30 Reliability 
was tested using the intraclass correlation coefficient (ICC). ICC’s were calculated using a two-
way mixed effect model (ICC3.1
agreement
) with 95% confidence intervals (CI). The Interpretation 
of ICC values was based on guidelines offered by Byrt31: 0.01-0.20 poor reliability, 0.21-0.51 
slight reliability, 0.41-0.60 fair reliability, 0.61-0.80 good reliability, 0.81-0.92 very good 
reliability, and 0.93-1.00 excellent reliability. Standard error of measurement (SEM
agreement
) 
and the smallest detectable change (SDC
agreement
) were calculated to assess agreement. Both 
are expressed in the unit of the measurement (Nm). The SEM was calculated as SEM
agreement
= 
√σ2
error
=√(σ2o+ σ
2
residual
).32 The variance due to systematic differences between the observers 
(σ2o) and the residual variance (σ
2
residual
) were obtained from the varcomp analysis.32 The 
SEM
agreement
 was used to calculate the SDC
agreement
= 1.96 * √n * SEM.30 In this formula ‘n’ refers 
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to the number of measurements, which is two in our study.30 Additionally, the SEM% and 
SDC% were calculated as outcomes independent of the unit of measurement. The SEM% and 
SDC% were calculated by dividing the SEM and the SDC, respectively, by the average torque 
value of the test and the retest and then multiplying by 100.21,23 A Bland-Altman plot was 
constructed to determine if there was bias in measurement error.33,34 This plot shows the 
rater difference against the mean muscle torque. The plot visualises the relationship between 
the measurement error and the observed value including the presence of systematic bias 
and bias related to the magnitude of hip abduction strength.34 The 95% limits of agreement 
(95% LoA) were shown in the plot (mean difference ± 1.96 SD of the difference). All analyses 
were performed using IBM SPSS Statistics v22 (SPSS Inc., Chicago, Illinois, United States). In all 
cases, two sided p-values <0.05 were considered to be statistically significant.
RESULTS
We included 26 participants (20 men) with a lower extremity amputation (Table 1). The mean 
age of this group was 52 years (range: 24-80 years). We did not have to adjust the default 
lever-arm of 22cm in any of the included participants (n=18) with a transfemoral amputation.
Table 1. Participant characteristics
Participant characteristics Phase 1 Phase 2 Phase 3
HHD-technique 1 HHD-technique 2
Group A Group B
n= 26 n= 44 n= 30 n= 7
Male gender, n (%) 20 (77) 28 (64) 18 (60) 4 (57)
Age (yrs), mean (SD) 51.7 (15.0) 53.9 (12.7) 33.1 (15.6) 22.0 (1.9)
Amputation level
- Transfemoral amputation, n (%) 18 (69) 35 (80) NA NA
Length residual limb (cm), mean (SD) 21.4 (3.7) 21.1 (4.4) NA NA
- Through knee amputation, n (%) 1 (4) 1 (2) NA NA
- Transtibial amputation, n (%) 7 (27) 7 (16) NA NA
 - Foot amputation, n (%) NA  1 (2) NA  NA  
HHD: handheld dynamometer; Yrs: Years; cm: Centimetre; SD: Standard deviation
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The test-retest reproducibility of HHD-technique 1 is summarised in Table 2. We found fair 
to very good reliability (ICC3.1
agreement
: 0.80, 95% CI: 0.58-0.91) for the residual limb and very 
good to excellent reliability (ICC3.1
agreement
: 0.92, 95% CI: 0.83-0.97) for the sound limb. The 
SEM was 5.4 Nm and 3.1 Nm and the SDC was 15.1 Nm and 8.6 Nm in the residual limb and 
the sound limb, respectively. The SEM% was 9.1% and 5.4% and the SDC% was 25.5% and 
15.0% in the residual limb and the sound limb, respectively. The 95% LoA was -17.2 to 10.6 
Nm and -9.6 to 6.8 Nm for the residual limb and the sound limb, respectively (Table 2 and 
Figure 3). 
Interpretation of the results
The reproducibility of HHD-technique 1 seemed good and no within-rater bias was present, 
but the results questioned the internal validity of the measurement. The mean hip abduction 
torque of the residual limb and sound limb were almost similar (Table 2), which did not 
correspondent with our observations during walking. Furthermore, these results were 
unexpected as no previous research reported on these.7,8 In the residual limb, Ryser et al.8 
found a deficit of 28% in the hip abductor muscle torque and Kowal et al.7 found a deficit of 
15% in the hip extensor muscle torque compared to the sound limb. We identified two possible 
confounders which could have influenced the validity: 1) inconsistent participants’ fixation on 
the table because of differences between participants’ capacity to fixate themselves on the 
table with a residual limb or a sound limb, and 2) the relative high muscle strength values due 
to the use of the short-lever-arm (22 cm) and the break-technique.20 High muscle strength 
values can also influence the participants’ fixation on the table and may have led to biased 
Figure 3. Bland–Altman plots for within-rater differences and their relation to the 
magnitude of hip abduction strength measured with HHD-technique 1
Nm: Newtonmetre; The solid line represents the mean difference (systematic bias) and 
the dashed lines illustrate the 95% limits of agreement (mean difference ± 1.96 SD of the 
difference)
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results because the strength of the rater will more likely influence the outcome.35 Because of 
these findings and possible confounders we adjusted the HHD-technique for the next phase, 
resulting in HHD-technique 2.
PHASE 2: TEST-RETEST AND INTER-RATER REPRODUCIBILITY OF 
HHD-TECHNIQUE 2
METHODS
The aim of this phase of the study was to determine the within-session test-retest and inter-
rater reproducibility of HHD-technique 2. With this HHD-technique we strived to gather 
internally valid outcomes by decreasing the torque values and increasing the participants’ 
fixation on the table (Figure 2b). Therefore, we changed to the use of a make-technique 
and the use of additional fixation-belt. A potential advantage of using the make-technique is 
that it reduces the influence of the strength of the rater on the outcomes, whereas a break-
technique produces higher torque values.36,37
Participants
All consecutive individuals within 30 months, with a lower extremity amputation who were 
invited for a pre-operative assessment for a bone-anchored prosthesis between May 2014 
and October 2016 were eligible for this part of the study (Figure 1).38 A written informed 
consent was obtained from all participants prior to the assessment. The study was conducted 
according to the principles of the Declaration of Helsinki (64th version, 19-10-2013). The 
protocol of this phase of this study (registration number 2014/196) was approved by the 
Ethics Committees of the Radboud university medical centre.
Study procedure
First, the test-retest assessments were performed by the first author (RL). Second, an 
experienced colleague (GvH) performed an additional assessment to test the inter-rater 
reproducibility. All assessments were performed consecutively in one session on the same 
day. All assessments started with muscle strength testing of the left limb followed by the 
right limb. The participants were offered sufficient time (at least 1 minute) to rest before 
the muscle strength test of each limb and between the assessments. The muscle strength 
value was not visible for the raters during the test as the screen of the HHD was positioned 
downwards (Figure 2b), to decrease the chance of measurement bias.
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Testing procedure
The testing procedure of HHD-technique 2 was similar to HHD-technique 1, with the exception 
of the following: 1) a make-technique was used and 2) an additional fixation-belt at the level 
of the pelvis to fixate the participant on the table was used to prevent sliding (Figure 2b). This 
kind of fixation has previously been described by Pua et al.22 The make-technique involved 
a resistance, applied by the rater, that was sufficient to counteract the force generated by 
the participant. The participant was instructed to gradually increase the force aiming at a 
maximal contraction after 3 to 5 seconds.
Statistical analysis
Participant characteristics were calculated and presented in the same way as described in 
phase 1 of the study. The torque values (Nm) of both the residual limb and the sound limb 
were calculated. The difference in muscle torque (Nm) within the test-retest and within the 
inter-rater assessment was calculated. ICC’s were calculated using a two-way mixed effects 
model (ICC3.1
agreement
) with 95% CI for the test-retest reliability and using a two-way random 
effects model (ICC2.1
agreement
) for the inter-rater reliability.32,34 The same parameters of 
agreement calculate in phase 1 (SEM
agreement
, SDC
agreement
, SEM% and SDC%) were calculated in 
this phase, for both the test-retest and the inter-rater reproducibility. The presence of bias in 
measurement error was assessed using the 95% LoA. All analyses were performed using IBM 
SPSS Statistics v22 (SPSS Inc., Chicago, Illinois, United States). In all cases, two sided p-values 
<0.05 were considered to be statistically significant.
RESULTS
We included 44 participants (28 men) with a lower extremity amputation (Table 1). The 
mean age of this group was 54 years (range: 27-78 years). In 3 out of 35 participants with a 
transfemoral amputation we had to adjust the default lever-arm from 22 cm to 18 cm.
The test-retest reproducibility of HHD-technique 2 is summarised in Table 3. The test-retest 
reliability was excellent for both the residual limb (ICC3.1
agreement
: 0.96, 95% CI: 0.93-0.98) and 
the sound limb (ICC3.1
agreement
: 0.97, 95% CI: 0.94-0.99). The SEM was 4.7 Nm and 3.9 Nm 
and the SDC was 12.9 Nm and 10.9 Nm in the residual limb and the sound limb, respectively. 
The SEM% was 8.3% and 5.7% and the SDC% was 22.7% and 16.0% in the residual limb and 
the sound limb, respectively. The 95% LoA was -14.1 to 10.9 Nm and -12.4 to 7.6 Nm for the 
residual limb and the sound limb, respectively (Table 3 and Figure 4).
The inter-rater reproducibility of HHD-technique 2 is summarised in Table 4. The inter-
rater reliability was fair to excellent for the residual limb (ICC2.1
agreement
: 0.92, 95% CI: 0.59-
0.97) and very good to excellent for the sound limb (ICC2.1
agreement
: 0.92, 95% CI: 0.84-0.96). 
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The SEM was 6.9 Nm and 7.6 Nm and the SDC was 19.2 Nm and 21.2 Nm in the residual limb 
and the sound limb, respectively. The SEM% was 11.6% and 11.0% and the SDC% was 32.8% 
and 30.8% in the residual limb and the sound limb, respectively. The 95% LoA was -20.9 to 
7.3 Nm and -23.9 to 16.5 Nm for the residual limb and the sound limb, respectively (Table 4 
and Figure 4).
The measurements of both rater 1 as rater 2 identified an asymmetry in muscle torque 
between the two limbs. The muscle torque of the residual limb was 11 to 16% lower than the 
muscle torque of the sound limb.
Figure 4. Bland–Altman plots for within-rater and between-rater differences and their 
relation to the magnitude of hip abduction strength measured with HHD-technique 2
Nm: Newtonmetre; The solid line represents the mean difference (systematic bias) and 
the dashed lines illustrate the 95% limits of agreement (mean difference ± 1.96 SD of the 
difference)
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Interpretation of the results
The test-retest reproducibility of HHD-technique 2 was good. The reliability had increased 
(ICC3.1
agreement
: 0.96 – 0.97 versus ICC3.1
agreement
: 0.80 – 0.92) and the SEM was similar (3.9 – 
4.7 Nm versus 3.1 – 5.4 Nm), compared to HHD-technique 1 (Table 2 and 3). The SDC of the 
residual limb was better (12.9 Nm versus 15.1 Nm) and the SDC of the sound limb was slightly 
worse (10.9 Nm versus 8.6 Nm), relative to HHD-technique 1. No within-rater bias was found, 
but there were suspicions for systematic bias and bias related to the magnitude of the muscle 
torque within the inter-rater test, in particular for the test of the residual limb. On average, 
the values of the second rater were higher than those from the first rater. The difference 
between raters increased when the subjects exhibited larger hip abduction strength (Figure 
4).
We found a muscle torque deficit up to 16% in the residual limb compared to the sound 
limb. This is in line with previous research, where deficits of 15 to 28% are described.7,8 Based 
on these results we were more confident that the internal validity of HHD-technique 2 was 
superior to HHD-technique 1. To test the internal validity of HHD-technique 2, phase 3 of this 
study was conducted.
PHASE 3: CONCURRENT VALIDITY OF HHD-TECHNIQUE 2
METHODS
The aim of this phase was to determine the concurrent validity of HHD-technique 2 using 
an isokinetic dynamometer. In the HHD assessment the default participants’ position was 
a supine position, a gravity neutralised position22, to prevent measurement bias due to 
different weight of the residual limb and sound limb. The default position for participants 
during the isokinetic dynamometer assessment was a side-lying position. This could not be 
changed, therefore this phase of the study involved two parts (Figure 1): 1) assessment of 
the concurrent validity of HHD-technique 2 in supine position and 2) assessment of the hip 
abduction strength using HHD-technique 2 in side-lying position. The aim of the second part 
was to rule out bias resulting from of the participants’ position on the table.
Participants
This phase of the study was conducted at the HAN University of Applied Sciences. All 
physiotherapy students of the HAN and their relatives were eligible for this part of the study. 
They were recruited within a time period of three months using posters, leaflets and social 
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media. All included participants were assessed in supine position (group A). Twenty-five 
percent of these participants (group B) were randomly selected, based on their availability, 
to also perform the HHD assessment in side-lying position (Figure 1). A written informed 
consent was obtained from all participants prior to the assessment. The study was conducted 
according to the principles of the Declaration of Helsinki (64th version, 19-10-2013). The 
protocol of this phase of this study (registration number 2014/196) was approved by the 
Ethics Committees of the Radboud university medical centre. The individual displayed in 
Figure 5 has given written informed consent (as outlined in PLOS consent form) to publish 
this image.
Study procedure
The HHD assessment and the isokinetic dynamometer assessment were performed by trained 
physiotherapist students (respectively by YB and JD). A pilot, including three individuals, was 
performed to ensure standardised tested methods. In part 1, the participants (group A) 
were randomised into two groups using opaque sealed envelopes. One group started with 
the HHD assessment followed by the isokinetic dynamometer assessment. The other group 
had a counterbalanced programme in order to avoid bias as result of fatigue. In part 2, the 
participants (group B) performed an additional HHD assessment, in side-lying position, one 
week after the initial assessment.
Both assessments started with muscle strength testing of the left limb followed by the 
right limb. The participants were offered sufficient time (at least 1 minute) to rest before the 
muscle strength assessment of each limb and between the assessments.
Testing procedure
In part 1, HHD-technique 2 was used as previously described in phase 2. For comparison 
we obtain the isometric maximum voluntary contraction (Nm) of the hip abductor using 
an isokinetic dynamometer (Humac Norm, Computer Sports Medicine Inc., Stoughton, 
Massachusetts, United States). When using the Humac Norm, the participants were positioned 
in side-lying position with a fixation-belt on the thigh of the non-tested limb (Figure 5a). The 
stabiliser pad of the Humac Norm was positioned on the tested limb, 20 cm distal of the 
most prominent aspect of the greater trochanter. Following a warming-up of one submaximal 
contraction, all participants performed three maximal contractions of 3 to 5 seconds with a 
1-minute rest interval for each limb.22,23 The highest score was used for analysis.23 During all 
strength measurements verbal encouragement was given.22
In part 2, hip abduction strength using HHD-technique 2 in side-lying position was tested 
(Figure 5b). The position of the fixation-belt was adjusted so that it was similar to the fixation 
on the Humac Norm. The testing procedure was similar to the procedure described in part 1.
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Statistical analysis
Participant characteristics including sex, age were calculated and presented in the same 
way as described in phase 1 of this study. The highest muscle torque values (Nm) of the left 
and the right limb were pooled. The difference in muscle torque values (Nm) obtained with 
HHD technique-2 and the Humac Norm were calculated. The concurrent validity between 
the muscle torque detected by HHD-technique 2 and the Humac Norm was determined by 
calculating the two-way mixed effects model (ICC3.1
consistency
) with 95% CI.39 The presence of 
bias in measurement error was assessed using the 95% LoA. To determine bias resulting from 
the participants’ position on the table we analysed the muscle torque differences between 
the HHD-technique 2 in supine and side-lying position using the Wilcoxon signed-rank test. 
All analyses were performed using IBM SPSS Statistics v22 (SPSS Inc., Chicago, Illinois, United 
States). In all cases, two sided p-values <0.05 were considered to be statistically significant.
RESULTS
We included 30 healthy participants (group A), of which 18 men. The mean age of this group 
was 33 years (range: 20-64 years). The subgroup that was also assessed in side-lying position 
(group B) consisted of 7 participants (4 men), with a mean age of 22 years (range: 20-25 
years) (Table 1).
Results of the comparison of HHD-technique 2 to the Humac Norm outcomes (Table 5) 
revealed that the concurrent validity was good to very good (ICC3.1
consistency
: 0.84, 95% CI: 0.69-
0.92), but that there was a systematic bias in measurement error (Figure 6). Hip abduction 
torque measured with the HHD was 28% higher than when the muscle torque was measured 
with the isokinetic dynamometer. The 95% LoA was -9.9 to 54.7 Nm (Table 5 and Figure 6). 
Figure 5. Assessment set-up
A: Humac Norm; B: Handheld dynamometer-technique 2, in side-lying position
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The hip abduction torque of the sample (n= 7) that performed the HHD-technique 2 both 
in supine and in side-lying position was 107.1 (9.0) Nm and 104.1 (21.5) Nm, respectively. 
Comparison of these results showed that the participants’ position did not influence the 
outcome (p= 0.799). The hip abduction torque on the Humac Norm was 93.1 (31.9) Nm in 
this sample.
Table 5. Phase 3: Validity HHD-technique 2
Type of instrument Torque (Nm) Difference HHD-Humac 95% LoA (Nm) ICC3.1
consistency
 
 mean (SD) (Nm) mean (SD) (95% CI)
HHD (n= 30) 103.7 (29.3) 22.4 (16.5) -9.9; 54.7 0.84 (0.69-0.92)*
Humac Norm (n= 30) 81.3 (28.9)
HHD: Handheld dynamometer; Nm: Newtonmetre; SD: Standard deviation; LoA: limits of agreement *: p<0.001
Interpretation of the results
The concurrent validity of HHD-technique 2 was good in healthy subjects and the participants’ 
position did not result in biased results. A systematic bias in measurement error was present. 
The muscle torque measurement with a HHD resulted in a consistent overestimation of the 
Figure 6. Bland–Altman plot for between-device differences and their relation to the 
magnitude of hip abduction strength measured with HHD-technique 2 and Humac norm
Nm: Newtonmetre; The solid line represents the mean difference (systematic bias) and 
the dashed lines illustrate the 95% limits of agreement (mean difference ± 1.96 SD of the 
difference)
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hip abduction torque compared to measurement with an isokinetic dynamometer. The mean 
overestimation was 28%.
DISCUSSION
The reproducibility of both presented HHD-techniques was good, however HHD-technique 
1 may have resulted in less valid outcomes. This was illustrated by the absence of muscle 
torque asymmetry between the residual limb and sound limb. The second phase of this study 
revealed that an adjustment of HHD-technique 1, by adding a fixation-belt and changing 
the type of resistance (HHD-technique 2), may have led to internal valid outcomes. This 
was confirmed in phase 3 of this study. However, hip abduction torque measured by a HHD-
technique 2 overestimated the muscle torque while the gold standard measurement revealed 
lower muscle torque values. Because the overestimation is consistent it is possible to convert 
values obtained with a HHD-technique 2 to isokinetic dynamometer values.
The test-retest reliability of HHD-technique 2 (ICC3.1
agreement
 0.96 – 0.97) was similar 
as previously reported HHD test-retest reliability (ICC 0.74 – 0.98)17,22,24,25 and intra-rater 
reliability (ICC 0.81 – 0.96)18-21,26,27 of hip abduction strength measurements. The inter-rater 
reliability of HHD-technique 2 (ICC2.1
agreement
 0.92) was better than outcomes reported in 
previous studies (ICC 0.58 – 0.88).18,20,23,26,27 These findings suggest that the test-retest and 
inter-rater reliability of HHD-technique 2 is sufficient. This means that, despite measurement 
errors, HHD-technique 2 is appropriate to distinguish individuals with a lower extremity 
amputation from each other.30 Krause et al.20 previously stated that a short lever-arm could 
negatively influence the level of reliability. This was not confirmed in our study as the results 
showed very good to excellent reliability for HHD-technique 2.
Agreement parameters for HHD measurements of hip abduction strength are scarcely 
described in the current literature.18,19,21-24 This makes comparison difficult, partly because 
the SEM and SDC are reported in various units of the measurement. Newton19,21,23,24, 
Newtonmetre18,22,26 and kilogram27 were used, but information concerning the exact lever-
arm was missing hereby eliminating the possibility to recalculate the outcomes. In four 
studies21,23,24,27 the SEM% and/or SDC% was described, and in three other studies19,22,26 
there was enough data available to calculate them. Because both the SEM% and SDC% are 
independent of the unit of measurement it was possible to compare our HHD-technique 
2 results to these studies. The test-retest SEM% and SDC% of HHD-technique 2 ranged 
from 5.7 to 8.3% and 16.0 to 22.7%, respectively. These results are within the range found 
in the literature19,22,24,26; 2.9 to 13.7% for the SEM% and 8.1 to 31.7% for the SDC%. These 
findings combined with the absence of bias in measurement error, as illustrated in Bland and 
Altman plots (Figure 4), show that HHD-technique 2 is a valuable tool for test-retest repeated 
measurements to identify changes in hip abduction strength in patients with a lower extremity 
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amputation. The inter-rater SEM% and SDC% of HHD-technique 2 ranged from 11.0 to 11.6% 
and 30.8 to 32.3%, respectively. The literature21,23,26,27 shows similar values; 3.3 to 20.2% for 
the SEM% and 9.4 to 26.7% for the SDC%. The large inter-rater SDC% and the fact that the 
results raised suspicions for (systematic) bias in measurement error, also illustrated in Bland 
and Altman plots (Figure 4), limits applicability of HHD-technique 2 in an inter-rater clinical 
practice. A possible explanation for these results is the presence of variation in rater strength.
Between-rater bias as result of variation in rater strength is, particularly found in 
measurements of hip abduction strength with a short lever-arm.35 The level of between-
rater bias may be decreased with the use of an external device to fixate the HHD instead of 
stabilisation by a human rater.23 Despite the use of an external device, less desirable results 
were found in short-lever set-ups than in long-lever set-ups.23 The short-lever set-up used 
by Thorburg et al.23, was a HHD placement just above the knee. This is much longer than 
the lever-arm we used (22 cm). Using external devices to stabilise the HHD could potentially 
increase both the test-retest as inter-rater agreement parameters of HHD-technique 
2. Therefore, the use of external devices to stabilise the HHD within HHD-technique 2 is 
worthwhile to explore, but the use of a longer lever-arm is not an option for individuals with 
a transfemoral amputation.
The concurrent validity of HHD-technique 2 (ICC3.1
consistency
: 0.84, 95% CI: 0.69-0.92) is 
good to very good and is similar to the concurrent validity of other HHD-techniques used to 
obtain hip abduction strength.17,18 Aramaki et al.17 found a Pearson’s correlation coefficient of 
0.82 in healthy young adults. Hebert et al.18 found an ICC3.1 of 0.69 in healthy adolescents. 
On average, HHD-technique 2 produced a 28% higher hip abduction strength value than the 
isokinetic dynamometer. This illustrates that the instruments are not interchangeable. This 
is a problem when both instruments are used interchangeably within the evaluation of the 
muscle strength of one individual, but this is not likely in daily clinic. However, these findings 
must be taken into account when comparing different cohorts, as different research studies 
often use different testing methods. We did not use a gravity-correction within the analysis of 
the assessments in side-lying position. This may led to lower hip abduction torque values and 
is thus a possible confounding factor.40 Previous research of the concurrent validity of manual 
muscle testing with a portable HHD revealed inconsistent results; higher41, lower42,43 but also 
similar magnitude17,44-46 of the muscle strength have been described when compared to the 
assessment with an isokinetic dynamometer. Thus, the difference in muscle strength found 
in this study between the assessments with the HHD and the isokinetic dynamometer is not 
surprising. More important to note is that the difference was consistent in relation to the 
magnitude of the hip abduction strength (Figure 6). Therefore it is possible to convert values 
obtained with HHD-technique 2 to isokinetic dynamometer values.
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Strengths and limitations
An important strength of this study is that it resulted in a test-retest reproducible and valid 
measurement technique to evaluate hip abduction strength in patients with a lower extremity. 
A measurement technique like this was absent up to now. A second strength, is that we 
used a stepwise approach to optimise the HHD-technique where the findings of the first step 
were used to improve the HHD-technique. This approach resulted in the following insights: 
a fixation belt is of added value, an inter-rater setting is not desirable and the procedure can 
be standardised except for the lever-arm. Deviating from the default lever-arm of 22 cm is 
rarely needed, but when necessary it is possible to so because the unit of measurement is 
Nm. A third strength, is the sample size (26 to 44 participants) within the various phases of 
the study. The sample in this study is much larger than previous clinimetric studies regarding 
assessment of hip abduction strength17-19,21-25,35, which ranged from 9 to 20 participants. 
Despite the lack of an a priori power calculation we are confident that our study was sufficient 
powered. Previous studies22,23 that conducted an a priori power calculation determined that 
a sample size of 18 to 19 participants was necessary to achieve an acceptable ICC of at least 
0.70. 
A few limitations were identified. First, the point of force application was marked by the 
first rater on the skin one time and reused during subsequent assessments. A new point was 
marked only for the HHD test in side-lying position in phase 3, which was executed a week after 
the assessment in supine position. We chose to reuse the point marked to rule out differences 
in lever arm between the assessments. In a clinical practice with repeated measures, reusing 
the same marking point is not possible. This could lead to additional measurement variation 
of the within-rater and the between-rater results due to inconsistency in the placement of 
the force application. Second, the test-retest and inter-rater reproducibility was tested in 
one session on the same day which potentially could have resulted in recall bias of both 
the participant and the rater. Also the assessments to test the validity where in one session 
on the same day. The following reduced the chance on biased results: the muscle strength 
testing were alternated between the left limb followed by the right limb, sufficient time 
was taken between the assessments and the rater could not see the muscle strength value 
during the test. In clinical practice a retest of the muscle function is typically performed over 
a period of several weeks. However, in our study we assessed test-retest performance on the 
same day. We chose this procedure because the muscle strength of the included participants 
with a lower extremity amputation might have otherwise changed over time because the 
participants followed a rehabilitation programme (phase 1) or had surgery on a very short 
notice (phase 2). Whether test-retest performance is adequate over a longer period of time 
needs to be established in a stable population of patients. Third, changing HHD-technique 1 
into HHD-technique 2 resulted in an asymmetry in muscle torque of the residual limb and 
sound limb which was expected7,8, but the muscle torque did not decrease. We expected a 
reduction in muscle torque36,37, because a make-technique instead of a break-technique was 
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used in HHD-technique 2. We aimed to achieve lower muscle torque values because this may 
positively influence the participants’ fixation on the table and decrease the level of between-
rater bias as result of variation in rater strength. A possible explanation for the absence of the 
muscle torque decrease may be that the true muscle strength of the participants in phase 2 
was greater than that of the participants of phase 1 of this study. Another explanation may 
be the influence of the short-lever arm on the magnitude of the muscle torque. This may 
be so large that the effect of change in the type of resistance is irrelevant. Despite the high 
muscle torque values we did not find a ceiling effect in our study, illustrated by the Bland–
Altman plots (Figure 3 and 4). To avoid a ceiling effect, which negatively influences the level 
of reproducibility, it is important that the strength of the rater is sufficient to overcome the 
strength of the participant. A possible advantage of the make-technique is that it is more 
comfortable and have shown a lower risk for injury than the break-technique.18 Finally, HHD-
technique 2 was validated within a healthy subject population while it was optimised for 
individuals with a lower extremity amputation. This could affect the generalisability of our 
results, because the magnitude of the muscle torque in healthy subjects is greater than that 
of individuals with a lower extremity amputation. However, the Bland and Altman plot (Figure 
6) showed that the level of overestimation of the muscle torque by the HHD assessment was 
not related to the magnitude of the muscle torque. We do recommend that future studies 
include individuals with a lower extremity amputation to further validate HHD-technique 2.
CONCLUSION
HHD-technique 2 is a valuable test-retest measurement technique to assess hip abduction 
torque in individuals with a lower extremity amputation. It is not recommended to use the 
test in a setting where the measurements are performed by various raters. The validity was 
established in healthy subjects. Future research could establish validity of the HHD-technique 
2 in individuals with a lower extremity amputation and explore the potential advantage of 
incorporating an external stabilisation device to further optimise this technique.
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ABSTRACT
Introduction
Measuring coronal plane gait kinematics of the pelvis and trunk during rehabilitation of 
participants with a lower extremity amputation is important to detect asymmetries in gait 
which are hypothesised as associated with secondary complaints. The aim of this study was 
to test the reproducibility and discriminant validity of a three-dimensional (3-D; inertial 
measurement units) and a two-dimensional (2-D; video-based) system.
Methods
We tested the test-retest and inter-rater reproducibility of both systems and the 2-D system, 
respectively, in participants with a lower extremity amputation (group 1) and healthy subjects 
(group 2). The discriminant validity was determined with a within-group comparison for the 
3-D system and with a between-group comparison for both systems.
Results
Both system showed to be test-retest reliable, both in group 1 (2-D system: ICC3.1
agreement
 0.52-
0.83; 3-D system: ICC3.1
agreement
 0.81-0.95) and in group 2 (3-D system: ICC3.1
agreement
 0.33-
0.92; 2-D system: ICC3.1
agreement
 0.54-0.95). The 2-D system was also inter-rater reliable (group 
1: ICC2.1
agreement
 0.80-0.92; group 2: ICC2.1
agreement
 0.39-0.90). The within-group comparison of 
the 3-D system revealed a statistically significant asymmetry of 0.4°-0.5° in group 1 and no 
statistically significant asymmetry in group 2. The between-group comparison revealed that 
the maximum amplitude towards the residual limb (MARL) in the low back (3-D system) and 
the (residual) limb - trunk angle (2-D system) were significantly larger with a mean difference 
of 1.2° and 6.4°, respectively, than the maximum amplitude of healthy subjects. However, 
these average differences were smaller than the smallest detectable change (SDC) of group 
1 for both the MARL (SDC
agreement
: 1.5°) and the residual limb - trunk angle (SDC
agreement
: 6.7°-
7.6°).
Conclusion
The 3-D and 2-D systems tested in this study were not sensitive enough to detect real 
differences within and between participants with a lower extremity amputation and healthy 
subjects although promising reproducibility parameters for some of the outcome measures.
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INTRODUCTION
Asymmetries in spatiotemporal1-6, kinematic7-12 and kinetic9,12,13 parameters during gait are 
common in individuals with a lower extremity amputation. These asymmetries are associated 
with increased metabolic energy cost14-16 and low back pain.17,18 Especially, the asymmetries 
in the coronal plane kinematic parameters of the pelvis and trunk lead to increased joint and 
muscle forces and may therefore contribute to higher low back injury risk.18-20 Low back pain is 
in 52-84% of the individuals with a lower extremity amputation a secondary disability.17,18,21-23 
Therefore, rehabilitation programmes typically focus on optimising gait symmetry.14,24-26
Evaluating gait parameters in daily clinical practice to track the patient’s progress during 
the rehabilitation is challenging. Spatiotemporal parameters can be measured quite easily 
with a transducer27 or ‘GAITRite walkway system’.28,29 For obtaining kinematic and kinetic 
parameters a three-dimensional (3-D) motion capture system such as ‘Vicon’ is the gold 
standard. However, it is not suitable in daily clinical practice because it is high in cost, time-
consuming and not portable.30,31 The ‘gait real-time analysis interactive lab’ (GRAIL)32 and 
‘computer-assisted research environment’ (CAREN)14 have an added option to use real-time 
visual feedback and virtual reality to enhance the integration of these systems in rehabilitation 
programmes. However, both systems have the same limitations as the Vicon system.
Alternatively, wireless movement analysis systems using body-worn sensors (e.g. 
Valedo®Motion from Hocoma or MVN Biomech from Xsens) can be used: they are cheaper 
and easy to use. Additionally, they have the ability to provide real-time visual feedback.33-37 
These clinical feasible systems measure the 3-D angular tilt and velocity of body segments with 
respect to magnetic fields and gravity using multiple small light weight inertial measurement 
units (IMU).38,39 The degree of accuracy and reproducibility is specific to the used anatomical 
landmark and IMU-system.34,40 Another option for obtaining kinematic data is using a two-
dimensional (2-D) video-based system (e.g. Dartfish from Dartfish Inc.)41,42, which is also 
inexpensive and easy to use, although current drawbacks are the absence of real-time visual 
feedback and the limited validity compared to 3-D systems because the measured kinematic 
constructs differ from each other.41-43
The aim of this cross-sectional study was to test the reproducibility and discriminant 
validity (whether a method was able to detect asymmetries and/or distinguish groups) of 
two measurement methods for collecting coronal plane gait kinematics in participants with a 
lower extremity amputation in daily clinical practice. We obtained the kinematic parameters 
using both an IMU-system and a 2-D video-based system. Additionally, we measured healthy 
subjects with both systems in order to gather norm values and to determine the discriminant 
validity (Figure 1).
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METHODS
We tested the test-retest reproducibility and the discriminant validity of both an IMU-system 
(Valedo®Motion, Hocoma, Volketswil, Switzerland) and a 2-D video-based system (Dartfish-
software, Dartfish, Fribourg, Switzerland). We also determined the inter-rater reproducibility 
of the 2-D video-based system. A priori we verified the accuracy of the IMU-system using a 
goniometer in an experimental setting (Appendix A). This experiment showed that the IMU 
system had an excellent accuracy, but a slight asymmetry (0.2 to 0.7 degree) in maximum 
amplitude between left and right was present. The COSMIN Checklist was followed for the 
preparation of the manuscript to ensure methodological quality.44
Participants
Two groups participated in this study (Figure 1). Group 1: all consecutive individuals with 
a lower extremity amputation who followed a rehabilitation program in our centre or had 
a regular follow-up within a time period of three months were eligible for the study if they 
walked unaided. Group 2: healthy subjects who were relatives or acquaintances of the 
researchers were approached to participate in the study. Prior to the assessment a written 
informed consent was obtained from all participants. The study was conducted according 
to the principles of the Declaration of Helsinki (64th version, 19-10-2013). The protocol 
(registration number 2012/547) was approved by the Ethics Committee of the Radboud 
university medical centre. The individuals displayed in Figure 2 had given written informed 
consent (as outlined in PLOS consent form) to publish this image.
Study procedure
The test-retest assessment was performed by a physiotherapy student (BvD), following training 
from an experienced physiotherapist (RL). The training included a pilot measurement in three 
healthy individuals to ensure standardisation of the procedure. Both, the test- and retest-
Figure 1. Flowchart study
ValedoMotion: the inertial measurement units system; Dartfish: the two-dimensional video-
based system
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assessment were performed consecutively in one session on the same day. The participants 
were offered sufficient time (at least 5 minutes) to rest between the two assessments. During 
an assessment the participant wore simultaneously two IMU’s and four tape-markers. The 
tape-markers were used to facilitate the analysis with the 2-D video-based system. The IMU’s 
and tape-markers were removed after the first assessment and reattached after the break.
Testing procedure
The IMU-system consisted of three wireless IMU’s containing a tri-axillar gyroscope, 
magnetometer, and accelerometer with a fixed axle system. Two of the IMU’s were designed 
for positioning on an anatomical landmarks (low back and pelvis) using double-sided tape, 
the third IMU was designed for calibrating the low back and pelvic IMU using an additional 
reference holder including a level instrument (Appendix A, Figure A.3). In the calibration 
process the orientations of the IMU’s following the magnetometer are used to determine the 
zero-angles, which are the measured rotation angles at which the patient is standing upright. 
The calibrated rotations were measured using a sampling frequency of 300 Hz and exported 
to a notebook (Hewlett-Packard).
Each assessment started with the attachment of IMU’s using double-sided tape. The 
pelvic IMU was positioned on the basis of the sacrum (at the height of the posterior superior 
iliac spine). An applicator was used to determine the position of the low back IMU, which 
was 17.5 centimetre (cm) cranial of the pelvic IMU (Figure 2). Thereafter, the 1.0 by 1.0 cm 
tape-markers were placed on: 1) the anterior superior iliac spine (ASIS) on both sides, 2) 
the proximal part of the manubrium, and 3) 30 cm distal of the ASIS on the ventral side of 
the residual limb or a randomly selected limb in group 1 or group 2, respectively (Figure 
2). After calibrating the IMU’s the participants were instructed to walk three times up and 
down a 15-meter long walkway, on self-selected comfortable walking speed. The gait of the 
participants was recorded at 50 frames per second (1080/50p) using a camcorder (Panasonic 
HC-X920, Panasonic Netherlands, ‘s-Hertogenbosch, The Netherlands). At the start of each 
assessment day the location of the experiment was checked for magnetic fields using the 
Valedo®Motion software. Participants and researchers where instructed to keep cell phones 
out of the measuring location to avoid magnetic interference.
Data analysis
We analysed the coronal plane kinematic parameters of the low back and pelvic IMU. Of each 
assessment we only analysed the data of the three trials towards the camera because this was 
the orientation in which the IMU’s were calibrated. MATLAB (Release 2015b, The MathWorks 
Inc., Natick, Massachusetts, United States) was used to process the csv-file containing the 
raw data (Appendix A, Figure A.4). First, a filter was used to get rid of low frequencies caused 
by substantial integration drift picked up over the duration of the trial measurement, and 
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high frequencies as a result of soft-tissue, and skin artefacts and high frequency noise.45,46 
The angle output of the IMU’s was filtered using a band-pass filter (bi-directional 2nd order 
Butterworth filter, low-pass frequency of 5 Hz, high-pass frequency of 0.3 Hz). Second, the 
transition in the data between the way towards the camera and the way back was defined 
manually by an engineer (LD) who performed the data analysis of both the test- and the 
retest-assessment. Third, a MATLAB protocol was used to automatically detect peak angles 
for each trial based on an expected cadence interval within 0.5 and 2 Hz; due to the nature 
of the automated detection, negative peak angles (maximum amplitude to the right; MAR) 
were identified in between two positive peak values (maximum amplitude to the left; MAL) 
resulting in an unequal number of peaks to the right and to the left. Fourth, the detected 
peaks were visually checked and manually corrected if necessary before proceeding. Finally, 
we calculated the average for both the MAL and the MAR for each assessment. Additionally, 
the extent of asymmetry within each assessment was calculated as the average difference 
between MAL and MAR, resulting in a symmetry value. For the healthy subject (group 2), 
the MAL and MAR of the low back IMU represented the maximum lateral flexion angle to 
the left or to the right, respectively. The MAL and MAR of the pelvic IMU represented a 
lateral tilt angle to the left or to the right, respectively. For the participants with a lower 
extremity amputation (group 1) the direction of the movement was related to the side of the 
amputation; maximum amplitude towards the residual limb (MARL), maximum amplitude 
towards the sound limb (MASL), symmetry value (difference between MARL and MASL).
The 2-D video-based system (Dartfish-software) was used for photo goniometry. The video 
was played in slow motion and frame-by-frame, and was paused during the mid-stance phase 
of the fourth gait cycle of the second trial towards the camera. This moment was chosen 
to ensure that the gait was constant and to standardise the measurement. Within the still 
image the graphical goniometer included in the software was used to perform on-screen 
measurements. We measured the pelvis - limb (A) and pelvis - trunk angles (B) in degrees using 
the tape-markers (Figure 2). These angles were used to calculate an overall angle (limb - trunk 
angle; C) by the formula: C= A + (180 - B). The limb - trunk angle represents the posture in 
coronal plane with respect to global space. A larger angle represents a posture with a greater 
ipsilateral lateral flexion of the trunk and/or a greater abduction of the (residual) limb during 
the mid-stance phase. To determine the test-retest reproducibility of the 2-D video-based 
system the test-assessment was analysed twice with 4 weeks in between by a physiotherapy 
student (ER). A second physiotherapy student (RvE) assessed the test-assessment as well to 
establish the inter-rater reproducibility.
Statistical analysis
Participant characteristics including sex, age, level of amputation and type of prosthesis were 
described. The test-retest reproducibility was determined for both the IMU-system (low back 
and pelvic IMU) and the 2-D video-based system. The inter-rater reproducibility was only 
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relevant to determine for the 2-D video-based system. The difference in angles (degrees) 
within the test-retest and within the inter-rater assessment was calculated. The discriminant 
validity of the IMU system was determined by a within-group comparison and between-group 
comparison. In the within-group comparison the MARL was compared to the MASL (group 
1) and the MAL was compared to the MAR (group 2). In the between-group comparison the 
MARL and MASL (group 1) were compared to the average of MAL and MAR (group 2). The 
discriminant validity of the 2-D video-based system was determined by a between-group 
comparison. All data were checked for normality and if applicable for equality of variance. 
The within-group analysis were evaluated with a paired T-test. The between-group analysis 
were evaluated with an independent T-test or the Welch test. The categorical data were 
presented as exact numbers and percentages and were calculated for the various levels. For 
the continuous data, means and standard deviations were calculated.
Figure 2. Position of the IMU’s and tape-markers
Left: low back (upper) and pelvic (lower) IMU; Middle: tape-markers; Right: on-screen 
measurement of angle A= pelvis – limb angle and angle B= pelvis - trunk angle. Limb - trunk 
angle= A + (180 - B)= 187,6° (in this example).
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Test-retest and inter-rater reproducibility were both divided in reliability and agreement 
parameters.47 Reliability was tested using the intraclass correlation coefficient (ICC) with 
95% confidence intervals (CI). ICC’s were calculated using a two-way mixed effects model 
(ICC3.1
agreement
) with 95% CI for the test-retest reliability and using a two-way random effects 
model (ICC2.1
agreement
) for the inter-rater reliability.48,49 Agreement was assessed by calculating 
the standard error of measurement (SEM
agreement
) and the smallest detectable change 
(SDC
agreement
). Both are expressed in the unit of the measurement (degrees). The SEM was 
calculated as SEM
agreement
= √σ2
error
=√(σ2o+ σ
2
residual
).48 The variance due to systematic differences 
between the observers (σ2o) and the residual variance (σ
2
residual
) were obtained from the 
varcomp analysis.48 The SEM
agreement
 was used to calculate the SDC
agreement
= 1.96 * √n * SEM.47 
In this formula ‘n’ refers to the number of measurements, which is two in our study.47 A Bland-
Altman plot including 95% limits of agreement (95% LoA) was constructed to determine 
if there was bias in measurement error.49,50 The interpretation of ICC values was based on 
guidelines offered by Byrt51 (Appendix A, statistical analysis). All analyses were performed 
using IBM SPSS Statistics v22. In all cases, two sided p-values <0.05 were considered to be 
statistically significant.
RESULTS
Group 1 consisted of 25 participants with a lower extremity amputation (21 men) and group 
2 consisted of 41 healthy subjects (19 men) as presented in Table 1. The mean age was 51 
and 29 years in group 1 and 2, respectively. In group 1, 11 participants used a socket attached 
prosthesis (transfemoral: 4, through knee: 1, transtibial: 6) and 14 participants used a bone-
anchored prosthesis (transfemoral: 13, transtibial: 1). In 5 healthy subjects a technical error 
occurred during the data collection with the IMU-system which resulted in undetectable 
peak values due to an inconsistent waveform, hence only 36 participants were included in 
the analyses of the IMU-system.
Test-retest reproducibility
IMU-system
The test-retest reproducibility of the IMU system in group 1 and group 2 is detailed in Table 2. 
In group 1, the test-retest reliability of the low back IMU and the pelvic IMU was good to very 
good and fair to good, respectively. The SEM and SDC of the low back IMU ranged from 0.4° 
to 0.5° and 1.1° to 1.5°, respectively. The SEM and SDC of the pelvic IMU ranged from 1.1° to 
1.5° and 1.2° to 2.9°, respectively. In group 2, the test-retest reliability of the low back IMU 
and the pelvic IMU was good to very good and slight to very good, respectively. The SEM and 
SDC of the low back IMU ranged from 0.4° to 0.6° and 1.1° to 1.6°, respectively. The SEM and 
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SDC of the pelvic IMU ranged from 0.5° to 0.7° and 1.4° to 1.9°, respectively. In both groups 
no bias in measurement error was detected as shown in the Bland-Altman plots (Figure 3 
and 4).
2-D video-based system
The test-retest reproducibility of the 2-D video-based system in group 1 and group 2 is 
detailed in Table 2. In group 1, the measured and calculated angles showed a very good to 
excellent reliability. The SEM and SDC ranged from 1.5° to 2.4° and 4.1° to 6.7°, respectively. 
In group 2, the angles showed a fair to excellent reliability. The SEM and SDC ranged from 
1.0° to 1.9° and 2.6° to 5.4°, respectively. In both groups no bias in measurement error was 
detected as shown in the Bland-Altman plots (Figure 5).
Inter-rater reproducibility
The inter-rater reproducibility of the 2-D video-based system in group 1 and group 2 is 
detailed in Table 3. In group 1, the measured and calculated angles showed a good to very 
good reliability. The SEM and SDC ranged from 1.4° to 2.7° and 4.0° to 7.6°, respectively. In 
group 2, the angles showed a slight to very good reliability. The SEM and SDC ranged from 
1.3° to 2.5° and 3.6° to 7.0°, respectively. In both groups no bias in measurement error was 
detected as shown in the Bland-Altman plots (Figure 6).
Table 1. Participant characteristics
Participant characteristics Group 1 Group 2
n = 25 n = 41
Male gender, n (%) 21 (84) 19 (46)
Age (yrs), mean (SD) 50.7 (15.0) 29.2 (12.8)
Amputation level
- Transfemoral amputation, n (%) 17 (68) NA
- Through knee amputation, n (%) 1 (4) NA
- Transtibial amputation, n (%) 7 (28) NA
%: percentage; yrs: years; SD: standard deviation; NA: not applicable; Group 1: participants 
with a lower extremity amputation; Group 2: healthy subjects
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Figure 3. Bland–Altman plots for test-retest reproducibility of the IMU-system in 
participants with a lower extremity amputation
The solid line represents the mean difference (systematic bias) and the dashed lines illustrate 
the 95% limits of agreement (mean difference ± 1.96 SD of the difference)
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 175
175
Chapter 7 | Measurement methods to obtain coronal plane gait kinematics
7
Figure 4 Bland–Altman plots for test-retest reproducibility of the IMU-system in healthy 
subjects
The solid line represents the mean difference (systematic bias) and the dashed lines illustrate 
the 95% limits of agreement (mean difference ± 1.96 SD of the difference)
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Figure 5 Bland–Altman plots for test-retest reproducibility of the 2-D video based system
The solid line represents the mean difference (systematic bias) and the dashed lines illustrate 
the 95% limits of agreement (mean difference ± 1.96 SD of the difference)
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Figure 6 Bland–Altman plots for inter-rater reproducibility of the 2-D video based system 
The solid line represents the mean difference (systematic bias) and the dashed lines illustrate 
the 95% limits of agreement (mean difference ± 1.96 SD of the difference)
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Discriminant validity
IMU-system
In group 1, the within-group comparison (Table 4) revealed that the MARL was significant 
larger than the MASL with a mean difference of 0.5° (95% CI: 0.26; 0.80) in the low back 
IMU and 0.4° (95% CI: 0.12; 0.77) in the pelvic IMU. In group 2 the within-group comparison 
revealed no statistically significant difference between MAL and MAR in both IMU’s. The 
between-group comparison (Table 5) revealed that the MARL (group 1) was significant larger 
than the averaged maximum amplitude of group 2 with a mean difference of 1.2° (95% CI: 
0.50; 1.89) in the low-back IMU. The MASL of the low back IMU, and the MARL and MASL 
of the pelvic IMU (group 1) showed no statistically significant differences compared to the 
averaged maximum amplitude of group 2. The mean differences between group 1 and 2 on 
these outcomes ranged from 0.1° to 0.7°.
2-D video-based system
The between-group comparison (Table 6) revealed that group 1 had a larger pelvis - residual 
limb angle and residual limb - trunk angle than of group 2 with a mean difference of 6.3 ° 
(95% CI: 3.3; 9.3) and 6.4 ° (95% CI: 3.1; 9.6), respectively. The pelvis - trunk angle revealed 
no statistically significant difference between the two groups.
Table 4. Within-group comparison IMU-system
Participants with a lower extremity amputation (n = 25)
IMU Mean (SD) max amp to Mean (SD) max amp to Mean (SD) 95% Confidence
residual limb side: MARL (°) sound limb side: (MASL) (°) difference (°) Interval
Low back IMU 4.3 (1.3) 3.8 (1.2) 0.5 (0.7) 0.26; 0.80**
Pelvic IMU 4.7 (1.9) 4.3 (1.7) 0.4 (0.8) 0.12; 0.77*
Healthy subjects (n = 36)
IMU Mean (SD) max amp to left Mean (SD) max amp to right Mean (SD) 95% Confidence
side: MAL (°) side: MAR (°) difference (°) Interval
Low back IMU 3.1 (1.4) 3.2 (1.4) -0.1 (0.7) -0.36; 0.09
Pelvic IMU 5.5 (1.5) 5.3 (1.7) 0.2 (0.8) -0.04; 0.52
Max amp: Maximum amplitude; %: percentage; *: significant at p < 0.05; **: significant at p < 0.001; Statistics 
based on the paired T-test
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DISCUSSION
The IMU-system showed to be accurate in measuring coronal plane kinematics in both the low 
back and the pelvic IMU in an experimental setting. In a clinical setting, the IMU-system and 
2-D video-based system showed to be reliable systems to measure the most coronal plane 
kinematic parameters during gait both in participants with a lower extremity amputation 
(group 1) as in healthy subjects (group 2). The asymmetry detected by the IMU-system in 
the low back and pelvic coronal plane kinematics in group 1 is in line with previous reported 
studies.7-12 The between-group comparison revealed that only the MARL in the low back IMU 
and the (residual) limb - trunk angle were significantly larger than the maximum amplitude 
of healthy subjects. These results suggest that both systems are suitable for daily clinical 
practice with exception of the pelvic IMU, but the between-group comparison also revealed 
that the average difference was smaller than the SDC of the systems. The within-group 
asymmetry detected by the IMU system was also smaller than the SDC. So, it is questionable 
whether both systems will be sensitive enough to detect real differences within and between 
participants with a lower extremity amputation and healthy subjects.
The test-retest reproducibility of measuring coronal plane kinematics of the trunk is better 
compared to the pelvis if a 3-D motion capture system is used52, which is similar as our findings 
with the IMU-system. The reproducibility parameters of our IMU-system are comparable as 
found in a 3-D motion capture system52, however, likely the construct that is measured by 
the two systems differs. Previous studies which used a 3-D motion capture system reported 
a symmetry value of 2.1° for the trunk9 and 1.9° to 2.0° for the pelvis9,10 in individuals with a 
lower extremity amputation, which is much higher than the symmetry values found in our 
study. In addition, these higher symmetry values result in a more favourable ratio between 
the symmetry values and the SDC than with the IMU-system and the 2-D video-based system 
used in our study. The use of multiple surface markers per body segment versus one IMU as 
used in our study could explain the difference in measured construct. Another explanation 
for the relative low asymmetry values in our study could be that outcomes of IMU-systems 
are influenced by noise, limited resolution and constraints on mathematical calculations as 
concluded by Bauer et al.38 They used a similar IMU-system as we did to examine the validity 
of ROM tests of the trunk and concluded that the IMU-system underestimated the coronal 
plane movements ranging from 0.7° to 3.1°. So, our results may also be underestimated. The 
construct we measured with our 2-D video-based systems is not measured before, which 
makes it difficult to put our results in perspective. Grunt et al.53 assessed the reproducibility 
of sagittal plane measurements with a 2-D video-based system. The pelvic tilt angle was 
assessed compared to the laboratory floor and the trunk tilt angle was assessed compared to 
the pelvis. The pelvic tilt showed a similar test-retest reproducibility (ICC 0.92, SDC: 4.0°) but 
a worse inter-rater reproducibility (ICC 0.67, SDC: 8.5) than we found in measuring the pelvis 
- residual limb angle. The trunk tilt showed worse reproducibility for both the test-retest (ICC 
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0.77, SDC: 6.7°) and the inter-rater assessment (ICC 0.67, SDC: 8.5°) compared to our pelvis 
- trunk angle measurement.
Strengths and limitations
A strength of this study is that we examined the reproducibility of an IMU system obtaining 
trunk and pelvic kinematic parameters during gait in a patient population. The reproducibility 
of IMU-systems is an underexposed topic and trunk and pelvic kinematic parameters are to 
our knowledge only examined in healthy subjects. Orlowski et al.54 fixated an IMU on the 
pelvis and on the cervical spine during a gait measurement. Compared to our results they 
found lower and higher reliability for the trunk IMU (ICC: 0.76) and the pelvis IMU (ICC: 0.77), 
respectively. We estimated the SDC using their presented LoA and mean difference between 
the test and the retest, which is a slightly different method to calculate the SDC as we used. 
The SDC of the trunk IMU and the pelvic IMU were 1.7° and 2.2°, respectively. Our trunk IMU 
performed better and our pelvic IMU performed worse. A second strong point of our study is 
that we presented agreement parameters of the two examined systems, which enhances the 
interpretation by clinicians. Previous studies examining the reproducibility of IMU systems 
often presented reliability parameters (e.g. ICC’s) combined with a ‘coefficient of variation’ 
(CV) as a measure of agreement.38,55,56 The CV is an inappropriate parameter to indicate the 
level of measurement error in the field of medicine, it is a measure to determine the level 
of reliability in the phase of calibration of an apparatus.48 A third strong point is that we 
marked anatomical landmarks with tape to increase the visibility on screen aiming at lesser 
measurement variation within the 2-D video-based analysis of the kinematic parameters. 
The use of tape-markers may be the result of better reproducibility parameters than Grunt et 
al.43 found by measuring trunk kinematics in the sagittal plane with 2-D video-based system. 
This hypothesis is supported by the test-retest findings of Ortiz et al.42 who found excellent 
reliability (ICC 0.95 - 0.99) and a SEM of only 0.8° - 2.1° for a 2-D video-based valgus angle 
measurement of the knee using tape-markers. A fourth strong point is that we examined 
simultaneous the discriminant validity and reproducibility of gait kinematics. Insight in both 
parameters raised questions about the clinical viability of both the IMU system and the 
2-D video-based system, because the SDC was larger than the average difference between 
individuals with a lower extremity amputation and healthy subjects.
This study also contains limitations. First, an a priori power calculation is lacking. COSMINs’ 
quality criteria suggest that at least 50 participants should be included in reproducibility 
studies.57 However, using a power calculation proposed by Walter et al.58 a minimum sample 
size of 19 participant should be enough to achieve an ICC of at least 0.70 (alpha level, α= 
0.05 and beta level, β= 0.20) when using two assessments or two raters. Based on these 
guidelines it is inconclusive whether our sample size was sufficient, but owing that we found 
significant differences in our within- and between-group comparisons that were in line with 
the literature we are confident that our study was sufficiently powered. Second, we did not 
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measure spatiotemporal parameters, therefore we can only interpret the symmetry values 
obtained with the IMU-system and not the MARL and MASL in relation to the phase of the 
gait cycle. Third, the test-retest data was collected within one session. We removed the IMU’s 
and tape-markers after the first assessment and reattached them after the break to include 
measurement error as result of inconsistent identification of anatomical landmarks.52 However 
the used time lag does not mimic the clinical setting correctly, because normally the time lag 
will be a couple of weeks. By increasing the time lag the risk on measurement error will likely 
increase as well due to natural variability in participants’ gait. Additional bias was ruled out by 
the automated data-analysis of the IMU’s and the 4 week time lag in the test-retest analysis 
of the 2-D video based system. Fourth, we did not use a fixed anatomical landmark for the 
low back IMU. We chose to standardise the measurement procedure using the applicator 
of the Valedo®Motion with a fixed length of 17.5 cm. Due to differences in the height of the 
participants the low back IMU was positioned within a range of the thoracic spine which may 
have resulted in a larger variation in the obtained amplitudes and difficulty to understand the 
construct of the gait adaptations used by participants with a lower extremity amputation. 
Fifth, we analysed the peak values of the filtered data instead of the waveform which is a 
more detailed analysis59 and is commonly used to analyse IMU data.40,60-62 We chose to use 
the peak values because this was possible for both the IMU-system and the 2-D video-based 
system. The peak value analysis also resulted in clinical feasible outcome measures such as 
the SDC, which is not the case for waveform similarity statistics. Finally, within the 2-D video-
based analysis only one specific video frame was examined which is a poor representation of 
the entire gait cycle. Previous studies already concluded that a 2-D measurement measures 
a different construct than a 3-D measurement, probably due to additional movements in 
other planes.42,43 Rotation deviations in the transversal plane of the limb, pelvis or trunk will 
influence the angles measured in the coronal plane. For example, an external rotation of the 
limb will lead to an overestimation of the pelvis - limb angle.
The criterion validity of trunk46,63 and pelvic40,46,60,62,63 IMU’s during various applications 
(e.g. gait) is established in healthy subjects, but it is necessary that this is also examined in 
individuals with a lower extremity amputation. Gait adaptations vary tremendously within 
persons, so it should be examined if the currently used two IMU’s and the chosen anatomical 
landmarks were optimal to identify gait adaptations. Longitudinal validity (responsiveness) of 
both the IMU-system and the 2-D video-based system should also be investigated before the 
systems are applicable for evaluating gait kinematics within a rehabilitation trajectory.57 Most 
likely, a smaller average difference can be expected between subgroups of individuals with a 
lower extremity amputation and over time within rehabilitation trajectory than we found in 
our between–group comparison. Future research should establish this and the impact on the 
ratio between the symmetry values obtained with the IMU system and the (residual) limb - 
trunk angle obtained with the 2-D video-based system and their SDC.
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CONCLUSION
The IMU-system and 2-D video-based system tested in this study were not sensitive enough 
to detect real differences within and between participants with a lower extremity amputation 
and healthy subjects although promising reproducibility parameters for some of the outcome 
measures. It is therefore not likely that they will be suitable for evaluation of coronal plane 
kinematic parameters of the low back and pelvis in a clinical setting.
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APPENDIX A
METHODS
The aim of this experiment was to determine the accuracy of the IMU-system using a 
goniometer in an experimental setup (Figure A.1).
Study procedure
The accuracy experiment of the IMU-system (Valedo®Motion, Hocoma, Volketswil, 
Switzerland) was performed by an experienced physiotherapist who was familiar with the 
IMU system (RL). All trials within the experiment were performed on the same day.
Testing procedure
The Valedo®Motion IMU-system was developed for low back pain therapy but was modified 
by Hocoma for this research. As result of modification the IMU’s raw data was exported to 
a comma-separated-value (csv)-file and we had access to a training application to provide 
Figure A.1. Experimental setup
Left: notebook with receiver; Middle: metronome; Right: goniometer and reference holder 
with IMU’s (Upper: reference IMU, Middle: low back IMU, Lower: pelvic IMU)
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patient’s real-time visual feedback (Figure A.2). The IMU-system consisted of three wireless 
IMU’s containing a tri-axillar gyroscope, magnetometer, and accelerometer with a fixed axle 
system. Two of the IMU’s were designed for positioning on an anatomical landmarks (low 
back and pelvis) using double-sided tape, the third IMU was designed for calibrating the low 
back and pelvic IMU using an additional reference holder including a level instrument (Figure 
A.3). In the calibration process the orientations of the IMU’s following the magnetometer 
are used to determine the zero-angles, which are the measured rotation angles at which the 
patient is standing upright. The calibrated rotations were measured using a slightly variable 
sampling frequency around 300 Hz and exported to a notebook (Hewlett-Packard).
To examine the accuracy of the IMU system in the experimental setup, the three 
IMU’s were placed in the reference holder which was fixed with double-sided tape onto a 
goniometer (Topcraft). The calibration process was performed while the goniometer was 
pointing upwards (Figure A.1). Within a trial ten consecutive fixed angle displacements in 
the coronal plane were made by the physiotherapist with a fixed cadence (1 Hz) guided by a 
metronome. The fixed angle displacements ranged from 1 degree to 30 degrees. At the start 
of each trial the IMU’s were calibrated. Before the start of the experiment, the location of the 
experiment was checked for magnetic fields using the Valedo®Motion software to prevent 
magnetic interferences influencing the measurements.39,64
Figure A.2. Training application Valedo®Motion
Left: avatar displaying the kinematics of the low back and pelvis IMU in real time; Right: 
adjustable bull’s-eye displaying the limits of displacement of the low back (upper) and pelvic 
IMU (lower). An additional auditory cue can be provided if the patient shifts beyond the set 
limits.
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MATLAB (Release 2015b, The MathWorks Inc., Natick, Massachusetts, United States) was 
used (RL) to process the csv-file containing the raw data. Only the coronal plane kinematic 
parameters of the low back and pelvic IMU were analysed. A MATLAB protocol was used to 
automatically detect peak angles for each trial based on an expected cadence interval within 
0.5 and 2 Hz; due to the nature of the automated detection, negative peak angles were 
identified in between two peak values. Therefore, each trial yielded five positive peak values 
(maximum amplitude to the left; MAL) and four negative peak values (maximum amplitude to 
the right: MAR) which could be processed (Figure A.4). Detected peaks were visually checked 
and corrected if necessary before proceeding. For each trial we calculated the average for 
both the MAL and the MAR. Additionally, the extent of asymmetry within each trial was 
calculated as the average difference between MAL and MAR, resulting in a symmetry value.
Statistical analysis
IBM SPSS Statistics v22 (SPSS Inc., Chicago, Illinois, United States) was used to calculate the 
group average including standard deviation for both the MAL, the MAR and the symmetry 
value using the trial averages, independently for the low back and pelvic IMU.
The difference in both the MAL and the MAR values (degrees) obtained with the IMU-
system and the goniometer were calculated. The accuracy of both the low back and the 
pelvic IMU was determined by calculating the intraclass correlation coefficient (ICC) using 
a two-way mixed effects model (ICC3.1
consistency
) with 95% confidence intervals (CI).65 The 
Figure A.3. Reference holder Valedo®Motion
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presence of bias in measurement error was assessed using a Bland-Altman plot including 
the 95% limits of agreement (95% LoA).49,50 The Interpretation of the ICC values was based 
on guidelines offered by Byrt51: 0.01-0.20 poor accuracy, 0.21-0.51 slight accuracy, 0.41-0.60 
fair accuracy, 0.61-0.80 good accuracy, 0.81-0.92 very good accuracy, and 0.93-1.00 excellent 
accuracy. In all cases, two sided p-values <0.05 were considered to be statistically significant.
RESULTS
No technical errors occurred during data collection or data analysis resulting in no missing 
data in the 29 trials (1 degree to 30 degrees). Results of the comparison of the IMU-system 
and the goniometer (Table A.1 and A.2) revealed that the accuracy of the IMU system was 
excellent for both the low back and the pelvic IMU (ICC3.1
consistency
: 1.00, 95% CI: 1.00-1.00). 
The 95% LoA was -1.08 to 0.59 degree and -0.58 to 0.98 degree for the low back IMU and the 
pelvic IMU, respectively. No bias in measurement error was detected in both IMU’s (Figure 
A.5), but a slight asymmetry (0.2 to 0.7 degree) in maximum amplitude between left and right 
was present as shown in Table A.1 and A.2.
Figure A.4. Selection of the peak values using a MATLAB application
Example of the 10 degrees trial; Note that step 2 (filter data) was not used within the accuracy 
experiment to filter the angle output of the IMU’s.
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Table A.1. Accuracy maximum amplitude low back IMU
Type of device Max Amp (°) Diff GM-VM (°) 95% LoA (°) ICC3.1
consistency
mean (SD) mean (SD) (95% CI)
Movement to left
Valedo®Motion (n = 30) 15.5 (8.7) 0.0 (0.3) -0.59; 0.59 1.00 (1.00; 1.00)**
Goniometer (n = 30) 15.5 (8.8)
Movement to right
Valedo®Motion (n = 30) 15.8 (9.0) -0.4 (0.6)  -1.08; 0.48 1.00 (1.00; 1.00)**
Goniometer (n = 30) 15.5 (8.8)
Symmetry (left - right)
Valedo®Motion (n = 30) -0.7 (1.2) NA NA NA
Goniometer (n = 30) 0 (0)
Max Amp: Maximum amplitude; Diff: Difference; VM: ValedoMotion; GM: Goniometer; LoA: Limits of agreement; 
ICC: Intraclass correlation coefficient; CI: Confidence; NA: Not applicable; °: degree; **: p<0.001
Table A.2. Accuracy maximum amplitude pelvic IMU
Type of device Max Amp (°) Diff GM-VM (°) 95% LoA (°) ICC3.1
consistency
mean (SD) mean (SD) (95% CI)
Movement to left
Valedo®Motion (n = 30) 15.3 (8.5) 0.2 (0.4) -0.58; 0.98 1.00 (1.00; 1.00)**
Goniometer (n = 30) 15.5 (8.8)
Movement to right
Valedo®Motion (n = 30) 15.2 (8.7) 0.3 (0.3) -0.29; 0.90 1.00 (1.00; 1.00)**
Goniometer (n = 30) 15.5 (8.8)
Symmetry (left - right)
Valedo®Motion (n = 30) 0.2 (1.5) NA NA NA
Goniometer (n = 30) 0 (0)
Max Amp: Maximum amplitude; Diff: Difference; VM: ValedoMotion; GM: Goniometer; LoA: Limits of agreement; 
ICC: Intraclass correlation coefficient; CI: Confidence; NA: Not applicable; °: degree; **: p<0.001
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Figure A.5. Bland–Altman plots for between-device differences and their relation to the 
magnitude of the maximum amplitude measured with the IMU-system and the goniometer
The solid line represents the mean difference (systematic bias) and the dashed lines illustrate 
the 95% limits of agreement (mean difference ± 1.96 SD of the difference)
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ABSTRACT
Objectives
1) To compare level of function, activity, health-related quality of life (HRQoL) and satisfaction 
in persons with a lower extremity amputation before surgery and six- and twelve-months 
after implantation of an osseointegration implant and 2) to report adverse events.
Design
Prospective cohort study.
Setting
University medical centre.
Subjects
A total of 40 consecutive persons (median age: 56y) who received a transfemoral (31) or 
transtibial (9) osseointegration implant, between April 2014 and March 2016.
Intervention
Osseointegration implant surgery followed by a predefined rehabilitation programme.
Main measures
Hip abductor strength, prosthetic use, back pain frequency, post-operative pain, mobility level 
(timed up and go (TUG), wheelchair-boundedness), walking ability (6-minute walking test 
(6MWT) and walking distance in daily life), HRQoL, satisfaction regarding to the prosthesis, 
and adverse events.
Results
Strength, prosthetic use, walking distance, HRQoL and satisfaction level increased significantly 
at six- and twelve-month follow-up compared to baseline (p≤0.002). The TUG showed 
no change at six-month follow-up (p= 0.420), but improved significantly at twelve-month 
follow-up compared to baseline (p= 0.005). Wheelchair-boundedness decreased from 12/40 
participants at baseline to 0 at follow-ups. The 6MWT (p≥0.038) and back pain (p≥0.437) 
did not change over time. Stump pain was present in 28/39 and 22/40 of the participants 
at six-and twelve-month follow-up, respectively. The major adverse events were managed 
successfully and included three dual-cone breakages, and four bone fractures. An uneventful 
course was completed by 19/31 transfemoral and 4/9 transtibial bone-anchored prostheses 
users.
Conclusion
Bone-anchored prostheses lead to improved performance and appears to be safe, so they 
might be considered for persons with socket-related problems.
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INTRODUCTION
Socket-suspended prostheses users suffer frequently from socket-related problems. Bone-
anchored prostheses using a transcutaneous osseointegration implant might be a solution.1 
This technique is already used for persons with trauma- or tumour-related transfemoral 
amputation but might be also useful for persons with a transtibial amputation, and in persons 
with peripheral vascular disease.2-4 Especially in these populations insight in the impact of 
osseointegration implant surgery on functional performance and the incidence of adverse 
events is scarce. Although it is hypothesised that bone-anchored prostheses facilitate early 
recovery of mobility level and walking ability, insight in the course within the first year is 
missing. 
This prospective study focussed on patients with a lower extremity amputation who 
had problems with using a socket-suspended prosthesis, and therefore, were scheduled 
for implantation of a press-fit osseointegration implant and a predefined rehabilitation 
programme.4,5 The primary aim was to describe the change in the body functions or structures 
(hereafter referred to as level of function), level of activity, level of health-related quality of life 
and level of satisfaction at six- and twelve-months after surgery compared to pre-operative 
while using a socket-suspended prosthesis. We hypothesised that hip abductor strength, 
prosthetic use, back pain, mobility level, walking ability, health-related quality of life and 
prosthetic comfort would improve over time.4 Outcomes are stratified by amputation level 
(i.e., transfemoral and transtibial) and we analysed the influence of wheelchair-boundedness 
prior osseointegration implant surgery on the course of the outcomes. The secondary aim of 
this study was to describe the number and severity of adverse events.
METHODS
Study Design
This is the first report of a prospective cohort study with a one-year follow-up. The detailed 
study protocol was published previously.4 Following the Strengthening the Reporting of 
Observational studies in Epidemiology (STROBE) statement, we present the results of the 
time trend analyses with follow-ups at six- and twelve-months.
Participants
All consecutive persons who received a transfemoral or transtibial press-fit osseointegration 
implant in our university medical centre (Radboudumc), between April 2014 and March 2016, 
were eligible for this study. Persons were eligible for this surgery if: a) they were adults with 
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a lower extremity amputation suffering from socket-related problems contributing to limited 
prosthetic use6, and b) the cause of primary amputation was congenital or due to a trauma, 
tumour resection, or stable vascular disease. Exclusion criteria for surgery were the presence 
of severe cognitive or psychiatric disorders. Prior to the inclusion a written informed consent 
was obtained from all participants. The study was conducted according to the principles of 
the Declaration of Helsinki (64th version, 19-10-2013). The protocol of this study (registration 
number 2014/196) was approved by the Ethics Committees of Radboudumc.
Intervention
Osseointegration implant implantation was performed in two surgeries six to eight weeks 
apart.2,6 First, a cementless intramedullary stem was press-fit inserted in the femur or tibia 
(either or not using locking screws), and the wound was closed. Second, a soft tissue stoma 
was created, and a transcutaneous adapter (dual-cone with safety weak points) was attached 
into the intramedullary stem (Figure 1). For the femur, the osseointegrated prosthetic 
limb (Permedica s.p.a., Via Como, 38, 23807 Merate LC, Italy) or integral leg prosthesis 
(Orthodynamics GmbH, Grapengießerstraße 34, 23556 Lübeck, Germany) implant was 
used, for the tibia a patient-specific implant (Orthodynamics GmbH or AQ Implants GmbH, 
Kurt-Fischer-Straße 22, 22926 Ahrensburg, Germany) was developed.2 All persons started 
rehabilitation one week after the second surgery, using a full length prosthesis with the 
same prosthetic components as prior to the osseointegration implant surgery. Rehabilitation 
focused on improving hip abductor strength, core stability, symmetry of gait parameters, 
and level of activity.5 The duration of the predefined twice weekly rehabilitation programme 
depended on amputation level and ranged from 4 weeks (transtibial amputation) to 11 weeks 
(transfemoral amputation).4 An interlude was initiated if pain or limited muscle strength was 
an obstacle to reduce walking aid use. Rehabilitation was prolonged if a person was making 
progress but had not yet met the predefined goals.
Figure 1. Radiographs of the used types of osseointegration implants
A: Integral leg prosthesis; B: Osseointegrated prosthetic limb; C: Patient-specific implant 
Left: Intramedullary stem immediately post-operatively; Right: Osseointegrated implant at 
the twelve-month follow-up
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Study procedures and outcomes
Participants were measured by the treating physiotherapist pre-operatively (baseline) and 
at the six- and twelve-month follow-up. The outcomes of this study were level of function, 
activity, health-related quality of life and satisfaction (Table 1). The obtained gait kinematics 
were not reported in this study, in contrast to what we described in our study protocol4, due 
to insufficient clinimetric properties of the used measurement systems.7 The adverse events 
during the study period were retrospectively extracted from the participants’ medical file 
using the classification described by Al Muderis et al. (Table 2).8
Statistical analysis
Categorical descriptive data was presented as exact numbers. Percentages were calculated 
for the various levels. For the continuous descriptive data, means and standard deviations 
were calculated for normally distributed variables. For data not-normally distributed median, 
25th and 75th percentile were used. Demographics and participant characteristics were used 
for descriptive statistics.
First, we analysed changes over time in the entire cohort. Generalised estimating 
equations with an exchangeable correlation matrix was used to analyse binary outcomes 
(back pain) and normally distributed continuous outcomes (hip abductor strength, mobility 
level: timed up and go test, walking ability: 6-minute walking test, health-related quality of 
life and prosthetic comfort). Back pain was dichotomised for this analysis into ‘no back pain’ 
and ‘back pain’ (representing the classes ‘yes, with episodes’ and ‘yes, chronic (daily)’). The 
mean change over time of the continuous outcomes and the odds ratio of the dichotomised 
outcome were presented with 99% confidence intervals. A 99% confidence interval was 
used to reduce the risk of type I errors due to multiple testing. Not-normally distributed 
continuous outcomes (prosthetic use and walking ability: walking distance in daily life) were 
visualized with histograms, and change over time was tested using the Wilcoxon signed-rank 
test. Wheelchair-bound participants were completely excluded in the complete case time-
trend analysis of prosthetic use and walking ability using the Wilcoxon signed-rank test with 
an alpha level of 0.01. In the generalised estimating equations analysis participants were only 
excluded from the follow-up moment in which they were wheelchair-bound with exception 
of the time-trend analysis of hip abductor strength which involved all participants.
Second, the change over time of the other categorical outcomes were analyse using 
descriptive statistics by calculating the change in levels at both follow-ups compared to 
baseline expressed as a percentage.
Third, stump pain (intensity and location) and global perceived effect of bone-anchored 
prosthesis were only obtained post-operatively, the course of both were analysed using 
descriptive statistics.
Moreover, outcomes are presented for subgroups stratified by amputation level using 
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descriptive statistics. Within the subgroups we also present the results stratified by the 
presence of wheelchair-boundedness before surgery.
All analyses were performed using SPSS v23 (SPSS Inc., Chicago, Illinois, United States).
RESULTS
All 40 eligible participants were included in the study; 31 participants received a transfemoral 
osseointegration implant and nine a transtibial osseointegration implant (Table 3). The 
median time from primary amputation was 8 years (range: 1-46 years). Twelve participants 
were wheelchair-bound at baseline. The median rehabilitation duration was 24 weeks (range: 
6-62 weeks, 7-71 sessions) and 9 weeks (range: 3-22 weeks, 7-21 sessions) for participants 
with a transfemoral and transtibial bone-anchored prosthesis (Figure 2), respectively. No 
participants were lost to follow-up. The six- and twelve-month follow-up measurements were 
completed by 39 and 40 participants, respectively (Table 4 and Figure 3). In the following 
paragraphs, we will first detail the impact of the intervention at the twelve-month follow-
up; second, we present the six-month follow-up results to increase the insight in the course 
within the first year; third, we describe the results for the stratified cohorts; and finally the 
adverse events within the study period will be detailed. 
Functional outcomes: twelve-month follow-up
At level of function hip abductor strength increased significantly (p≤ 0.002) at twelve-month 
follow-up (residual limb: β 0.16, SE 0.03 (23%), sound limb: β 0.17, SE 0.03 (20%)) compared to 
baseline. Prosthesis wearing time increased significantly (p< 0.001) at twelve-month follow-
up compared to baseline (Appendix A). Back pain did not change statistically significant over 
time (p= 0.437). Stump pain was present in 22/40 (55%) of the participants at twelve-month 
follow-up. Of these participants 14/22 (64%) experienced on average a mild stump pain on 
the distal part of the stump (circular or the soft tissue stoma) at twelve-month follow-up.
At the level of activity patient-reported mobility level increased at twelve-month follow-
up relative to baseline represented by an increased percentage of participants classified as 
Medicare Functional Classification Level K3-4 and Special Interest Group in Amputee Medicine 
Workgroup Amputation and Prosthetics mobility score grade E-F at twelve-month follow-up 
(K3-4: 11/40 (28%), grade E-F: 11/40 (28%)). None of the participants was wheelchair-bound 
at twelve-month follow-up. The percentage of unaided walkers increased at twelve-month 
follow-up (indoors: 12/40 (30%), outdoors: 9/40 (23%)) compared to baseline. The physical 
performance measurement (i.e. timed up and go) increased significantly (p= 0.005) by β -1.9, 
SE 0.7 (17%) at twelve-month follow-up compared to baseline. Walking ability represented 
by the 6-minute walking test increased, although non-significant (p= 0.038), by β 25, SE 12 
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(8%) at twelve-month follow-up compared to baseline. Patient-reported walking distance in 
daily life increased significantly (p≤ 0.001) at twelve-month follow-up compared to baseline 
(Appendix A).
Health-related quality of life increased significantly (p< 0.001) by β 25, SE 4 (54%) at 
twelve-month follow-up compared to baseline. The overall situation as an amputee improved 
at twelve-month follow-up, illustrated by the increased proportion (6/40 (15%)) of the 
participants that scored good or extremely good on question C at follow-up compared to 
baseline.
At the level of satisfaction prosthetic comfort increased significantly (p< 0.001) by β 3.2, 
SE 0.5 (65%) at twelve-month follow-up compared to baseline. Of all participants, 39/40 
(98%) would again opt for the bone-anchored prosthesis at six- and twelve-month follow-up, 
respectively.
Functional outcomes: six-month follow-up
At six month follow-up, all of the above presented outcomes measures improved significantly 
as well compared to baseline with exception of the timed up and go test (p= 0.420) and the 
6-minute walking test (p= 0.429). The outcome measures which were only analysed with 
descriptive statistics revealed at six-month follow-up similar trends as at twelve-months 
follow-up compared to baseline. The number of participants experiencing stump pain was 
higher at six-month follow up (28/39 (72%)) compared to the twelve-month follow-up (22/40 
(55%)). At six-month follow-up 37/39 (95%) participants would again opt for the bone-
anchored prosthesis.
Functional outcomes: stratified cohorts
Stratification based on amputation level revealed the following insights (Appendix B and C). In 
the transtibial bone-anchored prosthesis users we observed higher baseline values compared 
to transfemoral bone-anchored prosthesis users, with exception of walking distance in daily 
life and prosthetic comfort. The increase over time, in percentages, was larger in transtibial 
bone-anchored prosthesis users compared to transfemoral bone-anchored prosthesis users, 
with exception of hip abductor strength and prosthesis wearing time. At the twelve-month 
follow-up less transtibial bone-anchored prosthesis users experienced stump pain than 
transfemoral bone-anchored prosthesis users (transtibial: 2/9 (22%), transfemoral: 20/31 
(65%)), and the intensity of the pain was the lowest in transtibial bone-anchored prosthesis 
users (transtibial: 1.2 points, transfemoral: 3.8 points)).
Stratification on both amputation level and wheelchair-boundedness revealed that 
in transfemoral bone-anchored prosthesis users (Appendix B) all outcomes of the non-
wheelchair-bound participants were superior compared to wheelchair-bound participants, 
with exception of health-related quality of life at twelve-month follow-up and prosthesis 
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comfort at six-month follow-up. Contrary to the entire cohort, the residual limb hip abductor 
strength decreased by 10% at six-month follow-up (0.57 Nm/kg, SD 0.19) and showed no 
change at twelve-month follow-up (0.63 Nm/kg, SD 0.23) compared to baseline (0.63 Nm/
kg, SD 0.21) in the wheelchair-bound subgroup. In both transfemoral and transtibial bone-
anchored prosthesis users there was a trend that non-wheelchair-bound participants had 
less back pain at the follow-ups compared to baseline, while back pain frequency increased 
over time in wheelchair-bound participants (Appendix D).
Adverse events
The major adverse events that occurred are as follows: a) three breakages of the dual-
cone, all successfully replaced and b) four bone fractures (caused by a fall accident in daily 
use), all successfully treated. No breakage of the intramedullary stem, bone infection or (a)
septic implant loosening occurred. Minor adverse events concerned in particular low-grade 
soft-tissue infections; 8/18 (44%) of the participants with a chromium-cobalt-molybdenum 
osseointegration implant and 5/22 (23%) participants with a titanium osseointegration 
implant had one of more low-grade soft-tissue infections. In total, 19/31 (61%) and 4/9 
(44%) of the participants with a transfemoral bone-anchored prosthesis and transtibial bone-
anchored prosthesis, respectively, had an uneventful course (Table 5).
Figure 2. Bone-anchored prostheses
Left: transfemoral bone-anchored prosthesis; Right: transtibial bone-anchored prosthesis
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Figure 3. Flow chart illustrating the number of participants within the study
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DISCUSSION
Outcomes on the level of function, activity, health-related quality of life and satisfaction 
improved significantly after twelve-months use of a bone-anchored prosthesis compared 
to the use of a socket-suspended prosthesis, with exception of the 6-minute walking test. 
Six-months after surgery, this improvement was already visible in majority of the outcomes, 
including a complete absence of wheelchair-boundedness. All our a priori hypotheses were 
correct with exception of the expected decrease of back pain frequency which was only 
found in the subgroup of participants who were non-wheelchair-bound at baseline.
Stratification based on amputation level showed that stump pain was in particular a 
persistent problem in participants with a transfemoral bone-anchored prosthesis and 
seemed to be related to the soft tissue stoma. A possible explanation for this finding could 
be that transfemoral bone-anchored prosthesis users experience more mechanical friction 
between the soft tissue and the dual-cone due to more excessive soft tissue in the stump 
than transtibial bone-anchored prosthesis users.2 At least 95% of the participants would again 
opt for a bone-anchored prosthesis, demonstrating that the functional improvements and 
the absence of socket-related problems outweighs the presence of stump pain and adverse 
events.
Stratification based on wheelchair-boundedness revealed that wheelchair-boundedness 
negatively influenced the ability of transfemoral bone-anchored prosthesis users to recover 
and generally influence the presence of back pain.
The incidence of implant-related major adverse events was 8%. An uneventful course 
was more common in transfemoral bone-anchored prosthesis user than in transtibial bone-
anchored prosthesis users.
The previously reported improvement in prosthesis wearing time6,18 and health-related 
quality of life6,18,19 are comparable to our findings. In the 12-month and 22-month follow-up 
study by van de Meent et al.6 and Muderis et al.19, respectively, participants with a transfemoral 
bone-anchored prosthesis improved on the timed up and go test (32-49%) and the 6-minute 
walking test (40-46%) compared to baseline. Our transfemoral cohort performed only 14% 
and 4% better on the timed up and go and 6-minute walking test, respectively, despite 
comparable baseline values and participant characteristics. This discrepancy in results might 
be explained by the difference in the length of the 6-minute walking course between the 
studies and the decreased walking aid use over time found in our study.20,21 We used a 10m 
6-minute walking test course, while van de Meent et al.6 and Muderis et al.19 used a 20m and 
12.5m 6-minute walking test course, respectively (obtained by contacting the authors). Both 
authors did not report the used walking aids during the tests. It is easier to improve on a long 
6-minute walking test course than on a short 6-minute walking test course.20,21 In our study, 
walking aid use decreased over time. Although, this is beneficial for daily life activities, it does 
not implicate that unaided walking improves walking speed.
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Similar to our finding, Hagberg et al.22 found no change in back pain after transfemoral 
osseointegration implant surgery. However, wheelchair-boundedness stratification revealed 
that back pain frequency of non-wheelchair-bound participants decreased over time 
compared to baseline while wheelchair-bound participants showed an opposite trend. This 
trend in change of back pain is possibly associated with the change in hip abductor strength 
as observed in the transfemoral bone-anchored prosthesis users. The level of satisfaction was 
high in our cohort which is similar as found in another cohort of transfemoral bone-anchored 
prosthesis users.23
To our knowledge, this study is the first to report: a) functional outcomes and adverse 
events of a consecutive cohort of transtibial bone-anchored prosthesis users, b) a six-month 
follow-up, c) hip abductor strength outcomes, d) the prevalence and intensity of post-
operative stump pain, and e) the real rehabilitation duration and intensity of a cohort of 
bone-anchored prosthesis users using a press-fit osseointegration implant. In literature, 
various rehabilitation programmes are described ranging from 4 to 14 weeks5,6,19,24 for 
persons with a press-fit osseointegration implant and 6 months for persons with a screw-
type osseointegration implant.17 This cohort study showed that there are differences in the 
predefined duration of the rehabilitation programmes and daily clinical practice, while the 
number of rehabilitation sessions is comparable. In our study, 19/31 (61%) of the transfemoral 
and 4/9 (44%) of the transtibial bone-anchored prosthesis users needed an interlude in their 
rehabilitation programme due to pain or limited muscle strength which can explain the 
observed difference in rehabilitation duration. A recently published study of persons with 
a screw-type osseointegration implant revealed also a variability in rehabilitation duration 
despite a predefined rehabilitation programme.25
This study contains some limitations. First, the adverse events were extracted from 
the participants’ Radboudumc medical file. Minor adverse events (e.g. infection grade 1A 
and 2A) typically treated by participants’ general practitioners could have been missed 
resulting in an underestimation of these minor adverse events. Second, the sample size of 
the presented subgroups was small due to stratification on two levels, consequently only 
descriptive statistics were used to analyse the time trend of these strata. In future reports 
of this ongoing study4 we will present larger samples of each stratum thereby increasing the 
generalisability of the stratified results. Third, the outcome measures were collected by the 
treating physiotherapist as part of usual care. A blinded assessor is preferable to decrease 
the risk of measurement bias. This was not an eligible option in this study because blinding 
for the type of prosthesis is not possible. Fourth, self-reported outcomes could have been 
biased by response shift resulting in an overestimation of the benefits of bone-anchored 
prostheses compared to socket-suspended prostheses.26 We measured mobility level and 
walking ability both with patient-reported outcome measures as with performance tests, 
which is important because they measure different aspects of the construct and may vary in 
responsiveness.27,28 The findings at six-month follow-up and in part at twelve-month follow-up 
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were inconclusive because the patient-reported outcomes improved while the performance 
tests did not change significantly compared to baseline. In future research the use of an 
activity tracker can be of added value to gain insight into this discrepancy.27 Fifth, we used a 
robust measure to investigate back pain. Because of this, insight into back pain intensity and 
influence of back pain on the level of functional difficulties is still missing. Future research 
should include more sensitive measures such as an NRS11 and the Revised Oswestry Low Back 
Pain Disability Questionnaire29,30, and should explore possible underlying mechanisms by 
measuring gait kinematic parameters. Finally, because this is an observational study we are 
not able to determine the relative effectiveness of the bone-anchored prosthesis compared 
to the socket-suspended prosthesis. Controlled clinical studies are necessary although this 
provides an ethical challenge, while currently osseointegration implant surgery is not used as 
a primary intervention after amputation but as a last resort for persons suffering from socket-
related problems.
Besides insight into health benefits it is important to gain insight into the cost-effectiveness 
before implementation on a larger scale is initiated. A recent cost-effectiveness analysis31 
showed that bone-anchored prostheses had an incremental cost per quality-adjusted life-
year gained of €83,374 compared with socket-suspended prostheses. However, a decline 
in utility values for persons with a socket-suspended prosthesis, which is common in the 
target population for a bone-anchored prosthesis, resulted in a substantial reduction of the 
cost per quality-adjusted life-year up to €18,952 per quality-adjusted life-year. These results 
are gathered in persons using a screw-type osseointegration implant, which has a different 
treatment procedure compared to the press-fit osseointegration implants. Cost-effectiveness 
should be included in future research in persons using a press-fit osseointegration implant to 
gain insight into the impact of the type of implant, the treatment regimens, and the country 
in which the care is given on the cost-effectiveness of bone-anchored prosthesis.
CLINICAL MESSAGES
• Ratio between functional benefits of bone-anchored prosthesis and adverse events 
appears sufficient, and therefore an eligible alternative for socket-suspended 
prostheses in persons with socket-related problems.
• Wheelchair-boundedness decreased to zero, walking distance increased.
• Around 98% of the participants would again opt for the bone-anchored prosthesis.
• Adverse events occurred frequently but could be managed with relatively simple 
measures.
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INTRODUCTION
The overarching purpose of this thesis was to describe the treatment trajectory after 
osseointegration implant surgery and examine the potential health benefits of a bone-
anchored prosthesis in previous socket-suspended prosthesis users with a lower extremity 
amputation. The various chapters presented in this thesis reflect the development in daily 
care provided in our institute for persons receiving a press-fit bone-anchored prosthesis. This 
development has been driven by our clinical experience and subsequent research insights. 
In this final chapter we provide an overview of how and to what extent the individual studies 
contributed to the purpose of this thesis and weighed these studies against their (and the 
field’s) methodological shortcomings. Finally, we discuss the implications of this thesis for 
future clinical practice and future research directions.
MAIN RESULTS
Rehabilitation following osseointegration implant surgery: one-size 
fits-all?
We described and motivated the rehabilitation programme that we developed for 
transfemoral bone-anchored prosthesis users (chapter 3).1 Due to the change in anchoring 
of the prosthetic parts, bone-anchored prosthesis users have hypothetically the ability to 
use the residual limb muscles and align the residual limb more physiologically than socket-
suspended prosthesis users. This implies that bone-anchored prosthesis users have to 
reactivate muscles and unlearn compensation mechanisms that have been adopted while 
using a socket-suspended prosthesis. The capability of unlearning ‘old habits’ and limitations 
in training intensity due to pain varies per person and will result in a tailored rehabilitation 
programme for each individual. This is illustrated by the variability in rehabilitation duration 
as detailed in chapter 8. In our case study (chapter 3) we used outcome measures that we 
think are important to include in a future core-set of outcome measures such as e.g. hip 
abductor strength, gait symmetry, and back pain. We found that the hip abductor strength, 
symmetry in gait, and the activity level increased after rehabilitation. The improvements in 
gait symmetry and activity level were maintained at the 1-year follow-up. Outcomes were 
worse at the six-month follow-up presumably due to the presence of severe low back pain as 
a result of lumbar degenerative disc disease.
The predefined rehabilitation programme for bone-anchored prosthesis users is feasible as 
a guideline, but the treatment trajectory of every person appears unique and thus requests 
tailoring of the predefined rehabilitation programme.
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Outcome measures following osseointegration implant surgery:  
feasible in clinical practice?
Nowadays, osseointegration implant surgery and following rehabilitation is performed in a 
limited number of centres of expertise. If we want to decentralise this care, it is important that 
we can validly and reliably measure the quality of care with feasible measurement methods. 
In both chapter 6 and chapter 7 we illustrate the challenges to incorporate reproducible and 
valid measurement methods in daily clinical practice. In chapter 6, a cross-sectional study, we 
described the optimisation of the measurement method to test hip abductor strength which 
we introduced in chapter 3. The adjustments we made resulted in a test-retest reproducible 
and valid measurement method2, but appeared not usable in an inter-rater setting. The 
final version of the test was included in our 5-year follow-up longitudinal study (chapter 
5).3 To evaluate gait symmetry, we first used a gait analysis list (chapter 3). However, as we 
wanted to obtain gait symmetry in a greater detail we decided to incorporate more objective 
measurement methods in the 5-year follow-up longitudinal study. Therefore, we examined 
the clinimetric properties of two different measurement methods in a cross-sectional study 
(chapter 7).4 We used a three-dimensional (3-D; inertial measurement units) and a two-
dimensional (2D; video-based) system to obtain coronal plane gait kinematics. Unfortunately, 
the conclusion of this study was that both systems were not sensitive enough to detect real 
differences within and between participants with a lower extremity amputation and healthy 
subjects although promising reproducibility parameters for some of the outcome measures 
were found. This insight led to exclusion of gait kinematics as an outcome measure in the 
5-year follow-up longitudinal study.
From the research described in chapters 6 and 7 we learned that measurement of hip 
abductor strength is possible in daily clinic practice, but also that obtaining gait kinematic 
parameters is still a challenge that requires further research.
Health benefits of osseointegration implant surgery and following 
rehabilitation: limited level of evidence?
In our systematic review5 we found that the number of studies assessing functional outcomes 
in persons who received a bone-anchored prosthesis is limited, especially with regard to the 
press-fit implants (chapter 2). Our search did not retrieve any Randomised Controlled Trials 
(RCTs) or Controlled Clinical Trials. We included five (before-after) cohort and two cross-
sectional studies. All studies had several methodological shortcomings of which the used 
study design had the most impact on the methodological quality and thus also on the level 
of evidence of the findings. We concluded that, based on limited evidence, bone-anchored 
prostheses use resulted in higher quality of life, function and activity levels than socket-
suspended prosthesis use in persons with socket-related problems. The systematic review 
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also revealed that there was a lack of consensus regarding the outcome measures used to 
evaluate the clinical impact of osseointegration surgery and following rehabilitation.
In a study protocol we detailed the outcome measures and the a priori hypotheses of our 
5-year follow-up longitudinal study with multiple follow-ups (chapter 5).3 The first preliminary 
results (chapter 8)6 of our 5-year before-after cohort study3 showed that, at the 1-year 
follow-up, the influence of transfemoral and transtibial osseointegration implant surgery 
followed by rehabilitation was generally positive for outcomes on the level of function, 
activity, health-related quality of life and satisfaction. Wheelchair-boundedness decreased 
from 12/40 participants at baseline to 0 at follow-ups. Of all participants, 39/40 (98%) 
would again opt for the bone-anchored prosthesis. Bone-anchored prostheses appeared to 
be safe because all major adverse events were easily managed and included three minor 
osseointegration implant failures, and four bone fractures. An uneventful course was more 
common in transfemoral bone-anchored prosthesis user than in transtibial bone-anchored 
prosthesis users. We concluded that osseointegration implant surgery may be considered 
for persons using a socket-suspended prosthesis who suffer from socket-related problems. 
The a priori hypotheses regarding the improvement in functional outcomes were confirmed 
with exception of the expected decrease of back pain frequency which was only found in 
the subgroup of participants who were non-wheelchair-bound at baseline. In the same 
case as described in chapter 3 we also investigated whether it was feasible to measure hip 
abductor muscle volume (chapter 4).7 The magnetic resonance imaging (MRI)-based three-
dimensional (3-D) muscle reconstruction technique seemed feasible to provide insight into 
the change in muscle volume in a person with a bone-anchored prosthesis using a cobalt–
chrome–molybdenum implant. We also found that in this single case the total hip abductor 
volume of both the residual limb (six-month: 5.5%; twelve-month: 7.4%) and sound limb (six-
month: 7.8%; twelve-month: 5.5%) increased compared to baseline.
From the afore mentioned chapters we learned that persons who go from a socket-
suspended prosthesis to a bone-anchored prosthesis, will generally have health benefits. The 
knowledge about the change in functional outcomes is limited to a few constructs due to the 
limited number of studies assessing functional outcomes in persons who received a bone-
anchored prosthesis. All findings are of limited evidence, mainly due to the used research 
designs, and are only generalisable to persons suffering from socket-related problems.
METHODOLOGICAL CONSIDERATIONS
Study design
In five of the seven studies in this thesis, we gathered new data by the use of observational 
studies. Three studies had a longitudinal design1,6,7 and two had a cross-sectional design.2,4 An 
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advantage of observational studies is that potentially the generalisability (external validity) is 
high because the study is conducted in the target population within a natural setting8,9; given 
that the sample size is large and sufficient geographic variability is in place.8 A disadvantage of 
observational studies is that the internal validity is low because it is hardly possible to correct 
for systematic differences due to selection bias and confounding.8,9 Another disadvantage of 
observational studies is that they have a high risk of publication bias, selective reporting and 
data-dredging, because it is not obligatory to a priori register an observational study.10,11
Longitudinal studies
Two longitudinal studies1,7 in this thesis were used to present the rehabilitation programme we 
developed and a measuring method for obtaining muscle volume, respectively. Both studies 
had a descriptive character and did not claim a cause and effect relationship. Validity issues, 
publication bias, selective reporting, or data-dredging were no threat for the conclusions 
drawn in these studies. The third longitudinal study in this thesis6, a cohort study, did claim a 
cause and effect relation, namely that the improvement in functional outcomes was related 
to the time point of the osseointegration implant surgery and following rehabilitation. The 
internal validity was not compromised by selection bias because we used an before-after 
design with consecutive conclusion and we had no drop-outs. Due to the before-after design 
we were able to draw our conclusion based on a within subject comparison which excludes 
common confounding factors in cohort studies as result of group differences in gender, age, 
and socioeconomic circumstances. However, in cohort studies it is not possible to rule out 
all known and unknown confounders that may have influenced the outcomes.12 For instance 
the presence of a) the novelty-effect: increased performance due to increased interest in 
new technology, may have caused an overestimation of the perceived treatment effect13,14; 
b) sunk-cost fallacy: a decision-making bias that reflects the tendency to invest more future 
resources (e.g. exercise time, therapy adherence) in a situation in which a prior investment 
has been made (e.g. osseointegration implant surgery), as compared with a similar situation 
in which a prior investment has not been made (e.g. rehabilitation after receiving a socket 
prosthesis)15; and c) response shift: a change in patient-reported outcomes due to a 
change in patient perspective or attitude including recalibration, reconceptualization, and 
reprioritization.16 The external validity is decreased because we included all participants in 
one centre. However, because our centre was the only centre in the Netherlands providing 
this surgery and we included all consecutive persons who were eligible for surgery we can 
generalise our results to the Dutch target population. The patient characteristics in our cohort 
(male: 55%, mean age: 52 years, mean time from primary amputation to inclusion: 14 years)6 
are quite similar as in cohorts of other geographic locations (male: 55-74%, mean age 44-46 
years, mean time from primary amputation to inclusion: 11-13 years).17-20 However, there 
are differences between centres such as the policy regarding the inclusion of smokers21 and 
predefined rehabilitation programmes.20,22,23 Multi-centre studies are necessary to investigate 
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the impact of known and unknown differences and to clarify if our results are generalisable 
to other geographic locations than the Netherlands. In generalising our results it must be 
taken into account that we included only socket-suspended prosthesis users suffering from 
socket-related problems and abandoned socket-suspended prosthesis users due to socket-
related-problems. Publication bias, selective reporting, or data-dredging were not an issue in 
our cohort study as can be verified by examining the published study protocol.3 By following 
the STROBE-statement24 for the description of the cohort study we were as transparent as 
possible so that the readers are also able to weigh the weaknesses of the study themselves.9
Cross-sectional studies
A cross-sectional design was used to evaluate the clinimetric properties of measurement 
instruments as presented in chapter 6 and 7.2,4 The internal validity may have been 
compromised due to the fact that the reproducibility in these studies was tested in one 
session on the same day which potentially could have resulted in recall bias. The external 
validity of the validation of the handheld dynamometer technique2 was decreased because 
we used a healthy subject population instead of the target population; persons with a lower 
extremity amputation. Another threat for the external validity is that in both studies the 
participants were recruited in a single centre. Although we cannot prove that publication bias, 
selective reporting, or data-dredging were not an issue in these studies we have attempted to 
maximise the transparency by publishing our raw data.
Systematic review
The systematic review5 (chapter 2) included an extensive search and firm methodology while 
systematically assessing: a) the impact of bone-anchored prosthesis use on the quality of life, 
function, activity, and participation level compared to socket-suspended prosthesis use in 
persons with a lower extremity amputation, and b) the type of measurement instruments used 
to evaluate these outcomes. A strength was the use of two independent raters for assessing 
both the eligibility and the methodological quality of the studies. Another strength is the use 
of the International Classification of Functioning, Disability and Health (ICF) framework to 
structure the outcomes. The PRISMA statement25 was used to ensure a transparent and high 
quality report of our reviewing process. A potential flaw of our review was the used risk of 
bias tool. There is no gold standard tool to assess the risk of bias in observational studies.26,27 
Commonly used tools are the Newcastle-Ottawa tool28 and the Downs-Black tool29, but they 
lack of a comprehensive manual which may lead to variability in interpretation.30 We used 
the EPHPP Quality Assessment Tool for Quantitative studies31 to assess the risk of bias of 
the individual studies within the systematic review because it had a sufficient manual.32 All 
included studies had methodological shortcoming of which the most were related to their 
observational design. Five of the seven studies had a before-after design which was hard 
to score with the EPHPP tool and where therefore rated as having a weak methodological 
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quality. This influenced the conclusions of our best-evidence synthesis. A risk of bias tool that 
is more tailored for before-after cohort studies may have had a more positive outcome. The 
in 2016 introduced ROBINS-I tool is a promising tool for assessing the risk of bias in cohort 
studies, but does currently not include the possibility to evaluate non-controlled before-after 
cohort studies.30
Opening the black box
The use of a before-after cohort study (chapter 8)6 to observe the effect of a combined 
intervention (surgery and rehabilitation) limits the possibility to gain insight in the effectiveness 
of the two parts within the intervention. On the other hand we aimed to identify potential 
predictors for health benefits of bone-anchored prosthesis use (chapter 5).3 This can help a) 
both patients and clinicians, to establish realistic expectations of the expected natural course 
after BAP surgery and following rehabilitation, and b) to identify the correct population for 
the intervention. However, our findings in chapter 7 will partially limit unpacking the black 
box.4
Combined Intervention (surgery and rehabilitation)
It is important to note that the evaluated intervention in our cohort study (chapter 8) was a 
combined intervention of an osseointegration implant surgery and a rehabilitation trajectory. 
It is therefore not clear what part of the intervention has caused the change in functional 
outcomes. An RCT with two or three treatment arms could possibly clarify this issue. Treatment 
arm 1 should receive the combined intervention which is currently usual care. Treatment arm 
2 should only receive osseointegration-implant surgery. Treatment arm 3 should only receive 
a rehabilitation programme. Abandoned socket-suspended prosthesis users will not be able 
to benefit of the intervention in treatment arm 3. Most likely 30% of the eligible persons for 
this RCT will be abandoned socket-suspended prosthesis users (chapter 8)6, resulting in a high 
risk of selection bias despite a randomisation procedure. Another limitation of treatment 
arm 3 will be that a bone-anchored prosthesis rehabilitation programme most likely will have 
a different effect on socket-suspended prosthesis users because of different anchoring of 
the prosthetic parts. In addition ethical issues will limit the eligibility of an RCT in this target 
population as detailed below in the ‘recommendation for future research’ section.
Based on the change in anchoring of the prosthetic parts and the regain of physiological 
control of the residual limb in bone-anchored prosthesis users compared to socket-
suspended prosthesis users it is in our opinion likely that a rehabilitation programme is of 
added value. From a health economics perspective it would interesting to know which part of 
the intervention is (the most) effective and whether the used rehabilitation programmes can 
be optimised in content, frequency and duration. For example, adding a self-management 
intervention to the rehabilitation programme to increase daily use of the prosthesis may 
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improve the outcomes and may help preserving improvement on long-term.33,34 Patients, 
however, care a lot less about health economics and want to get the most out of the 
treatment trajectory. In their opinion an intensive rehabilitation programme is facilitating 
them to achieve this goal.35
Gait kinematic parameters
The cross-sectional study4 presented in chapter 7 revealed that the used instruments to collect 
coronal plane kinematic parameters of the pelvis and the trunk were not sensitive enough to 
detect real differences within and between participants with a lower extremity amputation 
and healthy subjects. This conclusion affected the outcome measures we could present in 
our cohort study (chapter 8)6, but will also affect other aims of the 5-year longitudinal study 
as described in our study protocol (chapter 5).3 In future reports of our cohort study: a) 
mid- and long-term changes in gait kinematic parameters, b) predictors for the change in 
gait kinematics, and c) potential mechanisms for changes in back pain will not be presented.
IMPLICATIONS FOR FUTURE CLINICAL PRACTICE
Clinimetric properties of measurement instruments
This thesis increased the insight in the importance of knowledge of the clinimetric properties 
of measurement instruments. In research, gold standard measurement instruments are 
preferred, but in daily clinical practice the use of these instruments are often not feasible 
because they are high in cost, time-consuming and not portable.36,37 The knowledge we 
obtained in chapter 6 led to a change in daily clinical practice in our centre.2 Hip abductor 
strength within a patient is no longer evaluated in an inter-rater setting but only in an intra-
rater setting. We also optimised the testing procedure. We added a fixation-belt to fixate 
the patient on the table and we changed from a break-technique to a make-technique. 
The optimised handheld dynamometer technique is a feasible alternative for the gold 
standard, an isokinetic dynamometer, but one has to take into account that they are not 
interchangeable. Chapter 7 revealed that we currently do not have a feasible alternative for a 
three-dimensional (3-D) motion capture system such as ‘Vicon’ which is the gold standard for 
obtaining kinematic and kinetic parameters.4 The search for a clinically feasible instrument 
is therefore still ongoing. It is clear that asymmetries in kinematic parameters are common 
in persons with a lower extremity amputation using a socket-suspended prosthesis38-43, 
but it will be a challenge to develop an instrument that is able to quantify all available gait 
adaptations and to examine the influence of osseointegration implant surgery and following 
rehabilitation on the existing gait asymmetries.
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Measurement instruments
In our longitudinal study (chapter 8)6 we used both patient-reported outcome measures as 
performance tests to evaluate a construct, e.g. the constructs mobility level and walking ability. 
This is important because they measure different aspects of the construct and may vary in 
responsiveness.44,45 Patient-reported outcome measures gain popularity in evaluating routine 
patient care and clinical research.46-48 Patient-reported outcome measures provide patient-
centred data46 which include a more holistic interpretation and a comprehensive assessment 
of the benefits of an intervention.47,48 A potential disadvantage of patient-reported outcomes 
might be that they can be biased by response shift resulting in an overestimation of the 
effect of an intervention.16 It is therefore important that a core-set of outcome measures 
includes both, patient-reported outcome measures, performance tests, and optionally also 
monitoring in daily life to cover all aspects of a construct.44,45,49
Our 1-year follow-up before-after cohort study (chapter 8) showed a substantial 
improvement in the patient-reported walking distance in daily life at the 1-year follow-up 
compared to baseline, but limited increase in the capacity of the participants measured with 
performance tests. Although the change over time on the 6-minute walking test and timed-
up and go was statistically significant it was not beyond the smallest detectable change.50 
A possible explanation for the discrepancy in performance in daily life and capacity of the 
participants could be that the participant reached their maximum capacity. Based on the 
studies in bone-anchored prosthesis users20,51 and socket-suspended prosthesis users52-55 this 
is not a likely explanation. We concluded that most likely the used walking course length and 
decreased walking aid use over time biased the comparison between the performance tests 
and the self-reported performance in daily life. A discrepancy between capacity and physical 
activity is odd because a good correlation is previously described.53 The use of monitoring in 
daily life could increase insight in the exact reason for our inconclusive findings.53
The measured constructs in our longitudinal study were used to examine the effect of 
osseointegration implant surgery and following rehabilitation. Future research should 
determine what the minimum core-set should be to evaluate the intervention while minimising 
patient burden. In determining this core-set it should be kept in mind that outcome measures 
are also important for tailoring a rehabilitation programme. In our opinion the degree of 
muscle strength, gait adaptations, use of walking aids, level of physical mobility, functional 
capacity and walking distance in daily life are essential quantifications for a physiotherapist to 
be able to tailor a rehabilitation programme.
Rehabilitation programmes
The predefined rehabilitation programme1 presented in chapter 3 is slightly different 
compared to the programmes described in our longitudinal study (chapter 5 and 8).3,6 Initially 
we started with two weeks of axial load bearing training on a short prosthesis. This part of 
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the training was adopted from the rehabilitation programme for persons who received a 
screw osseointegration implant23,56 and was also adopted by the German colleagues who 
introduced the press-fit osseointegration implant.22,57 At the end of 2013 we removed this 
part of the rehabilitation programme and shortened the predefined programme from 
13 weeks to 11 weeks. Both the patient described in chapter 3 and the cohort described 
in chapter 8 showed that a predefined rehabilitation programme is not set in stone. In a 
clinical setting where patient-centred care is given the intensity of an intervention may vary. 
For example, an interlude in the treatment trajectory can be necessary if pain or limited 
muscle strength is an obstacle to reduce walking aid use. Most previous studies20,22,23,51 only 
reported the predefined rehabilitation programmes and therefore do not provide insight into 
the variability in rehabilitation duration. The recently published rehabilitation details of 18 
screw osseointegration implant users also revealed that there was variability in rehabilitation 
duration despite a predefined rehabilitation programme.58 Insight in rehabilitation variability 
is important for persons who opt for a bone-anchored prosthesis in order to start the 
treatment trajectory with realistic expectations.
Organisation of health care
Currently there are four prominent centres in the world that perform the majority of the 
osseointegration implant surgeries. In larger countries it is known to be a challenge to 
organise the rehabilitation and the follow-ups in the centre where the osseointegration 
surgery took place.57 Decentralisation of health care, especially the rehabilitation, is an 
efficient way to decrease the patient burden as result of traveling. However, a qualitative 
study among bone-anchored prosthesis users in Denmark revealed that patients preferred 
rehabilitation in a centre of expertise over local rehabilitation because they did not benefit 
from attending local rehabilitation due to a lack of knowledge of the health care professionals 
about bone-anchored prostheses.35 Peer support in rehabilitation is greatly acknowledged 
by bone-anchored prosthesis users which is difficult to organise in locale rehabilitation 
centres.35 With this knowledge and the low numbers of osseointegration implant surgeries 
at this moment it is a challenge to investigate if and how decentralisation of care should take 
place. Perhaps information technology (e-health) should be used to develop a blended care 
intervention to decrease traveling burden of patients without losing peer support and team 
approach. E-health could also be used to tailor the post-rehabilitation aftercare because it 
is hypothesised to stimulate patients to maintain or even increase their daily performance 
in daily life in long-term.59,60 Traveling burden will obviously be a smaller problem in small 
countries such as the Netherlands compared to larger countries such as Australia. 
If the scale on which osseointegration implant surgeries take place increases, e.g. by 
broadening of the eligibility criteria for surgery, it is necessary to install a number of centres 
of expertise per county by educating local surgical and rehabilitation centres aiming at 
uniform care in every treatment centre. By determining the ideal timing and scale of 
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decentralisation it should be kept in mind that sufficient surgical volume is needed to prevent 
unnecessary adverse events.61-64 Literature about the impact of decentralisation of specialised 
rehabilitation is missing, but it is likely that sufficient volume is needed to build up expertise 
and to guarantee peer support.
RECOMMENDATION FOR FUTURE RESEARCH
The need to find strong evidence for the effectiveness
Both, our 1-year study6 and previous studies58,65 revealed that a treatment trajectory of 
bone-anchored prosthesis users is not flawless. Strong evidence that demonstrates the 
added value of bone-anchored prosthesis compared to the conventional socket-suspended 
prosthesis is necessary to motivate the application of this treatment. RCTs are the gold 
standard to increase the level of evidence of studies assessing the potential benefits of bone-
anchored prosthesis compared to socket-suspended prosthesis. However, because currently 
the main inclusion criteria for osseointegration implant surgery is that persons with a lower 
extremity amputation are limited due to socket-related problems20,51,66,67 an RCT is unlikely to 
be ethical. Currently 28-30%6,20 of the persons who are eligible for osseointegration implant 
surgery are abandoned prosthetic users. These persons are highly motivated to regain their 
walking ability. Thus a classic RCT in which one group receives a bone-anchored prosthesis 
and the other group remains to use a socket-suspended prosthesis would not be ethical; a 
delayed intervention RCT might be a logical alternative. However, insight in long-term effects 
(e.g. 5-year follow-up) of the use of bone-anchored prosthesis, both regarding to functional 
outcomes and safety, are necessary to be able to draw soled conclusions. This implies that 
a sub-cohort of persons with socket-related problems and abandoned prosthetic users have 
to wait for five years before they may receive a bone-anchored prosthesis, which will also 
encounter ethical problems. The waiting time may also introduce selection bias into the RCT. 
The sub-cohort that receives the delayed intervention may deteriorate in health status during 
the waiting period, both the ambulatory as the non-ambulatory persons. In ambulatory 
persons it is likely that continuing to use a socket-suspended prosthesis while suffering from 
chronic skin problems and pain associated with the socket68-73 will further negatively influence 
functional outcomes.51,68,70,74,75 It is unknown what the impact is of the duration of wheelchair-
boundedness prior to osseointegration implant surgery, but our cohort study (chapter 8)6 
revealed that persons who are wheelchair-bounded prior to the surgery performed worse 
than ambulatory persons. In persons receiving a primary amputation it is known that a non-
ambulatory status prior to the surgery is associated with inferior mobility level and walking 
ability after surgery, especially in frail persons.76-78 To rule out ethical issues and the risk of 
selection bias and due to the waiting period a stepped wedge cluster randomised trial could 
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be an adequate study design.79,80 This design could be used to randomise at group-level 
(clusters) instead of at patient-level, e.g. during the decentralisation of care. By the end of the 
study, the intervention (surgery and rehabilitation) will be implemented in all participating 
treatment centres, but the timing for the implementation will be randomised. Causality of 
the change in health status can be established within the clusters by comparing the health 
status of before and after the implementation of the intervention. In addition, the natural 
course in socket-suspended prosthesis users with socket-related problems can be studied 
by analysing the period before the intervention of all clusters. A drawback of this design 
could be that it will be hard to collect long-term control data. Treatment centres which are 
willing to participate in the study because they want to implement this innovative care do 
most likely not want to wait 5 years. Also, decentralisation has to take place on large scale 
to be able to include enough clusters to reach an sufficient power.81,82 Another alternative 
for the classic RCT could be to use of propensity score matched cohorts.83-85 Cohorts are 
created using a propensity score; the likelihood to receive an intervention based on potential 
explanatory baseline variables.83,85 The use of propensity score matching minimises the risk 
of indication bias, given that all relevant covariates are included.85 A drawback of propensity 
score based analyses is that only known and observed patient characteristics are used to 
match the cohorts.83,85 Furthermore, a large sample size is needed because not all patients 
can be included in the analyses due to difficulties in achieving an adequate match.83
All above described alternative study designs for the commonly used before-after study 
to examine health benefits of bone-anchored prosthesis compared to socket-suspended 
prosthesis have their drawbacks with respect to ethical issues or eligibility. A single-patient 
(N-of-1) trial86-91 may solve these limitations and equals an RCT to raise the level of evidence 
according to Oxford Centre for Evidence-Based Medicine.92 A single-patient trial is quite 
similar as a stepped wedge cluster randomised trial because the timing of receiving the 
intervention is randomised. However, instead of clusters, individual patients are included 
which enhances personalised medicine. Estimates of treatment effect at population level can 
be produced by combing the data of multiple N-of-1 trials.90,93
To implement the N-of-1 trial design in the current usual care, the intervention should be 
offered randomly instead of by the order of entry. In addition the intensity of the outcome 
assessment should be increased, both the assessment of before (during the waiting period) 
and after the intervention to gain a clear sight in trends. The intervention should not be 
initiated until a stable baseline has been recorded, and the study should not be finished until 
the outcomes regain stability.
The need for collaboration
In the almost 30 years that bone-anchored prostheses are around, safety 
outcomes17-23,51,56,57,66,67,94-103 (Figure 1) are more commonly published than functional 
outcomes17,18,20,51,58,67,94,96,101,104-109 (Figure 2). The majority of the studies have been published 
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in the last 10 years. However, there is a tremendous overlap in the presented data, resulting 
in a low number of studies presenting a unique cohort in the field of osseointegration implant 
surgery (Figure 1 and 2). A global registry for osseointegration implantation may help to 
increase the insight into the number of persons who received an osseointegration implant, 
the severity and the number of complications, the functional outcomes, and optionally 
cost-effectiveness.110 In such a registry all centres performing osseointegration implant 
surgery could add their data, also the centres that currently do not publish their results 
in the scientific literature.23 A global registry will: a) increase the transparency of the data 
collection, b) prevent publication bias and selective reporting, and c) prevent data dredging. 
These arguments were also the motivation to publish our study protocol (chapter 5).3 It will 
also increase the power to identify predictors for a successful treatment trajectory and to 
examine potential mechanisms for changes in functional outcomes. This insight is important 
to be able to select the persons who benefit the most from osseointegration implant surgery. 
An increased power could also facilitate in identifying factors which determine the intensity 
of the rehabilitation programme so patients can receive a priori a well estimated prognoses 
of the rehabilitation intensity. There will be a couple of challenges in setting up a global 
registry. First, it will be a challenge to reach consensus about a core-set of outcome measures 
to evaluate osseointegration surgery and following rehabilitation. A Delphi study among 
members of the centres of expertise (e.g. surgeon, rehabilitation physician, physiotherapist, 
occupational therapist, clinical psychologist, and orthopedic technician) should be initiated 
to develop a core-set of outcome measures. Ideally, this core-set should also be eligible for 
socket-suspended prosthesis users to enable broader comparison of the outcomes. Second, 
data ownership should be arranged so that the centres that add data are also able to publish 
their own data. A research consortium should be installed to publish global data from the 
registry and a priori there should be an agreement on how, when and which data will be 
published. Lastly, a global registry will result in big data and thus in high and rising costs.110 
Integrating the core-set of outcome measures into daily clinical care and linking local registries 
to the global registry may help to be cost-efficient.
The need for fundamental research
This thesis is mainly about the functional outcomes of bone-anchored prosthesis use 
compared to socket-suspended prosthesis use. In chapter 4 we introduced a technique to 
obtain insight in the impact of bone-anchored prosthesis use on tissue level.7 Insight in the 
time of the onset of muscle atrophy and change into of adipose tissue, and the reversibility 
of the atrophic process is important in the discussion regard to the eligibility criteria for 
osseointegration implant surgery. Based on chapter 4 and the work of Jaegers et al.111 our 
current hypothesis would be that osseointegration implant surgery early after primary 
amputation may be beneficial for prevention of the atrophic process. If future studies in 
larger cohorts would confirm this and the risk-benefit ratio is also sufficient on long-term, 
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then osseointegration surgery should be initiated earlier after the primary amputation. 
Nowadays the primary criterion for osseointegration implant surgery is that a person using 
a socket-suspended prosthesis is suffering from socket-related problems contributing to 
limited prosthetic use.51 The median time between primary amputation and osseointegration 
implant surgery was in our cohort 8 years (25th percentile: 3 years, 75th percentile: 20 years).6 
All these years the residual limb muscles are at risk for deterioration.111
Another possible shift in the eligibility criteria for osseointegration surgery might be 
initiated by better insight in the underlying risk mechanisms in persons with a vascular 
disease. In the majority of the centres providing osseointegration surgery the presence of a 
vascular disease is an exclusion criteria112, while the cause of amputation in majority of the 
persons with a lower extremity amputation is a vascular disease.113 This currently narrows the 
applicability of osseointegration implant surgery. Future research should try to identify if and 
which subgroups with a vascular disease are eligible for osseointegration implant surgery.
CONCLUSION
Knowledge of the exact change in functional outcomes is limited to a few constructs due to 
the limited number of studies assessing functional outcomes in persons who received a bone-
anchored prosthesis, the difficulty of combining research and daily clinical practice, and the 
challenge of developing an RCT in the field of osseointegration implant surgery. Despite the 
various limitations as outlined in this thesis, we can deduce that bone-anchored prosthesis 
use has a positive effect for the majority of the persons with socket-related problems, 
because the ratio between health benefits of bone-anchored prosthesis and adverse events 
appears sufficient. Hence, we will continue to treat patients with this surgical technique and 
subsequent tailored rehabilitation programme which we aim to further optimise for our 
future patients. We also will explore if the ratio between the benefits and adverse events 
remains sufficient in long-term and if the treatment is feasible in subgroups of patients such 
as high active prosthesis users and persons with a dysvascular amputation.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 256
256
9
Fi
gu
re
 1
. O
ve
rv
ie
w
 o
f s
tu
di
es
 a
ss
es
si
ng
 s
af
et
y 
ou
tc
om
es
 in
 lo
w
er
 e
xt
re
m
it
y 
bo
ne
-a
nc
ho
re
d 
pr
os
th
es
is
 u
se
rs
Re
d:
 s
tu
di
es
 w
it
h 
a 
to
ta
l o
ve
rl
ap
 in
 in
cl
us
io
n 
pe
ri
od
, p
ati
en
t 
po
pu
la
tio
n 
an
d 
ou
tc
om
e 
m
ea
su
re
s;
 B
lu
e:
 s
tu
di
es
 w
it
h 
pa
rti
al
 o
r 
no
 o
ve
rl
ap
 in
 
in
cl
us
io
n 
pe
ri
od
, p
ati
en
t 
po
pu
la
tio
n 
an
d 
ou
tc
om
e 
m
ea
su
re
s;
 T
F:
 T
ra
ns
fe
m
or
al
 o
ss
eo
in
te
gr
ati
on
 im
pl
an
t;
 T
T:
 T
ra
ns
tib
ia
l o
ss
eo
in
te
gr
ati
on
 
im
pl
an
t.
 T
he
 st
ud
ie
s 
in
 th
is
 o
ve
rv
ie
w
 w
er
e 
fo
un
d 
by
 a
 c
om
pr
eh
en
si
ve
 s
ea
rc
h 
on
 8
 Ja
nu
ar
y 
20
18
 in
 M
ED
LI
N
E 
(a
cc
es
se
d 
vi
a 
Pu
bM
ed
), 
Co
ch
ra
ne
 
Ce
nt
ra
l R
eg
is
te
r 
of
 C
on
tr
ol
le
d 
Tr
ia
ls
, E
m
ba
se
 (a
cc
es
se
d 
vi
a 
O
vi
dS
P)
, C
IN
A
H
L,
 W
eb
 o
f S
ci
en
ce
 a
nd
 S
ys
te
m
 fo
r 
in
fo
rm
ati
on
 o
n 
G
re
y 
Li
te
ra
tu
re
 
w
hi
ch
 w
as
 p
ar
t 
of
 a
 s
ys
te
m
ati
c 
re
vi
ew
 b
y 
At
al
la
h 
et
 a
l.6
5
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 257
257
Chapter 9 | General discussion
9
Fi
gu
re
 2
 O
ve
rv
ie
w
 o
f 
st
ud
ie
s 
as
se
ss
in
g 
fu
nc
ti
on
al
 o
ut
co
m
es
 i
n 
lo
w
er
 e
xt
re
m
it
y 
bo
ne
-a
nc
ho
re
d 
pr
os
th
es
is
 u
se
rs
 c
om
pa
re
 t
o 
so
ck
et
-
su
sp
en
de
d 
pr
os
th
es
is
 u
se
rs
Re
d:
 s
tu
di
es
 w
it
h 
a 
to
ta
l o
ve
rl
ap
 in
 in
cl
us
io
n 
pe
ri
od
, p
ati
en
t 
po
pu
la
tio
n 
an
d 
ou
tc
om
e 
m
ea
su
re
s;
 B
lu
e:
 s
tu
di
es
 w
it
h 
pa
rti
al
 o
r 
no
 o
ve
rl
ap
 in
 
in
cl
us
io
n 
pe
ri
od
, p
ati
en
t 
po
pu
la
tio
n 
an
d 
ou
tc
om
e 
m
ea
su
re
s;
 T
F:
 T
ra
ns
fe
m
or
al
 o
ss
eo
in
te
gr
ati
on
 im
pl
an
t;
 T
T:
 T
ra
ns
tib
ia
l o
ss
eo
in
te
gr
ati
on
 
im
pl
an
t.
 T
he
 s
tu
di
es
 in
 t
hi
s 
ov
er
vi
ew
 w
er
e 
fo
un
d 
in
 t
he
 s
ea
rc
h 
on
 1
6 
Ju
ne
 2
01
6 
w
hi
ch
 w
as
 p
ar
t 
of
 t
he
 s
ys
te
m
ati
c 
re
vi
ew
 p
re
se
nt
ed
 in
 t
hi
s 
th
es
is
 (c
ha
pt
er
 2
)5
 o
r 
fo
un
d 
in
 a
n 
up
da
te
d 
se
ar
ch
 in
 M
ED
LI
N
E 
(a
cc
es
se
d 
vi
a 
Pu
bM
ed
) o
n 
17
 A
ug
us
t 
20
18
 (m
ar
ke
d 
w
it
h 
*)
.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 258
258
9
REFERENCES
1. Leijendekkers RA, van Hinte G, Nijhuis-van der Sanden MW, Staal JB. Gait rehabilitation for a 
patient with an osseointegrated prosthesis following transfemoral amputation. Physiother Theory 
Pract. 2017;33(2):147-61.
2. Leijendekkers RA, Hinte GV, Sman AD, Staal JB, Nijhuis-van der Sanden MWG, Hoogeboom TJ. 
Clinimetric properties of hip abduction strength measurements obtained using a handheld 
dynamometer in individuals with a lower extremity amputation. PLoS One. 2017;12(6):e0179887.
3. Leijendekkers RA, Staal JB, van Hinte G, Frolke JP, van de Meent H, Atsma F, et al. Long-term 
outcomes following lower extremity press-fit bone-anchored prosthesis surgery: a 5-year 
longitudinal study protocol. BMC Musculoskelet Disord. 2016;17(1):484.
4. Leijendekkers RA, Hoogeboom TJ, van Hinte G, Didden L, Anijs T, Nijhuis-van der Sanden MWG, 
et al. Reproducibility and discriminant validity of two clinically feasible measurement methods to 
obtain coronal plane gait kinematics in participants with a lower extremity amputation [submitted].
5. Leijendekkers RA, van Hinte G, Frolke JP, van de Meent H, Nijhuis-van der Sanden MW, Staal 
JB. Comparison of bone-anchored prostheses and socket prostheses for patients with a lower 
extremity amputation: a systematic review. Disabil Rehabil. 2017;39(11):1045-1058.
6. Leijendekkers RA, van Hinte G, Frölke JP, Van de Meent H, Atsma F, Nijhuis-van der Sanden MW, et 
al. Performance and safety of bone-anchored prostheses using a press-fit osseointegration implant 
in persons with a transfemoral or transtibial amputation: a prospective one-year follow-up cohort 
study. Clin Rehab. 2018; 269215518815215.
7. Leijendekkers RA, Marra MA, Ploegmakers MJM, Van Hinte G, Frolke JP, Van De Meent H, et al. 
Magnetic-resonance-imaging-based three-dimensional muscle reconstruction of hip abductor 
muscle volume in a person with a transfemoral bone-anchored prosthesis: A feasibility study. 
Physiother Theory Pract. 2018;1-10.
8. Carlson MD, Morrison RS. Study design, precision, and validity in observational studies. J Palliat 
Med. 2009;12(1):77-82.
9. Lu CY. Observational studies: a review of study designs, challenges and strategies to reduce 
confounding. Int J Clin Pract. 2009;63(5):691-7.
10. Smith GD, Ebrahim S. Data dredging, bias, or confounding. BMJ. 2002;325(7378):1437-8.
11. Song F, Parekh-Bhurke S, Hooper L, Loke YK, Ryder JJ, Sutton AJ, et al. Extent of publication bias 
in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res 
Methodol. 2009;9:79.
12. Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, et al. Reader’s guide to critical 
appraisal of cohort studies: 2. Assessing potential for confounding. BMJ. 2005;330(7497):960-2.
13. A FL, Ahmed NU, Khan HM, Cevallos FG, Pekovic V. The Impact of Red Light Cameras on Crashes 
Within Miami-Dade County, Florida. Traffic Inj Prev. 2015;16(8):773-80.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 259
259
Chapter 9 | General discussion
9
14. Saladin SP, Hansmann SE. Psychosocial variables related to the adoption of video relay services 
among deaf or hard-of-hearing employees at the Texas School for the Deaf. Assist Technol. 
2008;20(1):36-47.
15. Strough J, Mehta CM, McFall JP, Schuller KL. Are older adults less subject to the sunk-cost fallacy 
than younger adults? Psychol Sci. 2008;19(7):650-2.
16. Howard JS, Mattacola CG, Howell DM, Lattermann C. Response shift theory: an application for 
health-related quality of life in rehabilitation research and practice. J Allied Health. 2011;40(1):31-
8.
17. Al Muderis M, H. H. Aschoff, B. Bosley, G. Raz, L. Gerdesmeyer, B. Burkett. Direct skeletal attachment 
prosthesis for the amputee athlete: The unknown potential. Sport Eng. 2016;19:141–5.
18. Branemark R, Berlin O, Hagberg K, Bergh P, Gunterberg B, Rydevik B. A novel osseointegrated 
percutaneous prosthetic system for the treatment of patients with transfemoral amputation: A 
prospective study of 51 patients. Bone Joint J. 2014;96-B(1):106-13. Epub 2014/01/08.
19. Juhnke DL, Aschoff HH. [Endo-exo prostheses following limb-amputation]. Orthopade. 
2015;44(6):419-25.
20. Muderis MA, Tetsworth K, Khemka A, Wilmot S, Bosley B, Lord SJ, et al. The Osseointegration 
Group of Australia Accelerated Protocol (OGAAP-1) for two-stage osseointegrated reconstruction 
of amputated limbs. Bone Joint J. 2016;98-B(7):952-60.
21. Al Muderis M, Khemka A, Lord SJ, Van de Meent H, Frolke JP. Safety of Osseointegrated Implants 
for Transfemoral Amputees: A Two-Center Prospective Cohort Study. J Bone Joint Surg Am. 
2016;98(11):900-9.
22. Aschoff HH, Kennon RE, Keggi JM, Rubin LE. Transcutaneous, distal femoral, intramedullary 
attachment for above-the-knee prostheses: an endo-exo device. J Bone Joint Surg Am. 2010;92 
Suppl 2:180-6. Epub 2010/12/09.
23. Hagberg K, Branemark R. One hundred patients treated with osseointegrated transfemoral 
amputation prostheses--rehabilitation perspective. J Rehabil Res Dev. 2009;46(3):331-44. Epub 
2009/08/14.
24. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for 
reporting observational studies. Lancet. 2007;370(9596):1453-7.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9, W64. 
Epub 2009/07/23.
26. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational 
studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 
2007;36(3):666-76. Epub 2007/05/02.
27. Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 260
260
9
tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice 
guideline: a systematic review. J Evid Based Med. 2015;8(1):2-10.
28. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale 
(NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://
www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed 27/06/2018).
29. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological 
quality both of randomised and non-randomised studies of health care interventions. J Epidemiol 
Community Health. 1998;52(6):377-84.
30. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool 
for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
31. Jackson N, Waters E, Guidelines for Systematic Reviews in Health P, Public Health T. Criteria for 
the systematic review of health promotion and public health interventions. Health Promot Int. 
2005;20(4):367-74. Epub 2005/09/20.
32. Thomas BH, Ciliska D, Dobbins M, S. M. Effective Public Health Practice Project. Quality Assessment 
Tool for Quantitative Studies. Available at: https://merst.ca/wp-content/uploads/2018/02/qualilty-
assessment-dictionary_2017.pdf (Accessed: 27/06/2018).
33. Pantera E, Pourtier-Piotte C, Bensoussan L, Coudeyre E. Patient education after amputation: 
systematic review and experts’ opinions. Ann Phys Rehabil Med. 2014;57(3):143-58.
34. Wegener ST, Mackenzie EJ, Ephraim P, Ehde D, Williams R. Self-management improves outcomes in 
persons with limb loss. Arch Phys Med Rehabil. 2009;90(3):373-80.
35. Hansen CH, Hansen RL, Jorgensen PH, Petersen KK, Norlyk A. The process of becoming a user of an 
osseointegrated prosthesis following transfemoral amputation: a qualitative study. Disabil Rehabil. 
2017:1-8.
36. McGinley JL, Baker R, Wolfe R, Morris ME. The reliability of three-dimensional kinematic gait 
measurements: a systematic review. Gait & posture. 2009;29(3):360-9.
37. Rusaw D, Ramstrand N. Motion-analysis studies of transtibial prosthesis users: a systematic review. 
Prosthet Orthot Int. 2011;35(1):8-19.
38. Jaegers SM, Arendzen JH, de Jongh HJ. Prosthetic gait of unilateral transfemoral amputees: a 
kinematic study. Arch Phys Med Rehabil. 1995;76(8):736-43.
39. Michaud SB, Gard SA, Childress DS. A preliminary investigation of pelvic obliquity patterns during 
gait in persons with transtibial and transfemoral amputation. J Rehabil Res Dev. 2000;37(1):1-10. 
Epub 2000/06/10.
40. Molina-Rueda F, Alguacil-Diego IM, Cuesta-Gomez A, Iglesias-Gimenez J, Martin-Vivaldi A, 
Miangolarra-Page JC. Thorax, pelvis and hip pattern in the frontal plane during walking in unilateral 
transtibial amputees: biomechanical analysis. Braz J Phys Ther. 2014;18(3):252-8.
41. Sjodahl C, Jarnlo GB, Soderberg B, Persson BM. Pelvic motion in trans-femoral amputees in the 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 261
261
Chapter 9 | General discussion
9
frontal and transverse plane before and after special gait re-education. Prosthet Orthot Int. 
2003;27(3):227-37. Epub 2004/01/20.
42. Tazawa E. Analysis of torso movement of trans-femoral amputees during level walking. Prosthet 
Orthot Int. 1997;21(2):129-40.
43. Molina Rueda F, Alguacil Diego IM, Molero Sanchez A, Carratala Tejada M, Rivas Montero FM, 
Miangolarra Page JC. Knee and hip internal moments and upper-body kinematics in the frontal 
plane in unilateral transtibial amputees. Gait & posture. 2013;37(3):436-9.
44. Shephard RJ. Limits to the measurement of habitual physical activity by questionnaires. Br J Sports 
Med. 2003;37(3):197-206. 
45. Wittink H, Rogers W, Sukiennik A, Carr DB. Physical functioning: self-report and performance 
measures are related but distinct. Spine (Phila Pa 1976). 2003;28(20):2407-13.
46. Kyte DG, Calvert M, van der Wees PJ, ten Hove R, Tolan S, Hill JC. An introduction to patient-
reported outcome measures (PROMs) in physiotherapy. Physiotherapy. 2015;101(2):119-25.
47. Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome 
Measures (PROMs). Health Serv Insights. 2013;6:61-8.
48. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
49. Mizner RL, Petterson SC, Clements KE, Zeni JA, Jr., Irrgang JJ, Snyder-Mackler L. Measuring functional 
improvement after total knee arthroplasty requires both performance-based and patient-report 
assessments: a longitudinal analysis of outcomes. J Arthroplasty. 2011;26(5):728-37.
50. Resnik L, Borgia M. Reliability of outcome measures for people with lower-limb amputations: 
distinguishing true change from statistical error. Phys Ther. 2011;91(4):555-65. Epub 2011/02/12.
51. Van de Meent H, Hopman MT, Frolke JP. Walking ability and quality of life in subjects with 
transfemoral amputation: a comparison of osseointegration with socket prostheses. Arch Phys 
Med Rehabil. 2013;94(11):2174-8. Epub 2013/06/19.
52. Lin SJ, Bose NH. Six-minute walk test in persons with transtibial amputation. Arch Phys Med 
Rehabil. 2008;89(12):2354-9. Epub 2008/11/04.
53. Lin SJ, Winston KD, Mitchell J, Girlinghouse J, Crochet K. Physical activity, functional capacity, 
and step variability during walking in people with lower-limb amputation. Gait & posture. 
2014;40(1):140-4.
54. Sions JM, Beisheim EH, Manal TJ, Smith SC, Horne JR, Sarlo FB. Differences in Physical Performance 
Measures Among Patients With Unilateral Lower-Limb Amputations Classified as Functional Level 
K3 Versus K4. Arch Phys Med Rehabil. 2018;99(7):1333-41.
55. Gailey RS, Gaunaurd I, Agrawal V, Finnieston A, O’Toole C, Tolchin R. Application of self-report 
and performance-based outcome measures to determine functional differences between four 
categories of prosthetic feet. J Rehabil Res Dev. 2012;49(4):597-612.
56. Sullivan J, Uden M, Robinson KP, Sooriakumaran S. Rehabilitation of the trans-femoral amputee 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 262
262
9
with an osseointegrated prosthesis: the United Kingdom experience. Prosthet Orthot Int. 
2003;27(2):114-20. Epub 2003/10/24.
57. Aschoff HH, Clausen A, Hoffmeister T. [The endo-exo femur prosthesis--a new concept of 
bone-guided, prosthetic rehabilitation following above-knee amputation]. Z Orthop Unfall. 
2009;147(5):610-5. Epub 2009/11/26.
58. Matthews DJ, Arastu M, Uden M, Sullivan JP, Bolsakova K, Robinson K, et al. UK trial of the 
Osseointegrated Prosthesis for the Rehabilitation for Amputees: 1995-2018. Prosthet Orthot Int. 
2018:309364618791616.
59. Kloek CJJ, Bossen D, Spreeuwenberg PM, Dekker J, de Bakker DH, Veenhof C. Effectiveness of a 
Blended Physical Therapist Intervention in People With Hip Osteoarthritis, Knee Osteoarthritis, or 
Both: A Cluster-Randomized Controlled Trial. Phys Ther. 2018;98(7):560-70.
60. Zanaboni P, Dinesen B, Hjalmarsen A, Hoaas H, Holland AE, Oliveira CC, et al. Long-term integrated 
telerehabilitation of COPD Patients: a multicentre randomised controlled trial (iTrain). BMC Pulm 
Med. 2016;16(1):126.
61. Spaliviero M, Eastham JA. Relationship between surgical volume and patient outcomes. Trends in 
Urology & Men’s Health. 2015;6(7).
62. Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon’s specialty for 
outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012(3):CD005391.
63. Boddy AP, Williamson JM, Vipond MN. The effect of centralisation on the outcomes of 
oesophagogastric surgery--a fifteen year audit. Int J Surg. 2012;10(7):360-3.
64. Sooriakumaran S, Uden M, Mulroy S, Ewins D, Collins T. The impact a surgeon has on primary 
amputee prosthetic rehabilitation: A survey of residual lower limb quality. Prosthet Orthot Int. 
2018;42(4):428-36.
65. Atallah R, Leijendekkers RA, Hoogeboom TJ, Frolke JP. Complications of bone-anchored prostheses 
for individuals with an extremity amputation: A systematic review. PLoS One. 2018;13(8):e0201821.
66. Aschoff HH, Clausen A, Tsoumpris K, Hoffmeister T. [Implantation of the endo-exo femur prosthesis 
to improve the mobility of amputees]. Oper Orthop Traumatol. 2011;23(5):462-72. Epub 
2011/11/16.
67. Hagberg K, Branemark R, Gunterberg B, Rydevik B. Osseointegrated trans-femoral amputation 
prostheses: prospective results of general and condition-specific quality of life in 18 patients at 
2-year follow-up. Prosthet Orthot Int. 2008;32(1):29-41. Epub 2008/03/12.
68. Butler K, Bowen C, Hughes AM, Torah R, Ayala I, Tudor J, et al. A systematic review of the key 
factors affecting tissue viability and rehabilitation outcomes of the residual limb in lower extremity 
traumatic amputees. J Tissue Viability. 2014;23(3):81-93.
69. Dudek NL, Marks MB, Marshall SC, Chardon JP. Dermatologic conditions associated with use of a 
lower-extremity prosthesis. Arch Phys Med Rehabil. 2005;86(4):659-63.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 263
263
Chapter 9 | General discussion
9
70. Hagberg K, Branemark R. Consequences of non-vascular trans-femoral amputation: a survey 
of quality of life, prosthetic use and problems. Prosthet Orthot Int. 2001;25(3):186-94. Epub 
2002/02/28.
71. Lyon CC, Kulkarni J, Zimerson E, Van Ross E, Beck MH. Skin disorders in amputees. J Am Acad 
Dermatol. 2000;42(3):501-7. Epub 2000/02/25.
72. Meulenbelt HE, Geertzen JH, Jonkman MF, Dijkstra PU. Determinants of skin problems of the 
stump in lower-limb amputees. Arch Phys Med Rehabil. 2009;90(1):74-81. Epub 2009/01/22.
73. Ortiz-Catalan M, Hakansson B, Branemark R. Enabling the clinical use of neuromuscular interfaces 
for prosthetic control via an osseointegrated implant. Neuromodulation. 2014;17(5):e45.
74. Demet K, Martinet N, Guillemin F, Paysant J, Andre JM. Health related quality of life and related 
factors in 539 persons with amputation of upper and lower limb. Disabil Rehabil. 2003;25(9):480-
6.
75. Dillingham TR, Pezzin LE, MacKenzie EJ, Burgess AR. Use and satisfaction with prosthetic devices 
among persons with trauma-related amputations: a long-term outcome study. Am J Phys Med 
Rehabil. 2001;80(8):563-71.
76. Mundell BF, Kremers HM, Visscher S, Hoppe KM, Kaufman KR. Predictors of Receiving a Prosthesis 
for Adults With Above-Knee Amputations in a Well-Defined Population. PM R. 2016;8(8):730-7.
77. Sansam K, Neumann V, O’Connor R, Bhakta B. Predicting walking ability following lower limb 
amputation: a systematic review of the literature. J Rehabil Med. 2009;41(8):593-603.
78. Taylor SM, Kalbaugh CA, Blackhurst DW, Hamontree SE, Cull DL, Messich HS, et al. Preoperative 
clinical factors predict postoperative functional outcomes after major lower limb amputation: an 
analysis of 553 consecutive patients. J Vasc Surg. 2005;42(2):227-35.
79. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 
2006;6:54.
80. Mdege ND, Man MS, Taylor Nee Brown CA, Torgerson DJ. Systematic review of stepped wedge 
cluster randomized trials shows that design is particularly used to evaluate interventions during 
routine implementation. J Clin Epidemiol. 2011;64(9):936-48.
81. Hemming K. Sample size calculations for stepped wedge trials using design effects are only 
approximate in some circumstances. Trials. 2016;17(1):234.
82. Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: 
a unified approach. J Clin Epidemiol. 2016;69:137-46.
83. Freemantle N, Marston L, Walters K, Wood J, Reynolds MR, Petersen I. Making inferences on 
treatment effects from real world data: propensity scores, confounding by indication, and other 
perils for the unwary in observational research. BMJ. 2013;347:f6409.
84. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for 
causal effects. Biometrika. 1883;70:41-55.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 264
264
9
85. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with 
the design of randomized trials. Stat Med. 2007;26(1):20-36.
86. Duan N, Kravitz RL, Schmid CH. Single-patient (n-of-1) trials: a pragmatic clinical decision 
methodology for patient-centered comparative effectiveness research. J Clin Epidemiol. 2013;66(8 
Suppl):S21-8.
87. Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate 
strategy for individualizing medicine? Per Med. 2011;8(2):161-73.
88. Schork NJ. Personalized medicine: Time for one-person trials. Nat New Biol. 2015;520(7549):609-
11.
89. Guyatt G. N of 1 randomized trials: a commentary. J Clin Epidemiol. 2016;76:4-5.
90. Stunnenberg BC, Woertman W, Raaphorst J, Statland JM, Griggs RC, Timmermans J, et al. Combined 
N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study 
rationale and protocol. BMC Neurol. 2015;15:43.
91. Irwig L, Glasziou P, March L. Ethics of n-of-1 trials. Lancet. 1995;345(8948):469.
92. OCEBM Levels of Evidence Working Group. The Oxford Levels of Evidence 2. Oxford Centre for 
Evidence-Based Medicine https://wwwcebmnet/indexaspx?o=5653.
93. Zucker DR, Ruthazer R, Schmid CH, Feuer JM, Fischer PA, Kieval RI, et al. Lessons learned combining 
N-of-1 trials to assess fibromyalgia therapies. J Rheumatol. 2006;33(10):2069-77.
94. Al Muderis M, Lu W, Li JJ. Osseointegrated Prosthetic Limb for the treatment of lower limb 
amputations : Experience and outcomes. Unfallchirurg. 2017;120(4):306-11. 
95. Aschoff HH, Juhnke DL. [Evaluation of 10 years experience with endo-exo femur prostheses - 
background, data and results]. Z Orthop Unfall. 2012;150(6):607-14. Epub 2012/11/23.
96. Hoffmeister T, Schwarze F, Aschoff HH. [The endo-exo prosthesis treatment concept : Improvement 
in quality of life after limb amputation]. Unfallchirurg. 2017;120(5):371-7.
97. Juhnke DL, Beck JP, Jeyapalina S, Aschoff HH. Fifteen years of experience with Integral-Leg-
Prosthesis: Cohort study of artificial limb attachment system. J Rehabil Res Dev. 2015;52(4):407-20.
98. Nebergall A, Bragdon C, Antonellis A, Karrholm J, Branemark R, Malchau H. Stable fixation of an 
osseointegated implant system for above-the-knee amputees: titel RSA and radiographic evaluation 
of migration and bone remodeling in 55 cases. Acta Orthop. 2012;83(2):121-8. Epub 2012/04/12.
99. Tillander J, Hagberg K, Hagberg L, Branemark R. Osseointegrated titanium implants for limb 
prostheses attachments: infectious complications. Clin Orthop Relat Res. 2010;468(10):2781-8. 
Epub 2010/05/18.
100. Aschoff HH, Juhnke DL. [Endo-exo prostheses : Osseointegrated percutaneously channeled 
implants for rehabilitation after limb amputation]. Unfallchirurg. 2016;119(5):421-7.
101. Li Y, Branemark R. Osseointegrated prostheses for rehabilitation following amputation: The 
pioneering Swedish model. Unfallchirurg. 2017;120(4):285-92.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 265
265
Chapter 9 | General discussion
9
102. Tillander J, Hagberg K, Berlin O, Hagberg L, Branemark R. Osteomyelitis Risk in Patients With 
Transfemoral Amputations Treated With Osseointegration Prostheses. Clin Orthop Relat Res. 
2017;475(12):3100-8.
103. McGough RL, Goodman MA, Randall RL, Forsberg JA, Potter BK, Lindsey B. The Compress(R) 
transcutaneous implant for rehabilitation following limb amputation. Unfallchirurg. 
2017;120(4):300-5.
104. Al Muderis M, Lu W, Tetsworth K, Bosley B, Li JJ. Single-stage osseointegrated reconstruction 
and rehabilitation of lower limb amputees: the Osseointegration Group of Australia Accelerated 
Protocol-2 (OGAAP-2) for a prospective cohort study. BMJ Open. 2017;7(3):e013508.
105. Hagberg K, Hansson E, Branemark R. Outcome of percutaneous osseointegrated prostheses for 
patients with unilateral transfemoral amputation at two-year follow-up. Arch Phys Med Rehabil. 
2014;95(11):2120-7. Epub 2014/07/30.
106. Li Y, Lindeque B. Percutaneous Osseointegrated Prostheses for Transfemoral Amputations. 
Orthopedics. 2018;41(2):75-80.
107. Tranberg R, Zugner R, Karrholm J. Improvements in hip- and pelvic motion for patients with 
osseointegrated trans-femoral prostheses. Gait & posture. 2011;33(2):165-8. Epub 2010/12/07.
108. Hagberg K. Bone-anchored prostheses in patients with traumatic bilateral transfemoral 
amputations: rehabilitation description and outcome in 12 cases treated with the OPRA implant 
system. Disabil Rehabil Assist Technol. 2018:1-8.
109. Muderis MA, Lu W, Glatt V, Tetsworth K. Two-Stage Osseointegrated Reconstruction of Post-
traumatic Unilateral Transfemoral Amputees. Mil Med. 2018;183(suppl_1):496-502.
110. Malchau H, Garellick G, Berry D, Harris WH, Robertson O, Karrlholm J, et al. Arthroplasty implant 
registries over the past five decades: Development, current, and future impact. J Orthop Res. 2018.
111. Jaegers SM, Arendzen JH, de Jongh HJ. Changes in hip muscles after above-knee amputation. Clin 
Orthop Relat Res. 1995(319):276-84.
112. Frolke JP, Leijendekkers RA, van de Meent H. Osseointegrated prosthesis for patients with an 
amputation: Multidisciplinary team approach in the Netherlands. Unfallchirurg. 2017; 120(4):293-
299.
113. Unwin N. Epidemiology of lower extremity amputation in centres in Europe, North America and 
East Asia. Br J Surg. 2000;87(3):328-37.
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 266
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 267
Summary
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 268
268
S
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 269
269
Summary
S
Persons with a lower extremity amputation who aim to regain their walking ability are 
generally provided with a conventional socket-suspended prosthesis. However, up to 63% of 
the prosthetic users suffer from chronic skin problems and pain associated with the socket. 
These problems have a negative impact on their quality of life (QoL), function level, activity 
level and participation level. Back pain is a common secondary disability in socket-suspended 
prosthesis users and is associated with gait asymmetry, specifically in the coronal and sagittal 
plane. In addition to socket fitting problems, decreased hip abductor strength, high levels 
of muscle atrophy, and changed muscle activity patterns may be a possible cause for this 
asymmetry.
Bone-anchored prostheses using a transcutaneous osseointegration implant might be a 
solution for socket-suspended prosthesis users suffering from socket-related problems. The 
bone-anchored prosthesis was introduced in 1990. Since then, various osseointegration 
implants have been developed. The majority of the research that was done in this field 
dates from the last ten year and focused mainly on safety outcomes. Rehabilitation after 
osseointegration implant surgery and functional outcomes are less studied. The central 
purpose of this thesis was to describe the treatment trajectory after osseointegration implant 
surgery and examine the potential health benefits of a bone-anchored prosthesis in previous 
socket-suspended prosthesis users with a lower extremity amputation.
In chapter 2, a systematic review, we provide an overview of the current body of knowledge 
concerning functional outcomes for persons with a bone-anchored prosthesis compared to 
a socket-suspended prosthesis. We found that, based on limited evidence, bone-anchored 
prostheses use resulted in higher QoL, function and activity levels than socket-suspended 
prosthesis use in persons with socket-related problems. The heterogeneity in outcome 
measures was large in the five cohort and two cross-sectional studies that were included. 
Ten different measurement instruments and two separate questions were used to assess 
outcome. There was some consensus regarding the use of the questionnaire for persons 
with transfemoral amputation (Q-TFA) to assess health-related QoL (HRQoL) and level of 
function (prosthesis wearing time), and the 6-minute walking test (6MWT) and timed up and 
go (TUG) to assess level of activity. Level of participation was rarely assessed. We concluded 
that there is a need for a core-set of outcome measures to evaluate the clinical impact of 
osseointegration implant surgery and following rehabilitation and detailed a proposal for a 
core-set.
The 13-week rehabilitation programme that we developed for transfemoral bone-anchored 
prosthesis users was detailed in a case study (chapter 3). In this case study we used outcome 
measures that we think are important to include in a future core-set of outcome measures 
such as e.g. hip abductor strength, gait symmetry, and back pain. We described the treatment 
trajectory of an active, 70-year-old man with a traumatic transfemoral amputation who had 
used a socket-suspended prosthesis for 52 years and received a bone-anchored prosthesis. 
The rehabilitation programme focused on improving hip abductor strength, core stability, 
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 270
270
S
symmetry of gait pattern and level of activity. Hip abductor strength, gait symmetry, and 
activity level increased after rehabilitation. The improvements in gait symmetry and activity 
level were maintained at the one-year follow-up. Outcomes were worse at the six-month 
follow-up presumably due to the presence of severe low back pain as a result of lumbar 
degenerative disc disease.
In chapter 4, we evaluated the eligibility of a magnetic resonance imaging (MRI) based 
three-dimensional muscle reconstruction technique to evaluate hip abductor muscle 
volume in a person after receiving a transfemoral press-fit cobalt-chrome-molybdenum 
osseointegration implant. This case study was performed in the same person as described in 
chapter 3. We concluded that the technique appears feasible to provide insight into muscle 
volume change in a person with a transfemoral bone-anchored prosthesis using a cobalt-
chrome-molybdenum osseointegration implant. We also found that in this single case the 
total hip abductor volume of both the residual limb (six-month: 5.5%; twelve-month: 7.4%) 
and sound limb (six-month: 7.8%; twelve-month: 5.5%) increased compared to baseline. 
Future research should focus on analysis of muscle tissue composition and the feasibility in 
osseointegration implants of other alloys.
In chapter 5 we presented the study protocol, including a priori hypotheses, of the in 
2014 started 5-year follow-up study in order to collect long-term outcomes following lower 
extremity press-fit bone-anchored prosthesis. In this study we used a slightly adjusted 11-
week rehabilitation programme for transfemoral bone-anchored prosthesis users compared 
to the programme detailed in chapter 3. For transtibial bone-anchored prosthesis users 
we used a 4-week rehabilitation programme. The focus of both programmes was similar 
to the programme detailed in chapter 3. The main study outcomes follow, in part, the ICF 
classification: a) level of function defined as kinematics in coronal plane, hip abductor strength, 
prosthetic use, back pain and stump pain; b) level of activity defined as mobility level and 
walking ability; c) HRQoL; d) satisfaction defined as prosthesis comfort and global perceived 
effect. Changes over time for the continuous outcomes and the dichotomized outcome (back 
pain) were analysed using generalised estimating equations (GEE). Publishing the study 
protocol of an observational study is not common but in our opinion equally important as 
for clinical trials to: a) increase the transparency of the data collection; b) prevent publication 
bias and selective reporting; c) prevent data dredging.
In next two chapters we introduced new outcome measures to evaluate the impact of 
osseointegration implant surgery and following rehabilitation. We hypothesised that coronal 
plane kinematics symmetry and hip abductor strength would improve after bone-anchored 
prosthesis use compared to socket-suspended prosthesis use (chapter 5). To be able to test 
this hypothesis we needed measurement methods to measure these outcome measures 
in daily clinical practice, because all assessments were part of usual care. In chapter 6, we 
described the development of a method for testing hip abductor strength using a handheld 
dynamometer. The final version of the test was valid and test-retest reproducible. The test 
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appeared not usable in an inter-rater setting despite good reliability estimates, due to the 
suspected presence of systematic bias and bias related to the magnitude of the muscle torque. 
The reproducibility of the final version of the test was tested in 44 participants with a lower 
extremity amputation, while the concurrent validity was established in 30 healthy participants. 
In chapter 7, we presented a three-dimensional (3D; inertial measurement units) and a two-
dimensional (2D; video-based) system to obtain coronal plane gait kinematics. We tested the 
test-retest and inter-rater reproducibility of both systems and the 2-D system, respectively, in 
participants with a lower extremity amputation (group 1; n= 25) and healthy subjects (group 
2; n= 41). The discriminant validity was determined with a within-group comparison for the 
3-D system and with a between-group comparison for both systems. Both systems showed 
to be test-retest reliable, both in group 1 and in group 2. The 2-D system was also inter-rater 
reliable. The within-group comparison of the 3-D system revealed a statistically significant 
asymmetry of 0.4°-0.5° in group 1 and no statistically significant asymmetry in group 2. The 
between-group comparison revealed that the maximum amplitude towards the residual limb 
(MARL) in the low back (3-D system) and the (residual) limb - trunk angle (2-D system) were 
significantly larger with a mean difference of 1.2° and 6.4°, respectively, than the maximum 
amplitude of healthy subjects. However, these average differences were smaller than the 
smallest detectable change (SDC) of group 1 for both the MARL (SDC
agreement
: 1.5°) and the 
residual limb - trunk angle (SDC
agreement
: 6.7°-7.6°). Therefore, we concluded that the 3-D and 
2-D systems tested in this study were not sensitive enough to detect real differences within 
and between participants with a lower extremity amputation and healthy subjects although 
promising reproducibility parameters for some of the outcome measures. This insight led to 
exclusion of coronal plane kinematics symmetry as an outcome measure in our 5-year follow-
up study.
In chapter 8, a before-after cohort study, we present the first preliminary one-year follow-
up results of our 5-year follow-up longitudinal study. The objectives were: 1) to compare level 
of function, activity, HRQoL and satisfaction in persons with a lower extremity amputation 
before surgery and six- and twelve-months after implantation of an osseointegration implant. 
2) to report adverse events. We included 40 consecutive persons (median age: 56y) who 
received a transfemoral (31) or transtibial (9) osseointegration implant, between April 2014 
and March 2016. The main outcome measures were: Hip abductor strength, prosthetic use, 
back pain frequency, post-operative pain, mobility level (TUG and wheelchair-boundedness), 
walking ability (6MWT and walking distance in daily life), HRQoL, satisfaction regards to the 
prosthesis, and adverse events. We found that hip abductor strength, prosthetic use, walking 
distance, HRQoL and satisfaction level increased significantly at six- and twelve-month follow-
up compared to baseline (p≤0.002). The TUG and 6MWT showed no change at six-month 
follow-up (p≥0.420), but improved significantly at twelve-month follow-up compared to 
baseline (p≤0.038). Wheelchair-boundedness decreased from 12/40 participants at baseline 
to 0 at follow-ups. Back pain did not change over time (p≥0.437). Stump pain was present 
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in 28/39 and 22/40 of the participants at six-and twelve-month follow-up, respectively. All 
our a priori hypotheses regarding the improvement in functional outcomes were confirmed 
with exception of the expected decrease of back pain frequency which was only found in the 
subgroup of participants who were non-wheelchair-bound at baseline. The major adverse 
events were easily managed and included three minor osseointegration implant failures, and 
four bone fractures. An uneventful course was completed by 19/31 transfemoral and 4/9 
transtibial bone-anchored prostheses users. We concluded that bone-anchored prostheses 
lead to improved performance and appears to be safe, so they might be considered for 
persons with socket-related problems.
In chapter 9, we provide an overview of our main findings and insight in our (and the 
field’s) methodological shortcomings. Finally, we discuss the implications of this thesis for 
future clinical practice and our recommendations for future research. Challenges for future 
research include: a) the use a research design that increases the level of evidence; b) 
collecting unique and multi-factorial outcomes of large cohorts; c) opening the black box in 
terms of insight in the impact of bone-anchored prosthesis use on tissue level, selecting the 
ideal target population for osseointegration implant surgery and following rehabilitation, and 
optimising the intervention (osseointegration implant surgery and following rehabilitation).
The content of this thesis emphasises the importance of research into functional outcomes 
in the field of osseointegration implant surgery, but also the challenges of combining 
research and daily clinical practice. Despite the various limitations as outlined in this thesis, 
we can deduce that bone-anchored prostheses use has a positive effect for the majority 
of the persons with socket-related problems, because the ratio between health benefits of 
bone-anchored prosthesis and adverse events appears sufficient. Hence, we will continue to 
treat patients with this surgical technique and subsequent tailored rehabilitation programme 
which we aim to further optimise for our future patients.
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Personen met een beenamputatie die ernaar streven hun mobiliteit te herwinnen zijn 
over het algemeen afhankelijk van een conventionele kokerprothese. Tot 63% van de 
prothesegebruikers heeft echter last van chronische huidproblemen en pijn als gevolg van 
de koker. Deze problemen hebben een negatieve impact op de kwaliteit van hun leven (QoL), 
functieniveau, activiteitenniveau en participatieniveau. Rugpijn is een veel voorkomende 
secundaire klacht bij gebruikers van een kokerprothese en is geassocieerd met asymmetrie 
van het gangpatroon, met name in het coronale en sagittale vlak. Naast problemen met de 
kokerfitting, kunnen de verminderde kracht van de heupabductor, hoge mate van spieratrofie 
en gewijzigde spieractiviteitspatronen een mogelijke oorzaak zijn van deze asymmetrie.
Botverankerde prothesen met een transcutaan osseointegratie implantaat kunnen een 
oplossing zijn voor patiënten met kokerprothese die lijden aan koker gerelateerde problemen. 
De botverankerde prothese werd geïntroduceerd in 1990. Sindsdien zijn verschillende 
osseointegratie implantaten ontwikkeld. Het merendeel van het onderzoek dat op dit gebied 
is gedaan, dateert van de laatste tien jaar en is vooral gericht op veiligheidsresultaten. 
Revalidatie na osseointegratie implantaatchirurgie en functionele uitkomsten worden 
minder bestudeerd. Het centrale doel van dit proefschrift was om het behandeltraject na 
osseointegratie implantaatchirurgie te beschrijven en de potentiële gezondheidsvoordelen 
van een botverankerde prothese te onderzoeken in voormalige kokerprothese gebruikers 
met een beenamputatie.
In hoofdstuk 2, een systematische review, geven we een overzicht van de huidige kennis 
over functionele uitkomsten van personen met een botverankerde prothese in vergelijking 
met een kokerprothese. We vonden dat, op basis van beperkt bewijs, het gebruik van een 
botverankerde prothese resulteerde in hogere QoL-, functie- en activiteitenniveaus dan 
kokerprothesegebruik bij personen met koker gerelateerde problemen. De heterogeniteit in 
uitkomstmaten was groot in de vijf cohort en twee cross-sectionele studies die geïncludeerd 
waren. Tien verschillende meetinstrumenten en twee afzonderlijke vragen werden gebruikt 
om de uitkomst te beoordelen. Er was enige consensus over het gebruik van de vragenlijst 
voor personen met transfemorale amputatie (Q-TFA) om de gezondheidsgerelateerde QoL 
(HRQoL) en functieniveau (draagtijd van de prothese) te beoordelen. Ook was er enige 
consensus over het gebruik van de 6-minuten-wandeltest (6MWT) en op de timed up and go 
test (TUG) om het activiteitenniveau te bepalen. Participatieniveau werd zelden beoordeeld. 
We concludeerden dat er behoefte is aan een core-set van uitkomstmaten om de klinische 
impact van osseointegratie implantaatchirurgie en de daaropvolgende revalidatie te 
evalueren. In hoofdstuk 2 doen we een suggestie voor een core-set van uitkomstmaten.
Het 13 weken durende revalidatieprogramma dat we ontwikkelden voor transfemorale 
botverankerde prothesegebruikers werd gedetailleerd beschreven in een case study 
(hoofdstuk 3). In deze case study hebben we uitkomstmaten gebruikt waarvan we denken 
dat ze belangrijk zijn om op te nemen in een toekomstige core-set van uitkomstmaten 
zoals bijvoorbeeld heupabductor kracht, loopsymmetrie en rugpijn. We beschreven het 
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behandeltraject van een actieve, 70-jarige man met een traumatische transfemorale 
amputatie die een botverankerde prothese kreeg na 52 jaar een kokerprothese gebruikt 
te hebben. Het revalidatieprogramma was gericht op het verbeteren van de heupabductor 
kracht, rompstabiliteit, symmetrie van het looppatroon en het activiteitenniveau. 
Heupabductor kracht, loopsymmetrie en activiteitenniveau waren toegenomen na revalidatie. 
De verbeteringen in loopsymmetrie en activiteitenniveau werden behouden bij de follow-up 
van één jaar. De uitkomsten waren slechter bij de zes maanden follow-up, waarschijnlijk als 
gevolg van de aanwezigheid van ernstige lage rugpijn als gevolg van lumbale degeneratieve 
discopathie.
In hoofdstuk 4 evalueerden we de bruikbaarheid van een driedimensionale spier-
reconstructietechniek op basis van een magnetische resonantiebeeldvorming (MRI) om het 
spiervolume van de heupabductoren te evalueren van een persoon die een transfemorale 
press-fit kobalt-chroom-molybdeen osseointegratie implantaat krijgt. Deze case study werd 
uitgevoerd bij dezelfde persoon als beschreven in hoofdstuk 3. We concludeerden dat de 
techniek bruikbaar lijkt om inzicht te geven in spiervolume verandering bij een persoon 
met een transfemorale botverankerde prothese die gebruik maakt van een kobalt-chroom-
molybdeen osseointegratie implantaat. We ontdekten ook dat in deze persoon het totale 
heupabductor volume van zowel de stomp (zes maanden: 5,5%, twaalf maanden: 7,4%) en 
het gezond been (zes maanden: 7,8%, twaalf maanden: 5,5%) in vergelijking met baseline 
toenam. Toekomstig onderzoek moet zich concentreren op de analyse van de samenstelling 
van het spierweefsel en de bruikbaarheid bij osseointegratie implantaten van andere 
legeringen.
In hoofdstuk 5 presenteerden we het onderzoeksprotocol, inclusief vooraf opgestelde 
hypothesen, van de in 2014 gestarte 5-jaar follow-up studie om de langetermijnresultaten 
te verzamelen van personen met een press-fit botverankerde beenprothese. In deze studie 
gebruikten we een aangepast revalidatieprogramma van 11 weken voor transfemorale 
botverankerde prothesegebruikers in vergelijking met het programma beschreven in 
hoofdstuk 3. Voor gebruikers van een transtibiale botverankerde prothese gebruikten we 
een revalidatieprogramma van 4 weken. De focus van beide programma’s was vergelijkbaar 
met het programma beschreven in hoofdstuk 3. De belangrijkste studie uitkomsten volgen 
gedeeltelijk de ICF-classificatie: a) functieniveau gedefinieerd als kinematica in het coronale 
vlak, heupabductor kracht, prothesegebruik, rugpijn en stomppijn; b) activiteitenniveau 
gedefinieerd als mobiliteitsniveau en loopvaardigheid; c) HRQoL; d) tevredenheid gedefinieerd 
als prothesecomfort en globaal ervaren effectscore. Veranderingen in de tijd voor de continue 
uitkomsten en de gedichotomiseerde uitkomst (rugpijn) werden geanalyseerd met behulp 
van generalised estimating equations (GEE). Publicatie van het onderzoeksprotocol van een 
observationeel onderzoek is niet gebruikelijk, maar naar ons oordeel even belangrijk als voor 
experimenteel onderzoek om: a) de transparantie van de gegevensverzameling te vergroten; 
b) publicatiebias en selectieve rapportage te voorkomen; c) het zoeken naar statistische 
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verbanden in een gegevensverzameling te voorkomen.
In de volgende twee hoofdstukken hebben we nieuwe uitkomstmaten geïntroduceerd 
om de impact van osseointegratie implantaatchirurgie en de daaropvolgende revalidatie te 
evalueren. Onze hypothese was dat symmetrie in de coronale vlak kinematica en heupabductor 
kracht zouden verbeteren na gebruik van een botverankerde prothese in vergelijking met het 
gebruik van een kokerprothese (hoofdstuk 5). Om deze hypothese te kunnen testen, hadden 
we meetmethoden nodig om deze uitkomstmaten in de dagelijkse klinische praktijk te 
meten. De evaluatie van de interventie (operatie en revalidatie) maakt namelijk deel uit van 
de standaard zorg. In hoofdstuk 6 hebben we de ontwikkeling beschreven van een methode 
voor het testen van de heupabductor kracht met behulp van een draagbare dynamometer. 
De definitieve versie van de test was valide en test-hertest reproduceerbaar. De test bleek 
niet bruikbaar in een interbeoordelaarssetting ondanks goede betrouwbaarheidsschattingen, 
vanwege de vermoedelijke aanwezigheid van systematische bias en bias gerelateerd aan de 
grootte van de spierkracht. De reproduceerbaarheid van de definitieve versie van de test 
werd getest bij 44 deelnemers met een beenamputatie, terwijl de concurrente validiteit 
werd vastgesteld bij 30 gezonde deelnemers. In hoofdstuk 7 presenteerden we een 
driedimensionaal (3D; inertial measurement units) en een tweedimensionaal (2D; op video 
gebaseerd) systeem om coronale vlak kinematica tijdens het lopen te verkrijgen. We hebben 
de test-hertest reproduceerbaarheid van beide systemen getest en de interbeoordelaar 
reproduceerbaarheid van het 2-D-systeem bij deelnemers met een beenamputatie (groep 1; 
n = 25) en gezonde proefpersonen (groep 2; n = 41). De discriminante validiteit werd bepaald 
met een vergelijking binnen de groep voor het 3D-systeem en met een vergelijking tussen 
de groepen voor beide systemen. Beide systemen bleken test-hertest betrouwbaar te zijn, 
zowel in groep 1 als in groep 2. Het 2-D systeem was ook interbeoordelaar betrouwbaar. 
De vergelijking binnen de groep van het 3-D-systeem onthulde een statistisch significante 
asymmetrie van 0.4° - 0.5° in groep 1 en geen statistisch significante asymmetrie in groep 
2. De vergelijking tussen de groepen toonde aan dat de maximale amplitude in de lage 
rug naar de aangedane zijde (MARL; 3-D-systeem) en de stomp - romphoek (2-D-systeem) 
significant groter waren, met een gemiddeld verschil van respectievelijk 1.2° en 6.4°, dan de 
maximale amplitude van gezonde proefpersonen. Deze gemiddelde verschillen waren echter 
kleiner dan de kleinste detecteerbare verandering (SDC) van groep 1 voor zowel de MARL 
(SDC
agreement
: 1.5°) als de stomp - romphoek (SDC
agreement
: 6.7° - 7.6°). Daarom concludeerden we 
dat de 3-D- en 2-D-systemen die in dit onderzoek werden getest niet gevoelig genoeg waren 
om echte verschillen te detecteren binnen en tussen deelnemers met een beenamputatie en 
gezonde proefpersonen ondanks de veelbelovende reproduceerbaarheidsparameters voor 
sommige van de uitkomstmaten. Dit inzicht leidde tot uitsluiting van coronale vlak kinematica 
symmetrie als een uitkomstmaat in de 5-jaar follow-up studie.
In hoofdstuk 8, een voor-na cohortstudie, presenteren we de eerste voorlopige resultaten 
van de één jaar follow-up als onderdeel van onze 5-jaar follow-up longitudinale studie. De 
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doelstellingen waren: 1) het niveau van functie, activiteiten, HRQoL en tevredenheid te 
vergelijken bij personen met een amputatie van de onderste extremiteit vóór de operatie 
en zes en twaalf maanden na implantatie van een osseointegratie implantaat. 2) om de 
complicaties te rapporteren. We includeerden de 40 opeenvolgende personen (mediane 
leeftijd: 56 jaar) die tussen april 2014 en maart 2016 een transfemoraal (31) of transtibiaal (9) 
osseointegratie implantaat ontvingen. De belangrijkste uitkomstmaten waren: heupabductor 
kracht, prothesegebruik, frequentie van rugpijn, post-operatieve pijn, mobiliteitsniveau (TUG 
en rolstoelgebondenheid), loopvaardigheid (6MWT en loopafstand in het dagelijks leven), 
HRQoL, tevredenheid met betrekking tot de prothese en complicaties. We ontdekten dat 
de abductor kracht, het prothesegebruik, de loopafstand, de kwaliteit van leven en het 
tevredenheidsniveau na zes en twaalf maanden aanzienlijk toenamen ten opzichte van 
baseline (p≤0.002). De TUG en 6MWT toonden geen verandering na zes maanden follow-
up (p≥0.420), maar verbeterden significant na twaalf maanden follow-up in vergelijking met 
baseline (p≤0.038). De rolstoelgebondenheid daalde van 12/40 deelnemers bij baseline tot 
0 bij follow-ups. Rugpijn veranderde niet over de tijd (p≥0.437). Stomppijn was aanwezig in 
respectievelijk 28/39 en 22/40 van de deelnemers na zes en twaalf maanden follow-up. Al onze 
vooraf opgestelde hypotheses met betrekking tot de verbetering in functionele uitkomsten 
werden bevestigd met uitzondering van de verwachte afname van de frequentie van rugpijn, 
dit werd alleen gevonden in de subgroep van deelnemers die niet-rolstoelgebonden waren bij 
baseline. De grootste complicaties waren gemakkelijk te behandelen en omvatten drie kleine 
osseointegratie implantaatdefecten en vier botbreuken. Een beloop zonder complicaties 
was er voor 19/31 transfemorale en 4/9 transtibiale botverankerde prothesegebruikers. We 
concludeerden dat botverankerde protheses tot betere prestaties leiden en veilig lijken, dus 
ze kunnen worden overwogen voor personen met koker gerelateerde problemen.
In hoofdstuk 9 geven we een overzicht van onze belangrijkste bevindingen en inzichten 
in de methodologische tekortkomingen van onze studies (en die van het veld). Ten slotte 
bespreken we de implicaties van dit proefschrift voor de toekomstige klinische praktijk en 
onze aanbevelingen voor toekomstig onderzoek. Uitdagingen voor toekomstig onderzoek 
zijn: a) het gebruik van een studie design dat het bewijsniveau verhoogt; b) het verzamelen 
van unieke en multi-factoriële resultaten van grote cohorten; c) het openen van de 
black box in termen van inzicht in de impact op weefselniveau door het gebruik van een 
botverankerde prothesen, het selecteren van de ideale doelpopulatie voor osseointegratie 
implantaatchirurgie en de daaropvolgende revalidatie en het optimaliseren van de interventie 
(osseointegratie implantaatchirurgie en revalidatie).
De inhoud van dit proefschrift benadrukt het belang van onderzoek naar functionele 
uitkomsten op het gebied van osseointegratie implantaatchirurgie, maar ook de uitdagingen 
van het combineren van onderzoek en dagelijkse klinische praktijk. Ondanks de verschillende 
beperkingen zoals uiteengezet in dit proefschrift, kunnen we concluderen dat botverankerde 
prothesegebruik een positief effect heeft voor de meerderheid van de personen met 
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koker gerelateerde problemen, omdat de verhouding tussen gezondheidsvoordelen van 
de botverankerde prothese en de complicaties gunstig lijkt. Daarom zullen we doorgaan 
met de behandeling van patiënten met deze chirurgische techniek en het daaropvolgende 
gepersonaliseerde revalidatieprogramma dat we verder zullen optimaliseren voor onze 
toekomstige patiënten.
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Het dankwoord, misschien wel het belangrijkste hoofdstuk van dit proefschrift. Dankzij de 
ondersteuning van onderstaande mensen is dit proefschrift voorspoedig tot stand gekomen. 
Een hoofdstuk zonder auteurs handleiding met daarin allerlei eisen omtrent de layout en 
een woordenlimiet, geen peer review procedure, geen impact factor en geen scope van 
het tijdschrift waar je rekening mee dient te houden. Het dankwoord: appeltje-eitje zou je 
verwachten. Niets is minder waar, want vind maar eens de juiste woorden én voor je het weet 
vergeet je iemand. Bij deze voor alle mensen die hieronder niet expliciet genoemd worden 
maar wel een bijdrage hebben geleverd aan mijn proefschrift; oprecht dank je wel!
Prof. dr. M.W.G. Nijhuis-van der Sanden, beste Ria. Wat had je een vooruitziende blik bij mijn 
start aan de pre-master klinische gezondheidswetenschappen toen je zei: “Zullen we er een 
promotietraject van maken?” Mijn antwoord daarop was: “Doe maar niet, eerst maar eens 
kijken of ik de wereld van de wetenschap wel leuk vind.” Nu, ruim 2 jaar na de afronding van 
de master, bleek dat je het goed gezien had, zoals zo vaak tijdens mijn promotietraject. Dank 
je wel voor je tomeloze inzet, precisie, helikopter view, zorgzaamheid en diplomatie. Door jou 
heb ik kunnen groeien als wetenschapper en was mijn promotietraject plezierig ondanks de 
pieken en dalen.
Prof. dr. ir. N.J.J. Verdonschot, beste Nico. Een refereerbijeenkomst over het TLEMsafe-project 
was de start van onze samenwerking en heeft tot hoofdstuk 4 van dit proefschrift geleid. 
Daarna volgde nog meer projecten, waaronder de ValedoMotion studie (hoofdstuk 7), de 
congenitale heupdysplasie studie en de MyLeg studie. Jouw ambitie om diagnostische en 
evaluatiemethoden te ontwikkelen voor orthopedische patiënten sluit naadloos aan bij 
mijn ambitie om de (revalidatie)zorg van patiënten met een beenamputatie te verbeteren. 
Hiervoor is het nodig dat we inzicht krijgen in de black box én klinimetrie te ontwikkelen die 
bruikbaar is in de klinische praktijk. Met de MyLeg studie kunnen we hier de eerste stappen in 
zetten. Dank voor het in mij gestelde vertrouwen tijdens verschillende projecten, je openheid 
en eerlijkheid, je kennis en kunde en het inzetten van je netwerk om de projecten succesvol 
te voltooien.
Dr. T.J. Hoogeboom, beste Thomas. Als dagelijkse begeleider heb ik jou het meest bestookt 
met mailtjes en vragen. Bijzonder genoeg kreeg ik altijd binnen afzienbare tijd antwoord, 
zelfs in de nachtelijke uren. Het antwoord was altijd verhelderend en vaak ook voorzien van 
de nodige onzin zoals de verwijzingen naar ninja’s en songteksten: “Lekker nummertje!” Je 
bent onnavolgbaar als het gaat om het aanleveren van websites met inhoudelijke, handige, 
nutteloze en grappige informatie. Het doorhakken van de spreekwoordelijke knopen werd 
door jouw input een stuk gemakkelijker. Dank voor je relativerend vermogen, je kennis, je 
humor en het briljante modellenwerk (hoofdstuk 6, figuur 5).
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Dr. J.P.M. Frölke en Dr. H. van de Meent, beste Jan Paul en Henk. Zonder jullie lef was er 
geen botverankerde prothese in Nederland geweest. Deze topreferente zorg en de 
wetenschappelijke niche, op het vlak van de revalidatie en de functionele uitkomsten 
na osseointegratie implantaatchirurgie, waren belangrijke drijfveren voor mijn prille 
wetenschappelijke carrière. Ook al zijn we het inhoudelijk niet altijd eens, ik waardeer oprecht 
jullie inspanningen om osseointegratie nationaal en internationaal meer bekendheid te geven 
en de kwaliteit van de zorg te verbeteren. Bedankt voor de samenwerking, de introductie bij 
jullie internationale netwerk, het faciliteren van congresbezoeken en het goede gezelschap 
tijdens de congresbezoeken.
Promotie commissie. Dank voor jullie bijdrage aan de promotieplechtigheid. Tevens wil ik de 
leden van de manuscript commissie, prof. dr. M.M. Rovers, prof. dr. W.J.H.J. Meijerink en prof. 
dr. P.U. Dijkstra bedanken voor het beoordelen van mijn proefschrift.
Gerben, Shanna, Charlotte, Peter Paul en Yvette. Dank voor jullie collegialiteit, flexibiliteit en 
gezelligheid. Deze belangrijke eigenschappen van het Radboud Amputatie Team hebben mij 
enorm geholpen om wetenschap te combineren met de dagelijkse klinische zorg. Ik ben blij dat 
jullie mijn naaste collega’s waren en zijn. Hopelijk kunnen we deze bijzondere samenwerking 
nog vele jaren voortzetten. Gerben en Shanna bedankt dat jullie mij als paranimfen bij willen 
staan op deze bijzondere dag. Gerben bedankt voor je bijdrage aan mijn publicaties. Shanna 
bedankt voor het faciliteren van mijn onderzoeksuren afgelopen twee jaar, dat droeg bij aan 
een betere balans tussen werk- en privétijd.
Beste Tom, Annemarie, Tjarda, Esther en Anouk. Dank voor jullie inzet om de logistiek rondom 
het Radboud Amputatie Team in goede banen te leiden. Ik waardeer jullie betrokkenheid.
Annick, Ineke en Joke. Dank voor de flexibiliteit en creativiteit bij het plannen van mijn 
(promotie) overleggen met Ria en Nico. Het was regelmatig een hele uitdaging, maar door 
jullie inspanningen lukte het ieder keer weer.
Instrumentmakers van het Radboud Amputatie Team. Harry, Marco, Tom, Yvo, Marco, Gijs, 
Stefan, Cornelis en Paul, dank voor jullie geduld en alle uren brainstormen over materiaalkeuze 
en uitlijning. Jullie geven een extra dimensie aan het Radboud Amputatie Team en maken de 
dinsdag- en donderdagmiddag extra plezierig.
Patricia en Erwin. Zonder ergotherapie is het Radboud Amputatie Team niet compleet. Dank 
voor de samenwerking en de gezellige etentjes en congresbezoeken.
Collega’s van de afdeling Fysiotherapie Centraal, in het bijzonder unit 1. De afgelopen jaren 
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waren voor mij regelmatig een rollercoaster waarbij ik probeerde alle ballen in de lucht te 
houden. Het in de lucht houden van de 'klinische bal' was soms lastig. Dank voor jullie begrip 
en collegialiteit.
Carien, Frank, Niek, Roel, Joost en Mike. Dank voor gezelligheid in de onderzoekerskamer en 
voor de mogelijkheid om laagdrempelig te kunnen sparren en mijn hart te kunnen luchten. 
Niek, Roel en Amy bedankt voor het controleren van de proefdruk.
Joanne. Helaas heb je de voltooiing van mijn proefschrift niet meer mee mogen maken. 
Dank voor je oprechte interesse in mij, mijn gezin en mijn onderzoek. Tevens dank voor het 
corrigeren van de manuscripten van mijn eerste artikelen.
Frank. Dank voor het faciliteren van de (pre-)master klinische gezondheidswetenschappen. 
Deze opleiding bleek de basis voor dit promotietraject. Hopelijk blijft er op de afdeling 
fysiotherapie ook in de toekomst ruimte voor persoonlijke ontplooiing en vindt er structurelere 
inbedding plaats van onderzoeksactiviteiten.
Docenten klinische gezondheidswetenschappen, programma fysiotherapiewetenschap. Zoals 
ik al eens in een column voor Scientia Fundus schreef was deze opleiding een life-changing 
experience, welke mij gevormd heeft op zowel persoonlijk als professioneel vlak. Dank voor 
jullie bijdrage aan mijn ontwikkeling.
Fysiotherapie wetenschap, cohort 2013. Isolde, Herman, Robbert, Fred, Thijs, Lieke, Suze, 
Sanne, Paul, Rosalie, Marloes, Petra, Sanne en Thymen, het waren 3 intensieve jaren op De 
Uithof. Door jullie ging ik iedere vrijdag met plezier naar Utrecht. Dank voor de inhoudelijke 
én inhoudsloze gesprekken, de talloze borrels en de gezellige weekendjes weg. Hopelijk 
kunnen we de traditie van weekendjes weg nog vele jaren voortzetten.
Patiënten en proefpersonen, in het bijzonder de klikprothese expert patiënten en Willie. 
Dank voor jullie nauwe betrokkenheid bij het Radboud Amputatie Team, het onderzoek, het 
onderwijs en de symposia. Jullie houden ons scherp. Blijf mij en mijn collega’s prikkelen met 
jullie wensen en vragen want alleen hierdoor wordt onderzoek klinisch relevant. Jullie zijn 
leidend, hoewel soms ook lijdend (sorry hiervoor) en jullie persoonlijke successen tijdens en 
na de revalidatie geven mij veel inspiratie en energie om de zorg te blijven optimaliseren en 
persoonsgerichter te maken!
Coauteurs. Bart, Marco, Marieke, Femke, Lars, Thomas en Amy dank voor jullie waardevolle 
bijdrage aan de artikelen voor dit proefschrift.
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Léon en Sjoerd. Dank voor jullie bijdrage aan de spiervolume studie. Léon bedankt voor 
het monniken werk dat je verricht hebt met het segmenteren. Sjoerd, bedankt voor de 
kennisoverdracht vanuit het TLEMsafe project.
Luc. Dank voor de handige tips met betrekking tot het opmaken van mijn proefschrift.
Studenten van de HAN en de RU. Esther, Roy, Ben, Jens, Yorick, Jelle, Koen, Nick en Tim dank 
voor jullie bijdrage aan de dataverzameling van de klinimetrische studies. 
Vrienden. Dank voor jullie interesse in mijn promotietraject en voor alle ontspannen 
momenten. Het samen sporten heeft de afgelopen jaren noodgedwongen op een laag pitje 
gestaan. Daar gaat nu verandering in komen. Echt? Ja, nu echt!
Familie en schoonfamilie, in het bijzonder pap, mam, Huub en Liesbeth. Jullie bedank ik 
uiteraard ook voor de interesse in mijn promotietraject en voor alle ontspannen momenten. 
Fijn dat jullie klaarstonden ter ondersteuning bij het draaiende houden van ons gezin. Jullie 
flexibiliteit, extra oppasmomenten, haal- en brengservice, invalbeurten bij het zwemmen met 
de kinderen en de gezamenlijke maaltijden hebben ons de afgelopen jaren enorm ontlast. 
Mieke bedankt voor het meelezen en Valerie voor het ontwerpen van de omslag van mijn 
proefschrift.
Lieve Maud, Tijn en Giel. Dank voor onvoorwaardelijke liefde! Ook al was papa de afgelopen 
jaren veel aan het werk op zolder. Hopelijk herinneren jullie met name onze leuke en gezellige 
momenten. Met de afronding van dit 'boekje' komt er ook meer ruimte voor quality time. 
Daar kijk ik naar uit!
Lieve Anne. Woorden schieten te kort voor wat jij voor mij betekent. Je stond er de laatste 
jaren vaak alleen voor. Knap dat je nooit geklaagd hebt over mijn afwezigheid. Dat we ons in 
de 'tropenjaren' van ons leven bevonden door de geboortes van Maud, Tijn en Giel maakt dit 
gegeven extra bijzonder. Je bent een super moeder voor onze kinderen. Sorry voor alle korte 
en gebroken nachten doordat ik ’s avonds laat en ’s nachts zat te werken. Dank voor je begrip, 
onvoorwaardelijke liefde en steun. We zijn samen een goed team en ook voor ons komt nu 
meer ruimte voor quality time! Beloofd! Ik hou van je!
Dit dankwoord teruglezend overspoel ik de lezer met de woorden ‘dank’ en ‘bedankt’. 
Taalkundig wellicht minder fraai maar voor de mensen die het betreft welverdiend. 
Alleen ga je sneller, samen kom je verder!
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Ruud Leijendekkers was born on June 22, 1982 in ‘s 
Hertogenbosch, the Netherlands. He completed in 
2000 his secondary school at the 'Maaslandcollege' 
in Oss, and studied Physical Therapy at the HAN 
University of Applied Sciences in Nijmegen, at which 
he graduated in 2004 (BSc). 
After graduation, his professional career as a 
physiotherapist started at the Radboud university 
medical centre. Within the following years he worked 
at several clinical units, but his main focus was 
inpatient rehabilitation within the orthopedic and 
trauma surgery unit. Furthermore, he was involved in outpatient rehabilitation of patients 
with a lower extremity amputation, both with a conventional socket-suspended prosthesis 
and with a bone-anchored prosthesis. To increase his practical skills as a physiotherapist 
he followed several courses such as Physical therapy in patients with COPD and asthma, 
Orthopedic Medicine Cyriax, and Prosthesis training. Apart from clinical work he supervised 
numerous internships and graduation projects for both bachelor students of Physical Therapy 
and master students of Human Movement Science. Teaching activities in Physical Therapy, 
Nursing, Medicine, and Human Movement Science were also part of his job. In 2013 he 
started the (pre)master Clinical Health Sciences (programme Physiotherapy Science) at 
the Utrecht University in Utrecht, at which he graduated in 2016 (MSc). The rehabilitation 
of bone-anchored prosthesis users was a recurring topic in the master, resulting in three 
accepted research papers at graduation. Hereafter, a PhD-trajectory was formalised including 
a combination of research and physiotherapy tasks. 
After completing his PhD, Ruud will continue his work as a physiotherapist at the Radboudumc 
and will be involved in research projects to improve health care and health care outcomes 
for persons with a lower extremity amputation, in particular bone-anchored prosthesis users. 
From 2018, he participates in the MyLeg project to develop an intuitive prosthesis using 
implantable myoelectric sensors on reinnervated targeted muscles.
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Promotoren:
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Year(s) ECTS
TRAINING ACTIVITIES
A) Courses & Workshops
• Master Clinical Health Sciences, Program in Physical Therapy 
Science, University Utrecht, the Netherlands.
2014-2016 60.0
• Workshop prosthetics and orthotics, Otto Bock, Duderstadt, 
Germany.
2016 0.3
• PhD retreat, RIHS, ‘s Hertogenbosch, the Netherlands. 2017 1.0
• Radboud Research Round ‘Computer simulations of human 
motion in health, trauma and degenerative diseases’, 
Radboudumc.
2018 0.1
• Perfecting your academic writing skills, Radboudumc. 2018 1.0
• Workshop prosthetics, Össur, Eindhoven, the Netherlands. 2018 0.1
• Basiscursus Regelgeving en Organisatie voor Klinisch 
onderzoekers (BROK cursus), Radboudumc.
2018 1.5
B) Seminars & lectures
• Refereeravond Revalidatiegeneeskunde -  circuit Nijmegen, 
Arnhem, Den Bosch, Presentatie Spierregeneratie met 
osseointegratie, Nijmegen, the Netherlands.
2015 0.25
PHD PORTFOLIO
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 306
306
R
• Open dag Radboud Institute for Health science. 2017 0.25
C) Symposia & congresses
Oral presentation
• Stump Muscle development and MRI protocol. 
Osseointegration Symposium ASAMI-BR & ILLRS, Brisbane, 
Australia.
2015 0.75
• Three-dimensional magnetic resonance imaging 
reconstruction of hip abductor muscle volume in a patient 
with a transfemoral prosthesis: a feasibility study. ISPO World 
Congress, Cape Town, South Africa.
2017 1.5
• One-year follow-up outcomes following lower extremity 
press-fit bone-anchored prosthesis surgery: a before-after 
study. ISPO World Congress, Cape Town, South Africa.
2017 0.5
• Revalidatietraject en uitkomsten. Osseointegratie Symposium 
Radboudumc Health Academy, Nijmegen, the Netherlands.
2017 0.25
• De transfemorale klikprothese revalidant. Osseointegratie 
Symposium Radboudumc Health Academy, Nijmegen, the 
Netherlands.
2017 0.25
• One-year follow-up outcomes following lower extremity 
press-fit bone-anchored prosthesis surgery: a before-
after study. ISPO Nederland Annual Congress, Houten, the 
Netherlands.
2017 0.5
• Nabehandeling: beweeglijkheid en belastbaarheid. Heup en 
Knie Symposium Radboudumc Health Academy, Nijmegen, 
the Netherlands.
2017 0.5
• Rehabilitation and outcomes. Osseointegration conference 
LTO Ortopedia Albanito, Milan, Italy.
2018 0.5
• Prosthetic aspects; Osseointegration for transtibial amputees. 
OT World Congress, Leipzig, Germany.
2018 0.75
• Is de klikprothese voor alle patiënten met beenamputatie 
de toekomst? NVZF Anniversary Congress, Nijmegen, the 
Netherlands.
2018 0.5
• Stompzwachtelen bij een patiënt met een beenamputatie. 
Onomwonden over wonden Radboudumc Health Academy, 
Nijmegen, the Netherlands.
2018 0.25
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Poster presentation
• One-year follow-up outcomes following lower extremity 
press-fit bone-anchored prosthesis surgery: a before-after 
study. Dag van de fysiotherapie KNGF Annual Congress. 
Utrecht, the Netherlands.
2016 0.25
• Osseointegrated implants in patients with peripheral vascular 
disease: a case series of 4 patients. ISPO World Congress, 
Cape Town, South Africa.
2017 0.5
• Three-dimensional magnetic resonance imaging 
reconstruction of hip abductor muscle volume in a patient 
with a transfemoral prosthesis: a feasibility study. WCPT 
World Congress, Cape Town, South Africa.
2017 0.5
Visiting (without oral or poster presentation)
• ISPO World Congress, Lyon, France. 2015 1.0
• OT World Congress, Leipzig, Germany. 2016 0.75
• Wetenschapsdag WCF - KNGF. 2017-2018 0.5
Organising
• Osseointegratie Symposium Radboudumc Health Academy, 
Nijmegen, the Netherlands.
2017 2.0
D) Other
• Interview NPO AVROTROS, Zorg.nu. ‘Hoe werkt een 
klikprothese?’.
2017
TEACHING ACTIVITIES
E) Lecturing
• Radboudumc Health Academie, Vervolgopleiding 
Wondverpleegkunde, Stomp zwachtelen, Nijmegen, the 
Netherlands.
2014-2018 1.6
• Radboud university, Bachelor Medicine and  Human 
Movement Science, Moving questions ‘amputation’, 
Nijmegen, the Netherlands.
2015-2017 1.6
• Radboud university, Bachelor Medicine and  Human 
Movement Science, Evidence Based Practice, Nijmegen, the 
Netherlands.
2016 0.1
527030-L-bw-Leijendekkers
Processed on: 18-12-2018 PDF page: 308
308
R
• Medische vervolgopleiding (AIOS) Revalidatiegeneeskunde, 
Ganganalyse en loopscholing, Nijmegen, the Netherlands.
2017 0.1
F) Supervision of internships / other
• Supervision master thesis Human Movement Science, L. 
Didden, Radboud university, Nijmegen, the Netherlands.
2014-2015 1.0
• Supervision master thesis Human Movement Science, T. Blom, 
Radboud university, Nijmegen, the Netherlands.
2014-2015 1.0
• Supervision bachelor thesis Fysiotherapie, Y. Bexkens, J. 
Diebels, K. Gerritsen, N. Meijers, Hogeschool van Arnhem en 
Nijmegen, Nijmegen, the Netherlands.
2014-2015 1.0
• Supervision bachelor thesis Fysiotherapie, I. Hengst, L. 
Janssen, S. Preijers, Hogeschool van Arnhem en Nijmegen, 
Nijmegen, the Netherlands.
2016 1.0
• Supervision bachelor thesis Fysiotherapie, K. Morris and M. 
Onofri, European School of Physiotherapy, Amsterdam, the 
Netherlands.
2016-2017 1.0
• Supervision bachelor thesis Fysiotherapie, M. Albrecht, J. 
Koenen, J. Lamers, Hogeschool van Arnhem en Nijmegen, 
Nijmegen, the Netherlands.
2017-2018 1.0
• Internship ‘Meet your PhD’ for Biomedical Sciences Bachelor 
students, Radboud university, Nijmegen, the Netherlands. 2x
2018
ANCILLARY ACTIVITITES
G) Supervision of internships / other
• Disability and Rehabilitation. 2016 0.1
• Disability and Rehabilitation. 2017 0.1
• Disability and Rehabilitation. 2018 0.1
TOTAL  86.45
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